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Thesis Abstract 
 
This thesis has been undertaken as part of the academic requirements for a 
Professional Doctorate in Clinical Psychology. The research questions were 
derived from the author’s prior clinical experiences. Smoking is linked to 
depression, anxiety and mortality amongst people with Chronic Obstructive 
Pulmonary Disease (COPD); cessation is the most important step in 
managing the condition. Chapter 1 of this thesis describes a review of the 
scientific literature that has researched why people with COPD continue to 
smoke. Twenty papers were found following a systematic search of 
electronic databases. All papers were assessed for quality and none were 
excluded on quality grounds. A thematic analysis identified fifty-two reasons 
under seven related themes: conflicting relationships in smoking; conflicting 
ideas about the relationship between COPD and smoking; conflicting views 
on control in smoking; damaging ways of treating the self; pessimism about 
change; mitigating and optimistic approaches to smoking; conflicting 
advantages of not quitting. Contradictory beliefs were found within each 
theme. Chapter 2 describes an empirical study that used Q-Methodology to 
understand how these individual reasons relate to one another to form 
viewpoints. Twenty-two people with COPD who smoked completed Q-sorts; 
by-person factor analysis identified three latent factors: ‘Stoic Fatalism’ 
describes smoking as an enjoyable choice that is justified by there being no 
point in stopping because the damage is done. ‘Optimistic Passivity’ is 
characterised by it not being too late to stop, but guilt from continued 
smoking is resolved by strategies such as planning to stop in future. 
‘Ambivalent Masochism’ describes being a slave to cigarettes, desperate to 
quit, yet really enjoying smoking. Difficulties with nicotine withdrawal, and 
management of low mood and anxiety were also strongly cited as reasons 
for continuing to smoke in the first two viewpoints. The integration of 
psychotherapeutic and smoking cessation strategies is discussed. Chapter 3 
is an accessible summary for service users. 
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Chapter 1  
Literature Review 
 
Why do people with Chronic Obstructive Pulmonary 
Disease (COPD) continue to smoke? 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
     
  9 
 
Contents 
Figures and Tables ................................................................................................ 10 
Abstract ................................................................................................................. 11 
Inroduction ............................................................................................................. 12 
Chronic Obstructive Pulmonary Disease ............................................................ 12 
Neurobiology of Smoking ................................................................................... 12 
Socio-Cognitive Models of Health Behaviour ...................................................... 13 
Relationships between COPD, Smoking & Anxiety ............................................ 14 
Cognitive-Behavioural Model of Addiction .......................................................... 14 
Reviews of Interventions for Smoking Cessation ................................................ 14 
Rationale for Review .............................................................................................. 15 
Aims ...................................................................................................................... 15 
Method .................................................................................................................. 15 
Search Strategy ................................................................................................. 15 
Inclusion Criteria ................................................................................................ 16 
Exclusion Criteria ............................................................................................... 16 
Methods of Appraisal.......................................................................................... 17 
Methods of Synthesis ......................................................................................... 17 
Results .................................................................................................................. 18 
Summary of Quality ............................................................................................... 18 
Aims and Methodology ................................................................................... 19 
Research Design ............................................................................................ 19 
Recruitment .................................................................................................... 19 
Data Collection ............................................................................................... 20 
Relationship to Participants ............................................................................ 20 
Ethical Issues ................................................................................................. 21 
Data Analysis and Rigour ............................................................................... 21 
Results, Findings and Value ........................................................................... 22 
Funding and Conflicts of Interest .................................................................... 23 
Synthesis of Findings ............................................................................................. 23 
Theme 1: Conflicting relationships in smoking ................................................ 23 
Theme 2: Conflicting ideas about the relationship between COPD and smoking
 ....................................................................................................................... 25 
Theme 3: Conflicting views on control in smoking ........................................... 26 
Theme 4: Damaging ways of treating the self ................................................. 27 
Theme 5: Pessimism about change ................................................................ 28 
     
  10 
Theme 6: Mitigating and optimistic approaches to smoking ............................ 28 
Theme 7: Conflicting advantages of not quitting ............................................. 29 
Discussion ............................................................................................................. 32 
Utility of Findings and Implications ..................................................................... 32 
Validity, Reliability and Limitations...................................................................... 33 
Recommendations and Conclusion .................................................................... 34 
References ………………………………………………………………………………..35 
Appendix A – Figures of Existing Models ............................................................... 42 
Appendix B – Search Terms and Diagram ............................................................. 45 
Appendix C – Data Synthesis Principles ................................................................ 47 
Appendix D – Literature Search Results ................................................................ 49 
Appendix E – CASP Sub-Questions and Raw Scores ........................................... 59 
Appendix F – AXIS and CASP Scores ................................................................... 60 
Appendix G – Theme Quality and Coverage by Paper ........................................... 62 
Appendix H – Comparison of Findings to Existing Theories, TTQ and TPB ........... 63 
Appendix I – Contextual Reflections ...................................................................... 65 
Appendix J – Journal Submission Guidelines for Authors ...................................... 66 
 
 
Figures and Tables 
 
Figure 1 Themes, subthemes and example codes ................................................. 31 
Figure 2 Neurobiological addiction model adapted from Benowitz (2010). ............. 42 
Figure 3 Expanded TPB model (adapted from Peretti-Watel, Halfen & Grémy, 2007)
 .............................................................................................................................. 42 
Figure 4 Expanded HAPA model (adapted from Radtke, Scholz, Keller & Hornung, 
2012) ..................................................................................................................... 43 
Figure 5 CBT anxiety information processing procedure vs hypothetical reversed 
process for smoking in COPD ................................................................................ 44 
Figure 6 CBT model of addictions, Beck, Wright, Newman and Liese (1993) ......... 44 
Figure 7 Search Strategy and Results ................................................................... 46 
Table 1 Literature Search Results Overview .......................................................... 49 
Table 2 Details of the sub-questions within CASP Qualitative checklist. ................ 59 
Table 3 Axis Scores for Quantitative Papers .......................................................... 60 
Table 4 CASP Scores for Qualitative Papers ......................................................... 61 
Table 5 Quality, Theme and Subtheme Coverage by Paper .................................. 62 
 
  
     
  11 
Abstract 
 
Attempts to understand predictors of smoking cessation and to enhance strategies 
for those with Chronic Obstructive Pulmonary Disease (COPD) have yielded 
questions about the differences between people who smoke with and without 
COPD. Psychological intervention types for people who smoke with COPD appears 
homogenous in their efficacy, which may indicate a lack of clarity about the beliefs 
that perpetuate smoking; the aim of this review is to identify and describe the 
research evidence about the beliefs held by people with COPD who continue to 
smoke. A systematic literature search of AMED, BNI, CINAHL, Embase, HBE, 
HMIC, Medline, PsycINFO, PubMed, Web of Science Core Collection and EThOS 
was conducted to identify papers which contained results on why COPD suffers 
cannot, do not, or struggle to quit smoking. Twenty papers met the inclusion criteria 
and were quality-assessed using CASP and AXIS tools: five papers were judged 
excellent quality, twelve good and three moderate. None were excluded on grounds 
of quality. A thematic analysis yielded seven related themes: conflicting 
relationships in smoking; conflicting ideas about the relationship between COPD 
and smoking; conflicting views on control in smoking; damaging ways of treating the 
self; pessimism about change; mitigating and optimistic approaches to smoking; 
conflicting advantages of not quitting. Most themes contained contradictory 
viewpoints which cast doubt on the utility of existing models which rely on simple 
taxonomic classification of attitudes. Further research is needed to identify how 
these contradictory viewpoints correlate, and if there are relationships between 
these viewpoints, emotional states, and motivation to quit. 
Keywords 
COPD, Smoking, Cessation, Cognitions, Beliefs, Reasons 
Funding Details 
This review was carried out as part of the requirements for a Professional Doctorate 
in Clinical Psychology, no funding or grants were received. 
Disclosure of Interest 
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Introduction 
 
Chronic Obstructive Pulmonary Disease 
Chronic Obstructive Pulmonary Disease (COPD) is an umbrella term for 
Chronic Bronchitis (damaged bronchi) and/or Emphysema (damaged alveoli), 
caused mainly by smoking tobacco products (1).  COPD is a progressive disease, 
and whilst often lengthy in trajectory, it is ultimately a fatal condition (2). 
Exacerbations of COPD, where symptoms of COPD are worsened rapidly, occur 
frequently and are often triggered by infections in the lungs, air pollution and 
allergies (3); repeated exacerbations damage lungs further. Lung damage causes 
difficulty exhaling, and feelings of breathlessness often lead sufferers to decrease 
their physical activity. Mobility is then further reduced through increased muscle 
weakness/inefficiency and decreased lung function. Quality of life is reduced, with 
anxiety, depression and panic attacks being highly prevalent compared to the non-
COPD population (4). There is no cure for COPD, but there are numerous 
treatments which include specific exercise programmes, medicines and inhalers; 
however, smoking being the primary cause of most COPD indicates cessation as 
the single most important, and effective, treatment for reducing the rate of 
progression of the disease (1). Prevalence of continued smoking among COPD 
sufferers is high at between 30% to 43% (5). 
Neurobiology of Smoking 
A large body of evidence indicates that the stimulant found in tobacco products, 
nicotine, is highly addictive. Nicotine acts upon nicotinic receptors in the 
acetylcholine system which leads to the release of dopamine. It also augments the 
release of glutamate and GABA, which over time further increase excitation of 
dopaminergic neurons in response to nicotine. Various other biochemical changes 
in the brain also occur with exposure to nicotine, and result in desensitisation to it 
(6) (See Appendix A Figure 2). The commonly believed concept of increased 
metabolism is more controversial, with some large-scale studies showing no 
difference in basal metabolic rate between smokers and non-smokers (7). 
Withdrawing from nicotine leads to side-effects such as cravings for smoking, 
irritability, sleep changes, and often an increased intake of food; hence cycles of 
repetitive usage of tobacco products commonly occur in those who smoke (3). 
Addiction models link physiological and behavioural theories but exclude cognition 
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and beliefs; they do not satisfactorily explain why people make decisions to initiate 
smoking, continue, or fail to quit smoking when ill.  
 
Socio-Cognitive Models of Health Behaviour  
The Theory of Planned Behaviour (TPB) and the Health Action Process 
Approach (HAPA) are two of the most common models used to explain health-
related behaviour and behavioural change (3). TPB has been applied to smoking 
cessation with positive behavioural control beliefs being the best predictors of 
intentions to quit smoking. However, a non-TPB construct of belief in susceptibility 
to negative health effects was found to be superior to other components of the 
model (8). The TPB model (see Appendix A Figure 3) has been expanded to include 
denial (self-exempting) beliefs, such as believing one smokes too few cigarettes to 
have any impact on health; these are also used to justify continued smoking (9).   
In contrast, the HAPA model (see Appendix A Figure 4) incorporates concepts of 
outcome expectancies and self-efficacy in decision making. Williams, Herzog and 
Simmons (2011) studied risk perceptions using the HAPA model, finding those who 
did not intend to quit smoking also perceived lower health risks (10).  Radtke, 
Scholz, Keller and Hornung (2012) found compensatory health beliefs (e.g. I do not 
need to quit because I exercise) are more negatively correlated with intentions to 
quit smoking than other HAPA constructs (11).  
Conceptually, models such as TPB and HAPA are used to understand predictors of 
health-related behaviours, and as such they are utilised to measure attitudes 
associated with behavioural change, rather than what maintains problematic or 
unhealthy behaviour. However, it could be inferred from the above models that 
compensatory beliefs, low-risk susceptibility, self-exemption and low behavioural 
control predict continued smoking. There are limitations of utilising behavioural 
change models with smoking; it is an addictive (rather than purely volitional) 
process, thus the models exclude the established neurobiological components. 
Stress reduction and weight control have also been cited as reasons for smoking, 
which are absent from models (3). No one model incorporates all categories of 
belief. Without knowing which beliefs are held by COPD sufferers who continue 
smoking it is difficult to comment on the utility of any of these health behaviour 
models. 
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Relationships between COPD, Smoking & Anxiety 
COPD sufferers who smoke experience higher levels of anxiety and 
depression compared to ex-smokers (12,13). Interactions have been shown 
between smoking, anxiety, depression and mortality suggesting that psychological 
difficulties are related to smoking and COPD progression (14).  Anxiety disorders, 
from a Cognitive-Behavioural perspective, arise due to neutral information being 
processed as threatening, which in turn leads to distress e.g. that a lack of phone 
call is interpreted as something terrible having happened to a person (15). 
Paradoxically, smokers with COPD appear to undertake the opposite process 
(simultaneously) with threatening information about smoking being neutralised (see 
Appendix A Figure 5). 
 
Cognitive-Behavioural Model of Addiction  
 The theories of Cognitive Behavioural Therapy (CBT) have been applied to 
excessive alcohol consumption and drug taking to model addiction processes, 
adding a concept of facilitation beliefs (that are not stratified into categories as in the 
TPB and HAPA) which provide permission to take the substance (16)  (Appendix A 
Figure 6). The model differs in that it is a cyclical maintenance model, compared to 
TPB and HAPA which are mostly linear behavioural change models. Whilst tobacco 
smoking has been neglected within applications of this model, it may offer a 
framework by which to understand the hypothesised parallel, yet opposite, 
information-processing procedures of anxious COPD-suffering smokers, whilst still 
incorporating the physiological components of addiction. Application of this model 
does prompt the question, what are the facilitation beliefs of smokers with COPD?  
 
Reviews of Interventions for Smoking Cessation 
 A Cochrane review of Motivational Interviewing (MI) for smoking cessation 
found it has a limited, but higher success rate than brief advice or no treatment for 
healthy smokers (17). Evidence for MI for smoking in COPD is limited to one study 
stating it is ineffective at evoking reasons for change, and inhibited by deviation 
from MI protocols (18). The Cochrane review for smoking interventions with COPD 
concluded that using a combination of pharmacotherapy and high intensity 
behavioural support appears more effective than high intensity behavioural support 
alone; however the reviewers were not able to find any evidence of difference 
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between the effectiveness of different types of behavioural interventions (BI) or 
pharmacological approaches (19). A relative lack of understanding of the 
differences in need for smoking cessation interventions of healthy smoking versus 
COPD sufferers is also highlighted. 
 
Rationale for Review 
 
Van Eerd, van der Meer, van Schayck and Kotz (2016) found no evidence 
amongst the reviewed articles for differences in effectiveness of BI. They describe 
the effect of BI on cessation as having a small but significant effect. However, to 
improve interventions there is a need to understand what maintains smoking in 
those with COPD to inform exactly what is undertaken in terms of psychological 
intervention. The reported homogeneity of BI effectiveness may be due to 
equivalence, but it could be equally due to a lack of precision in the interventions 
(i.e. what exactly are they targeting?). There remains a lack of broad understanding 
of the psychological processes involved in people with COPD unable, or unwilling, 
to stop smoking. The lack of evidence to support MI for smoking cessation implores 
an understanding of the beliefs that individuals hold to perpetuate their smoking. 
Aims  
There remains no adequate psychological model to satisfactorily explain the 
maintenance of highly-damaging smoking in those with COPD; furthermore, there is 
no published systematic review of the studies that have attempted to understand 
why COPD sufferers continue to smoke. This review will interrogate the evidence 
base to create a broad understanding of the reasons people with COPD continue to 
smoke. This will provide a broad knowledge base from which to undertake further 
research. 
 
 
Method 
Search Strategy 
A systematic strategy was undertaken to search for, and identify, academic 
papers that are related to the research question of ‘why do people with COPD 
continue to smoke?’.  Electronic database searches were undertaken until June 
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2017 using combinations of the terms with wildcards (allowing for different endings 
of words): Attitudes, Belief, Reasons, Motivation, Why, Experiences, Smoking, 
Quitting, Cessation, Give Up, Continuing, COPD, Chronic Obstructive, Emphysema 
and Bronchitis. Appendix B shows search strings with a diagram of the process 
(Figure 7).  
The following databases were searched: AMED, BNI, CINAHL, Embase, HBE, 
HMIC, Medline, PsycINFO, PubMed. Web of Science Core Collection was also 
searched. No date, geographic, or language restrictions were placed on the search 
to maximise results. To counteract publication bias the British Library’s Electronic 
Theses Online Services (EThOS) was also searched for ‘grey literature’, in the form 
of unpublished studies and doctoral dissertations. Hand searches for additional 
articles identified in reference lists and citations was undertaken using the 
Staffordshire University eJournals service. All results were extracted, cleansed 
(universally formatted for comparison), and sorted using Microsoft Excel for 
screening. 
One article required contact with the study’s lead author to clarify whether the 
inclusion criteria were met, the article was subsequently excluded.  
Inclusion Criteria  
 The paper contains or identifies reasons or viewpoints from COPD sufferers, 
directly or indirectly, about why they continue to smoke.  
 The paper is a research study or systematic literature review 
 The study is about COPD, or if about more than one condition then the main 
health problem is COPD, the results about continuing to smoke in the COPD 
group are clearly distinguishable from the non-COPD groups. 
 The study seeks to identify psychological/qualitative reasons why people 
continue to smoke, or contains at least a partial study of these reasons. 
Exclusion Criteria 
 Not containing data on COPD and barriers to quitting smoking.  
 Letters, conference papers, opinion, non-systematic reviews or commentary 
articles 
 COPD as a cohort of a larger study is not distinguishable from the other 
groups in terms of results around not being able to stop smoking. 
 Studies that test or evaluate an intervention (be that psychological or 
pharmacological) to quit smoking  
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 Studies that seek to find out how people change their behaviour/predictors 
(e.g. studies that only report physiological and pharmacological predictors), 
unless there is clear evidence of review of psychological/qualitative 
predictors of continuing to smoke with COPD 
 Studies that examine people’s experiences of actually quitting smoking, 
unless there is clear accounting of barriers to quitting smoking with COPD. 
Methods of Appraisal 
Qualitative research papers selected for review were appraised using the 
Critical Appraisal Skills Programme (CASP) Qualitative Checklist (20). The 
questions from the CASP (plus a supplementary question about potential conflict of 
interest/funding sources to ensure parity with the AXIS tool) were entered into a 
spreadsheet and for each study the respective questions were graded for quality: 
Excellent (0.9+), Good (0.7-0.89), Moderate (0.5-0.69), Poor (0.3-0.49) and Very 
Poor (<0.3) (see Table 2). These grades were calculated by answering all sub-
questions (see Appendix C) with points based categorical responses, each with a 
numeric value: Yes (3 points), Partially (2 points), Cannot Tell - but could be implied 
(1 point), No (0 points), Not Relevant (0 points and reduce scoring denominator by 3 
points). The sub-questions were totalled (where applicable) for each question and 
then divided by the maximum possible (minus any not applicable) to convert to a 
score (0-1) for each question. These question ratings were averaged to give a total 
rating for the paper and percentage for the paper. Weightings were considered but 
deemed unnecessary as virtually all questions on the CASP could highlight areas of 
bias. Quantitative research papers selected for review were all cross-sectional 
studies utilising questionnaires. The AXIS Cross-Sectional Study Review Tool (21) 
was selected for the purposes of this review. Numerical scores were assigned in the 
same way as to the CASP, but due to the simpler layout (i.e. no sub-questions) 
each question was scored 0-3 and an overall % quality given (see Table 3). To 
ensure rigour, inter-rater reliability was checked with a senior Clinical Psychologist 
and established at 0.85. 
Methods of Synthesis 
Data was extracted from the papers and followed principles from Noyes and 
Lewin (2011) and Sandelowski and Barroso (2002) (22,23). Deductive thematic 
analysis (24) was utilised to identify themes in the data (see Appendix C for full 
details). 
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Results 
 
The search screened eight-hundred and ninety papers, and yielded twenty 
that met the inclusion criteria for this review (see Appendix C). Seventeen (85%) 
papers used qualitative methodology, and three quantitative. Nine papers 
researched attitudes and reasoning for not quitting smoking with COPD (Bjarnason, 
Mikkelsen, & Tønnesen, 2010; Eklund, Nilsson, Hedman, & Lindberg, 2012; 
Halding, Heggdal, & Wahl, 2011; Hansen, Walters, & Wood Baker, 2007; Lundh, 
Hylander, & Törnkvist, 2012; Poureslami, Shum, & FitzGerald, 2015; Schofield, Kerr 
& Tolson, 2007; van Eerd, Risør, van Rossem, van Schayck, & Kotz, 2015; Wilson, 
Elborn, & Fitzsimons, 2011) (25–33). Three papers examined experiences and 
relationships to smoking (Gullick & Stainton, 2006; Jonsdottir & Jonsdottir, 2007; 
Nykvist, Larsson, & Dahlborg Lyckhage, 2014) (34–36). Five papers examined the 
smoking cessation experiences of people with COPD (Burrows & Carlisle, 2010; 
Lefcoe, Pederson, & Blennerhassett, 1988; Vuong, Hermiz, Razee, Richmond, & 
Zwar, 2016; Hilberink, Jacobs, Schlosser, Grol, & Vries, 2006; Lundh, 
Alinaghizadeh, Törnkvist, Gilljam, & Galanti, 2016) (37–41). Finally, three papers 
researched broader experiences of COPD and treatment but included viewpoints on 
smoking (Jones, Hyland, Hanney, & Erwin, 2004; Lindqvist & Hallberg, 2010; 
Robinson, 2005) (42–44). The results of the papers, with a synopsis of their noted 
strengths and weaknesses, are given in Appendix D. Detailed systematic analysis of 
quality can be found within the Summary of Quality . 
Summary of Quality  
 
Overall quality was rated 81.60% (±10.4%) for qualitative studies and 83.3% 
(±2.9%) for quantitative studies, none of the papers were of such low quality to 
exclude them from data synthesis. Five papers were assessed to be of excellent 
overall quality with an overall score of 90%+ (26,27,32,37,39). Twelve were rated as 
having a good overall quality scoring of between 70% and 89.9% (25,28–
31,33,35,36,40–43). The remaining three papers (34,38,44) were of moderate 
quality (50-69.9%). Specific scorings of papers can be seen in Tables 3 and 4 
(Appendix F); quantitative studies and the relevant questions are discussed under 
the headings derived from the CASP. Average section qualities are given for the 
qualitative studies due to their dominance in this review.  
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Aims and Methodology 
All studies reviewed had clearly stated aims. Qualitative or quantitative 
methodology were respectively deemed appropriate for such aims. Scores were 
universally excellent for these sections of the appraisal. 
Research Design 
Research designs were considered fully appropriate to all but three of the 
qualitative studies reviewed, with an average score of 90%. Lefcoe, Pederson, & 
Blennerhassett, (1988) offered no explanation as to how the method of collection of 
data was decided or the considerations taken in this process. Poureslami, Shum, 
and FitzGerald (2015) attempted to present in depth information on how the design 
was decided and involved COPD sufferers in the design of the project; however, the 
paper is very unclear as to exactly how a prior questionnaire, generated from a 
literature review, and on which the interview process was based, related to their 
qualitative study. References to coding answers to qualitative questions as 
correct/incorrect during a pilot were particularly opaque in their understandability. 
The study design of  Robinson (2005), whilst appearing appropriate, did not 
explicitly justify the choice of unstructured interviews or the approach to data 
analysis. The research designs of the three quantitative papers were judged 
appropriate. 
Recruitment 
Recruitment aspects of the qualitative studies were of good quality, with an 
average score of 82% on CASP criteria. However, the sub-question regarding 
discussions around recruitment had the lowest mean sub-question score on the 
CASP across all qualitative papers. Sixteen qualitative papers used a purposive or 
convenience sample; Robinson (2005) used a random sampling method (although 
did not detail how) to select 10 from 54 purposively selected participants. 
Recruitment was graded as good or excellent for ten of the qualitative papers. The 
remaining seven papers (28–30,34,35,42,43) were graded as moderate due to a 
lack of detail around the recruitment process which increases potential for sampling 
bias. All papers contained as a minimum a brief description of their sampling 
procedures, but typical omissions included not reporting invitation/response rates, 
not reporting reasons for declining to take part where these number have been 
recorded, not being clear on inclusion criteria or why specific criteria were used. 
This lack of reporting increases risk of selection bias. Of the quantitative papers, 
Hilberink, Jacobs, Schlosser, Grol and Vries (2006) and Lundh, Alinaghizadeh, 
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Törnkvist, Gilljam, and Galanti (2016) showed robust recruitment strategies, but the 
former were legally prohibited from following up non-responders, and the latter did 
not justify their sample size, which was less than one sixth the size of the former 
study. The study by Bjarnason, Mikkelsen and Tønnesen (2010) was less robust as 
refusal rates were not reported, and it remains unclear why a group of never-
smoked COPD sufferers were included in the similarly small and unclearly justified, 
sample. 
Data Collection 
Data collection was rated an average score of 80% for the qualitative 
studies. Thirteen of the seventeen qualitative studies were graded as good or 
excellent, with those rated as good addressing most issues excepting saturation of 
data (joint second lowest scoring CASP sub-question on average). Three papers 
(29,34,43) were rated as moderate and lacked details about their interview 
methods, as well as not discussing saturation of their data: Gullick and Stainton 
(2006) additionally did not discuss the settings for the intreviews sufficiently, 
Poureslami et al. (2015) account of the development of their interview schedule was 
unclear, and Robinson (2005) lacked detail on their justification of methods.  Lefcoe 
et al. (1988) was rated as very poor due to general omissions in describing how 
data were collected other than stating via interviews. Of the quantitative studies, 
basic data were adequately described in all three but the use of non-standard 
scales was of concern: Hilberink et al. (2006) utilised an arbitrary un-validated 
measure of smoking cessation intention to categorise participants’ contemplation 
levels; although other measures were validated, attitude scales were non-
standardised but had good internal consistency (Cronbach’s alpha >0.7). Lundh et 
al. (2016), whilst similarly using standardised measures for most aspects of the 
study, also used a non-standardised arbitrary single time point measure for intention 
to quit, converted into simple binary grouping. Bjarnason et al. (2010) utilised a 
similar approach, but with non-standardised questionnaires for cessation motivation 
as well as attitudes and emotions towards COPD and smoking; the latter described 
as “qualitative data” despite being a forced choice questionnaire. 
Relationship to Participants 
Four studies were rated as moderate quality in this domain. It was difficult to 
ascertain if location or recruitment had been considered at all by Nykvist et al. 
(2014) and whether this, and the formation of the questions, had been fully 
considered by Poureslami et al. (2015). Schofield and Tolson (2007) conducted a 
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secondary analysis so it was impossible to consider these factors fully. Jonsdottir 
and Jonsdottir (2007) utilised a clinician involved with their participants’ care 
(instead of a researcher) to inform and recruit which may have placed expectations 
on the recruits. Gullick and Stainton (2006) were rated poor on this question due to 
difficulties ascertaining if there was any consideration of bias in their questions or 
recruitment, although some reflection on this is implied through the type of 
methodology. Jones et al. (2004) were rated very poor as there was no evidence of 
these considerations. The remaining eleven studies demonstrated some degree of 
consideration to the relationship to their participants, gaining a good or excellent 
rating. However, despite consideration of most factors, it was not clear if Halding et 
al. (2011) also obtained participants in the same manner as Jonsdottir and 
Jonsdottir (2007). The mean quality for this section of the qualitative papers was 
75%. Whilst relationships to participants is less of a concern with questionnaire 
based quantitative studies, nothing about the three studies was considered of 
concern in terms of non-response bias, but it was not clear if the recruiting nurses 
were also treating the patients in Lundh et al. (2016). 
Ethical Issues 
Consideration of ethical issues had a mean quality standard score of 71% 
for the qualitative papers. Ten of the qualitative papers were rated as good or 
excellent in terms of their consideration and handling of the ethical issues. Better 
ratings were given to those which gave very clear and detailed accounts of the 
implementation of the principles, as well as receiving approval from an external 
body. Two studies were rated as moderate, one of which achieved ethical approval 
and considered some aspects, but also interviewed family members with no 
intention of using the data in the study which was ethically questionable (29). Van 
Eerd et al. (2015) contained very little evidence of ethical considerations other than 
approval. Four studies were rated as very poor for not discussing ethical 
considerations or approval at all in their respective papers (33,34,38,44). All three 
quantitative studies received ethical approval and discussed informed consent. 
Data Analysis and Rigour 
Data analysis was rated as good or excellent for fourteen of the qualitative 
papers, with excellent grades generally being assigned to those which provided an 
in-depth discussion of their analysis process with evidence of critical examination of 
their roles for bias. Moderate grades were assigned to three papers (30,38,44) for 
partial (or lack of) consideration of contradictory data despite its apparent presence, 
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lack of clarity as to how themes were derived, and in all three cases a lack of 
reflection on the effects of own bias in selection and analysis of the presented data. 
The mean quality of the seventeen papers was 86%. Of the quantitative studies, the 
lack of control of confounding variables in Lundh et al. (2016) introduced weakness 
into the process, and the a priori adjustments were unclear. Also, follow up status 
was verbal self-report so accuracy of smoking status cannot be assured. Data 
analysis appeared relatively robust in Hilberink et al. (2006) but the details of 
specific tests were a little sparse. Bjarnason et al.’s (2010) analysis and rigour were 
generally well described, but treated their smoking attitude data as qualitative, thus 
avoiding factor or regression analysis with quitting motivation, which appeared a 
strange omission as they later speculate on the relationships in their findings. 
Results, Findings and Value 
Qualitative papers averaged 92% quality for findings and 80% for value. All 
qualitative papers were graded as good or excellent quality in terms of statements 
of findings. However, four of the five papers rated as good (30,34,38,44) were 
vague about, or lacked, validation of their data through triangulation or participant 
validation. A few papers had errors in their reporting of data but these were minor 
(e.g. putting data in the wrong section of a table (29) or labelling the wrong quote for 
an interpretation (30)). Thirteen of the qualitative studies were of good or excellent 
quality in terms of their value. Two were considered moderate because of difficulties 
ascertaining their consideration of transferability of findings and identification of 
further research goals (34,38). Another was less clear again and rated poor (36). 
One was rated very poor for additionally lacking any discussion about contribution to 
policy and practice (42). Of the quantitative papers, Lundh et al. (2016) had limited 
statistically significant findings, so results were not particularly supportive of the 
utility of the novel questionnaire to predict smoking cessation in COPD patients. 
However, its limited utility could be due to poor categorisation of intentions to quit, 
and lack of control over interventions the patients were offered during the study 
period etc. Bjarnason et al. (2010) showed clear results, but lacked reference to 
smoking status in follow up of survival; their creation of a motivation measuring tool 
was not tested for any predictive power. No attitudes were included in any 
calculations. Results from Hilberink et al. (2006) were clear but missing the markers 
for p values. Meaningful suggestions were made from the data; however, inferences 
were limited by the arbitrary classification of contemplation levels, but a much larger 
sample size improved the credibility of the findings. 
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Funding and Conflicts of Interest 
Declaration of funding and potential conflicts of interest (COI), which may 
bias findings, was judged the weakest area for the qualitative papers examined. 
With a mean score of 45%, they rated overall as poor quality. Only four papers were 
rated excellent giving full clear accounts with no conflicts of interest (26,29,32,39), 
with a fifth, (37), declaring grants from pharmaceuticals companies to support the 
programme from which participants were drawn, but stating no involvement with the 
paper, and the decision was to rate them as having a moderate influence. 
Conversely three papers were rated as very poor for not declaring any information 
about funding or COI (28,42,43). The nine remaining studies were rated as poor due 
to not making any statements about COI, but providing acknowledgement of 
funding. Of the quantitative studies, two were poorer quality and at risk of bias due 
to one author receiving grants and consulting fees (25)  from pharmaceutical 
companies that develop cessation products and another not declaring any COIs but 
declaring funding from such companies (40). 
Synthesis of Findings  
 
Fifty-two category codes were recorded two-hundred and thirty-seven times 
across the twenty papers and grouped into sixteen sub-themes, which in turn were 
placed into seven themes. Due to repeated citing of studies, the numeric code is 
used to identify papers. Theme and sub-theme source reliability were calculated as 
an average based upon the reliability of the contributing papers. All themes and 
sub-themes were calculated to be of good quality, excepting 6.2 which was rated as 
excellent see Appendix G. An overview of themes and subthemes is shown in 
Figure 1. 
Theme 1: Conflicting relationships in smoking 
This theme spanned 19 papers and accounted for 17.64% of the coded 
data. The theme has a quality rating of 82.1% based upon the mean of the qualities 
of papers containing the coded data. It covered contradictory positions people took 
in relation to others about their smoking and COPD. Most commonly reported were 
feelings of being blamed by health professionals and the social function served by 
smoking. The phenomenon is grouped into two sub-themes, with one about shifting 
responsibility (in varying and contradictory ways) to other people for being unable to 
stop. The other has less of sense of blame associated and is more about social 
identity as a smoker.  
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1.1 Blaming Others 
This subtheme contained the most coded data (12.61%); seventeen papers (26–
28,30,32–38,40–42,44) demonstrated results that would place some, or all, of the 
responsibility for continuing to smoke onto others, either directly or indirectly. Of 
those papers, twelve (26–28,30–33,35–38,44) reported some form of indignation 
with health professionals (mostly doctors) as a barrier to smoking cessation, 
perceived as a lack of empathy or being blamed for their disease. For example, 
feeling told what to do (37), experiences of contempt “well what did you expect [from 
smoking]?” (27), feeling criticised and like “a villain” by doctors (28). The experience 
of nagging by professionals was also viewed as negative by some participants who 
were aware of the dangers but that it had no effect on them (26,36). Conversely, six 
papers (26,30,34,37–39) also reported a desire to be (or the effectiveness of being) 
told directly. For example, wanting a “slap in the face… you will die” statement 
about their smoking (26), being told “if you keep on smoking, don’t bother coming 
back to see me” (37), as well as being told how little lung function they had left 
being said at the right time (34) were reported in a positive way. A seventh paper 
could not to be coded for this sub-theme (43), despite evidence that participants 
wanted health professionals to be honest with them, it could not be discerned if this 
was about smoking. Six papers (27,28,32,34,41,42) also reported people felt 
unsupported to quit smoking in terms of help available. Participants reported not (or 
deny) being given any information about quit programmes or strategies (32,34), or 
feeling used by public media campaigns about illness to deter other smokers (27), 
that they are treated unfairly compared to drug-addicts and alcoholics who get 
access to rehabilitation (42), and that loved ones are unsupportive (28). Six papers 
(26,28,32–34,40) also reported laying some of the blame for their smoking 
and/disease on a lack of support by others (not medical professionals). Poignant 
examples included identifying their partner restarting smoking as the problem (34), 
or insisting they should stop simultaneously (28), or making plans as a family group 
to quit and letting them slip (26). These views all appeared to absolve the self of 
responsibility in facing up to quitting. 
1.2 Smoking as Relating 
 
Eight papers (29,32,36,38–40,42,43) contained relational aspects of smoking that 
were less conflictual with others. Baring one paper (43), results identified peer 
reinforcement and the social aspect of smoking as an important part in its 
maintenance within sufferers of COPD. Three papers (39,42,43) contained results 
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which attested to smoking being part of the sufferers’ identity, with one participant 
describing smoking as “the only normal thing left” about them since being diagnosed 
and treated for COPD. Two papers (32,36) contained descriptions where smokers 
expressed, or projected, their concern onto others, almost dissociating their needs 
and self-responsibilities, worrying how their smoking influences those around them. 
 
Theme 2: Conflicting ideas about the relationship between COPD and 
smoking  
This theme captured results which represent differing, sometimes 
contradictory, viewpoints on the relationship between smoking tobacco products 
and illness. Some papers, but not all, reported results that would indicate people 
both down-played the link between smoking and COPD, as well as stating that 
another factor or source could be responsible. Others contained results showing 
sufferers accept the relationship between their COPD and smoking. This theme 
spanned 16 papers and with an average quality of 80.8%, it contained the most 
coded data at 19.75%. 
2.1 Down-Playing Links 
 
Sixteen papers presented results that appeared to downplay the links between 
smoking and their COPD. Examples of this included sufferers stating they did not 
know the link between COPD and smoking (25,29,31,43), or denying there is a link 
at all (25,27,29,31,34,35,37,42,44). Sufferers also knew the links theoretically but 
did not feel threatened by them as evidenced by statements about knowing the 
benefits of cessation (26,29,33,34,36,38,43,44). One paper reported a participant 
describing smoking as “just an irritant” (30). 
2.2 Outsourcing Causes 
 
Ten papers presented results which evidenced COPD sufferers locate the cause of 
their disease either partially, or fully, in factors outside of smoking and/or their 
responsibility  (25,27,30,31,33–35,37,42,44). Most frequent was assigning the 
cause to industrial dust or paint fumes, or even to another illness such as asthma 
(27,30,31,33–35,37,44). In some of these papers participants’ COPD was 
normalised as a part of aging, or just bad luck, based on not all smokers developing 
COPD (30,33,34,42). In slightly tangential way, others absolved themselves by 
stating no-one knew the links when they started and that it was not fair or their fault 
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they had developed COPD (25,30,37,44). One paper contained accounts of COPD 
being described as an inherited condition (33). 
2.3 Acceptance of the Relationship 
 
Acceptance of the relationship between smoking and COPD by sufferers who 
continued to smoke was evident in seven papers (26,30–34,42). This included 
statements about not wanting sympathy, and COPD being the price they are paying 
for their smoking (33,34). 
 
Theme 3: Conflicting views on control in smoking 
Papers reported, in varied ways, results that appeared to encapsulate how 
people saw their relationship with smoking in terms of the control they had over the 
habit. These were categorised as opposing sub-themes in that some referred to 
smoking as a choice (and in some cases a defiance) whereas other accounts 
referred to addiction, habit and alluded to a range of difficulties in stopping, 
suggesting that smoking may be beyond choice and out of their control. Some 
papers included both, so sub-themes were not mutually exclusive. Quality was 
calculated to be 82.0% and the theme encompassed 19.33% of the coded data. 
3.1 My Choice 
 
Results that evidenced sufferers’ idea of choice around smoking were found in 
thirteen papers. The most common code was that of enjoyment and desire of 
smoking and/or a sense of not regretting this enjoyment in nine papers 
(25,26,29,31,32,34,35,38,40). A view of the need for ownership of the decision to 
smoke, or not smoke, was apparent in the results of six papers (26,31,32,36,37,39). 
A sense of defiance or rebellion, almost asserting the sufferers’ sense of choice and 
it being their own business was identified in five papers (26,27,31,32,35). 
3.2 Out of my Control 
 
Thirteen papers contained results that appeared to represent COPD sufferer’s lack 
of control around their smoking, with something else either causing them to smoke, 
or not be able to quit. In all thirteen, there were references to addiction, habit, 
cravings or withdrawal effects which inhibit smoking cessation (26,27,39,43,44,29–
31,34–38). Six papers contained results suggesting that life events (such as 
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bereavements) meant that it was never the right time to stop smoking 
(26,30,34,36,38,39). Four papers cited environmental triggers to smoking, such as 
coming home from hospital, or drinking alcohol, which would cue smoking 
(26,35,37,39). Participants in two studies expressed a need for some form of 
extreme or imaginary solution, namely being “lobotomised” or needing to have a 
“switch flipped” in their head (26,31). In one study a participant expressed a wish for 
smoking to be banned for them to give up (39). 
 
Theme 4: Damaging ways of treating the self 
Fifteen papers contained results that encapsulated difficulties that were 
negatively emotional in nature or involved some form of behavioural adaptation 
around smoking. These were grouped under the theme ‘damaging ways of treating 
the self’. Quality was calculated as 81.9% and it accounted for 10.5% of the 
findings. 
4.1 Critical-Self 
 
Thirteen papers were identified as containing results that related to a self-critical 
state. Twelve papers reported difficult emotional states from smoking which 
appeared to impede COPD sufferers’ thoughts and attempts to quit smoking, these 
states and processes were described in terms of guilt, shame, embarrassment, self-
blame, anger, self-criticism and referring to the self as a failure 
(25,27,43,44,28,32,33,35–37,41,42). Three papers contained results where 
sufferers had referred to themselves as lacking will-power or lacking self-discipline 
to be able to overcome smoking (31,32,35), which was interpreted as having a 
critical or stern tone towards oneself. 
4.2 Avoidance Strategies 
 
Changes in the way sufferers’ act or behave, or indeed the way they believe they 
must, were identified in eight papers. In six papers, results suggested that sufferers 
hid the fact they smoked from other people, denied smoking to others or avoided 
talking about smoking altogether (27,28,30,34,35,41). Three papers contained 
results that suggested some sufferers will avoiding seeing doctors or other health 
professionals due to their continued smoking (27,28,32). One study described 
participants as adapting their lives around worsening symptoms to possibly avoid 
the effect of, or not take seriously, the smoking related continuing damage (36). 
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Theme 5: Pessimism about change  
Pessimism about change spanned fourteen papers, accounting for 12.18% 
of the findings and had a quality rating of 82.0%. It described the reasoning behind 
not quitting in terms of anticipated negative outcomes, as well as describing 
unalterable or irreconcilable phenomena.  
5.1 Perceived Threats from Stopping Smoking 
 
Results showed people with COPD feared the consequences of giving up smoking 
(26,28–30,32–36,42). There was evidence that sufferers worried how their bodies 
would cope, or that it would cause them harm (28,30), with some believing that 
quitting would worsen their COPD (33), or that they had seen others quit and then 
just die (29).  Five papers reported results that cigarettes are friends to smokers 
with COPD and implied that quitting risks a loneliness (26,32,35,36,42), with a sixth 
paper talking about the anticipated loss and mourning that might be suffered with 
quitting (34). Other views contained concerns about side-effects (such as dizziness) 
and costs of pharmacological aids to smoking cessation (26,30,36). 
5.2 Resignation 
 
Six papers contained results that suggested people thought themselves too old or it 
was too late for them to stop as the damage had been done (28,32,36,39,40,44), 
and perception of there being no benefits from cessation was identified in four 
(28,29,40,41). Four papers reported people being unable to stop thinking about 
smoking, or very anxious when doing so, which made them smoke more 
(28,35,36,41). Two papers reported people feeling hopeless about their smoking 
(28,36). 
 
Theme 6: Mitigating and optimistic approaches to smoking 
This theme captured actions and viewpoints that could described as 
substitutional, deferring, falsely reassuring, or compensatory which somehow 
permitted the sufferers to continue to smoke perhaps with a lower sense of risk, or 
with a way out if things got worse. Twelve papers were noted to contain results that 
fitted with this theme, which covered 7.14% of the coded data and was quality-rated 
at 82.8%.  
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6.1 Compensatory Strategies 
 
Nine papers contained results that indicated people were inhaling less smoke, 
cutting down to less cigarettes generally, or smoking less when their COPD was 
worse (26,28–30,32,35,38,41,42). It would appear these were considered as ways 
to compromise or minimise damage, with a couple of papers demonstrating people 
believed there was a safe lower-level of smoking (29,30), intermittent quitting with 
one-off cigarettes being permitted leading to relapses (35), or as a way of reducing 
harm and preparing themselves to quit one day (30,41). Two studies suggested a 
squaring-it-away-with-yourself process, with one reporting that medics had treated 
their prior throat cancer successfully, so they will be able to with the COPD (37). 
The other reported any positive news about lung health being taken as permission 
to keep smoking as though they were not ill (36). Two other studies reported people 
buying nicotine replacements, but not using them or letting them expire, perhaps as 
a way of trying to feel better/that they are doing at least something/preparing 
towards quitting (28,35). 
6.2 Imagined Efficacy 
 
Three studies contained descriptions that could be classed as ways of deferring or 
easing the health threat by imagining being able to change things, such as planning 
a future date to quit instead of attempting it now, or stating that one could quit if they 
really wanted to  (26,28,31). A fourth study had an example of someone imagining 
how helpful their doctor would be should they ever want to quit (32). It should be 
noted this was the only subtheme to exceed the 90% quality threshold (all others 
were low to mid 80s). 
 
Theme 7: Conflicting advantages of not quitting 
Smoking was described positively in several, sometimes contradictory, ways 
across twelve papers with 13.45% of codes falling into this theme. Some results 
showed that smokers found that smoking calmed them down, whilst others 
described experiences of smoking as a stimulant. Some also found that the smoking 
assisted their body and its functions in other ways. The quality of this theme was 
calculated as 83.4% 
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7.1 Calms and Soothes 
 
Smoking was described as having a calming and soothing effect. Six papers (28–
30,35,36,39) referred to smoking as a way to relax and take a break, and for 
preventing irritability. Six papers (28–30,35,36,42) also described smoking as 
alleviating COPD sufferers’ anxiety. Four (29,31,35,39) had results that indicated 
participants believed that smoking prevented low moods, or even feelings of 
“wasting away”. 
7.2 Stimulation 
 
Conversely, smoking was also described as a stimulant. Five papers 
(32,35,36,39,40) reported results about sufferers having too much time on their 
hands if they quit smoking, and how their smoking alleviates boredom. Another 
paper also reported sufferers as stating that smoking both stimulates them and 
helps them concentrate (29). 
7.3 Assists the Body 
 
Smoking was attributed as helping sufferers with other aspects of their physical 
wellbeing. Six papers (26,29,31,36,38,39) reported sufferers as stating that smoking 
prevents weight gain and the associated hunger from quitting. In addition, another 
paper (30) found that some sufferers believed that smoking helped them to breathe 
and was a useful expectorant. One paper (29) reported sufferers as stating that 
smoking helped them digest their food, and to kills germs.  
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Figure 1 Themes, subthemes and example codes (n=number of papers per theme, subtheme and code respectively) 
Reasons, attitudes, strategies and beliefs that maintain 
smoking in sufferers of COPD
Pessimism about 
change
n=14
5.2 Resignation
n=7 
Too late damage is 
done/too old (n=6)
No benefits to i l lness 
by stopping (n=4)
Unstoppable 
thoughts of smoking 
lead to anxiety which 
means more smoking 
(n=4)
Feeling hopeless   
(n=2)
3.1 My Choice
n=13 
Enjoying smoking 
(n=9)
Having to be own 
decision to stop  (n=6)
My choice and my 
business (n=5)
Conflicting views on 
control in smoking 
n=16
Conflicting 
advantages of not 
quitting
n=12
7.1 Calms and Soothes
n=8 
Helps to relax, take a 
break and calm 
irritabil ity/anxiety  
(n=6)
Relieves anxiety     
(n=6)
Relieves low mood
(n=4)
2.1 Down-Playing Links
n=16 
Denying the l ink
 (n=9)
Knowing link but not 
feeling i l l  (n=8)
Not knowing link 
(n=4)
Smoking just an 
irritant (n=1)
Conflicting 
relationships in 
smoking 
n = 19  
1.1 Blaming Others
n=17 
Lack of empathy 
from health 
professionals (n=12)
 Wanting shock 
tactics directly (n=6)
 Not offered the 
support (n=6)
 Others will  not quit   
(n=6)
Conflicting ideas 
about the 
relationship 
between COPD and 
smoking 
n=16
Mitigating and 
optimistic 
approaches to 
smoking
n=12
6.1 Compensatory 
Strategies:
n=11 
Cutting down with 
future quit dates 
and/or inhaling less 
(n=9)
Buying NRT 
repeatedly without 
using it (n=2)
Doctors fixed it 
before they can again 
(n=1)
Good medical 
results permission to 
smoke more (n=1)
Damaging ways of 
treating the self
n=15
4.1 Critical Self
n=13  
Self criticism leading 
to embarrassment, 
shame and guilt for 
smoking (n=12)
Stating it's a lack of 
willpower/ self- 
discipline (n=3)
1.2 Smoking as 
Relating
n=8 
Smoking is part of 
socialising (n=7)
Being a smoker is 
part of my identity   
(n=3)
Projection of 
concern (n=2)
2.2 Outsourcing 
Causes:
n=10 
Blaming industry, 
dust etc (n=8)
Normalising COPD 
as age related / bad 
luck (n=4)
Did not know the 
dangers when starting 
(n=4)
Inherited condition 
(n=1)
2.3 Acceptance of the 
Relationship:
n=7 
 Accepting the 
relationship (n=7)
Paying the price   
(n=2)
3.2 Out Of My Control
n=13 
The power of the  
addiction / habit     
(n=13)
 Life Events (n=6)
 Environmental Cues  
(n=4)
 Need a magic 
solution (n=2)
Wish it was banned 
(n=1)
4.2 Avoidance 
Strategies
n=8 
Hiding / denying 
smoking (n=6)
Avoiding doctors   
(n=4)
Reducing activity to 
adapt to worsening 
symptoms (n=1)
5.1 Perceived Threats 
from Stopping
n=10 
Cigarettes are l ike 
friends (n=5)
People who stop 
come to harm/die    
(n=4)
Side effects of 
cessation medications 
(n=3)
Loneliness and 
mourning the loss of 
smoking (n=1)
6.2 Imagined Efficacy
n=4  
Could stop if  really 
wanted to (n=3)
Imagining GP would 
be very supportive   
(n=1)
7.3 Assists the Body
n=7 
Prevents weight gain 
and reduces appetite 
(n=6)
Expectorant and 
helps to breathe (n=1)
Smoking kil ls germs 
and aids digestion   
(n=1) 
7.2 Stimulation
n=6 
Alleviates boredom 
(n=5)
Stimulates and helps 
to concentrate (n=1)
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Discussion 
Themes generated were rated good quality and being found across multiple 
papers mitigated any concerns regarding individual paper quality. No themes 
spanned only moderate quality papers which further adds to the confidence in the 
findings. The themes present a broad base of contradictory view-points that 
illustrate the diversity and breadth of attitudes that may be held by COPD sufferers 
regarding their smoking; this was supported by no single paper covering all 
subthemes. The large number of papers, the avoidance of search limiters and the 
worldwide coverage of the papers adds to the strengths of the review and its results. 
Findings suggest that no model to date has been close to capturing the broad 
attitudinal positions available to smokers with COPD. 
Utility of Findings and Implications 
Information yielded may be of use to those trying to motivate suffers to 
consider quitting smoking, particularly given the difficulties with MI to date (17). 
Equally, understanding the varied positions COPD sufferers take might help discern 
the factors needed to improve the current homogenously-effective, yet diverse, 
psychological approaches to cessation as highlighted by van Eerd et al. (2016). The 
results from this paper provide clinicians with a very broad framework of positions 
that clients might adopt, and given the apparent lack of satisfactory models 
available, would suggest idiosyncratic psychological formulation from a Clinical 
Psychologist could be useful for those struggling to quit smoking, especially where 
there are co-morbid difficulties with mood and anxiety.  
Results suggest services need to provide accurate information (Theme 2), flexible 
approaches to offering treatment and support (Theme 3) and not be dogmatic in 
their approach (Theme 1). It might be important to collaboratively generate 
strategies to compensate for the perceived advantages of not quitting (Theme 7) 
whilst providing support, or psychological input to overcome difficulties, especially 
with problems seen in Themes 4, 5 and 6, with these encompassing a strong 
emotional thread. Particular consideration should be paid to all findings, especially 
Theme 1, when working with those who are not motivated to quit smoking 
(comparison to existing models and theories is continued in Appendix H and 
reflections on context are given in Appendix I). 
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Validity, Reliability and Limitations 
This review utilised validated assessment tools for quality appraisal, and 
inter-rater reliability was satisfactory. However, questions over how robust any 
current appraisal tool is have been raised (45) which means that some flaws within 
studies may have been overlooked.  Themes, sub-themes, and even codes, appear 
in places to overlap conceptually. Whilst attempts have been made to distinguish 
codes and themes, this review is limited in that it cannot test the correlation between 
these statements. Relationships should be tested in the form of a questionnaire and 
factor analysis, or Q-methodology sort to establish how-related the codes are to one 
another, and thus calculate their validity and reliability.  
This review was not able to ascertain emotional states across the papers, nor the 
quitting motivation or intentions as most papers did not report this information, so it 
is impossible to state if any of the themes or sub-themes correlate with particular 
levels of motivation or emotional difficulties. Additionally, this review sought to name 
and count themes and sub-themes (and the codes that constitute the sub-themes) 
present in the literature, it did not attempt to quantify their frequency within each 
paper as this was often not possible. So, for example whilst it may appear that 
“downplaying the links” is more evident than “acceptance” across papers, the same 
claim cannot be made within papers. Thus, variance in reasons for smoking is 
described as between, not within studies.   
It is not possible to know if saturation of reasons has been reached, as the review is 
limited by its papers. There are other denial beliefs in the literature, for example that 
smoking lighter cigarettes mitigates the damage (9), that did not appear here. 
Additionally, ethnicity was only mentioned by one paper (29) and despite broad 
geographic area covered, all were studied in developed countries. One cannot be 
sure that all perspectives on smoking, and its relationship to COPD have been 
captured (46). 
Whilst attempts to bracket existing knowledge and theories were made and an 
inductive approach taken, the author of the review has a background in CBT and 
Health Psychology, which may have influenced the themes generated. Attempts 
were made to mitigate this by bracketing components of existing models. The lack 
of obvious fit with the TPB (see Appendix H) would suggest that this approach was 
somewhat successful.  
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Recommendations and Conclusion 
There appear to be no existing satisfactory accounts or models that capture the 
broad viewpoints adopted by smokers with COPD. Findings suggest there may not 
be a simple rational relationship between particular thoughts and motivation, 
intention or actual quit attempts in COPD sufferers. This review demonstrates there 
is evidence of a multitude of contradictory positions people with COPD may take to 
justify continued smoking.  
What is not clear is how these positions and viewpoints relate to one another, how 
they are used and deployed. There is also a dearth in the understanding as to how 
these viewpoints correlate (if at all) with degree of desire to quit and with depression 
and anxiety disorders; further research is needed to ascertain this information. 
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Appendix A – Figures of Existing Models 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Neurobiological addiction model adapted from Benowitz (2010). 
 
 
Figure 3 Expanded TPB model (adapted from Peretti-Watel, Halfen & Grémy, 2007) 
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Figure 4 Expanded HAPA model (adapted from Radtke, Scholz, Keller & Hornung, 2012) 
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Figure 5 CBT anxiety information processing procedure vs hypothetical reversed process for smoking 
in COPD 
 
 
 
Figure 6 CBT model of addictions, Beck, Wright, Newman and Liese (1993)  
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Appendix B – Search Terms and Diagram 
 
Details of search strings utilised including any limiters 
Source Search String Limiters 
HDAS (NHS 
Library) 
((((Attitude* OR Belie* OR Reason* OR Motivat* 
OR Why OR Experienc*) AND Smok*) AND (Quit* 
OR Cessat* OR Continu* OR "Give up")) AND 
(COPD OR "Chronic Obstructive" OR 
Emphysema OR Bronchitis)).ti,ab 
 
Title/Abstract 
Web of Science (((((Attitude* OR Belie* OR Reason* OR Motivat* 
OR Why OR Experienc*) AND Smok*) AND (Quit* 
OR Cessat* OR Continu* OR "Give up")) AND 
(COPD OR "Chronic Obstructive" OR 
Emphysema OR Bronchitis)).) 
Topic 
EThOS COPD Smoking None 
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 Figure 7 Search Strategy and Results  
Search Terms: 
Attitude, Belief, Reason, Motivation, Why, Experiences, Smoking, Quit, Cessation, Continuing, Give up, 
COPD, Chronic Obstructive, Emphysema, Bronchitis
NHS Library
(AMED, BNI, CINAHL, EMBASE, HBE, 
HMIC, MEDLINE, PsycINFO, PubMed)
1,075 results
Web of Science
342 results
EThOS
76 results
Screened from reading 
title and abstract 
 890 results
Duplicates removed:
603 results
Full Text Articles Accessed
38 results
Do not meet inclusion criteria:
852 results
Not relevant, not journal article, only contain 
physiological or pharmacological 
measures/predictors of smoking cessation
Total Articles Selected for 
Review
20 results
BNI = 2
EMBASE = 2
Medline = 2
PsycINFO = 7
WoS = 4
Hand Search= 3
Do not meet inclusion criteria:
21 results
Not views about why people cannot stop = 12
Cannot distinguish COPD results from others = 5
Study of Intervention = 3
Non-systematic review = 1
Hand Search
(reference lists)
3 results
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Appendix C – Data Synthesis Principles  
 
It is recognised there are no universal definitions of what data is for the purposes of 
extraction and synthesis of qualitative findings. Data extraction followed the 
principles that only data relevant to the research question (i.e. findings that attempt 
to explain why, and how, people with COPD continue to smoke) was collected for 
synthesis (22). Some papers contained a lot relevant data about why people 
continue to smoke (those tended to be the detailed studies that enquired 
qualitatively and specifically about experiences of relationships to smoking, and 
those specifically about not being able to give up) whereas others contained less as 
they were only small part of the study (those that examined more general life with 
COPD or smoking cessation experiences) or were fixed constructs being measured 
(i.e. the broader quantitative studies that examined motivation/attitudes to quitting) – 
this trend is illustrated by comparing Table 4 to the results section. Additionally, to 
be considered for synthesis the qualitative data extracted had to follow three 
principles from Sandelowski and Barroso (2002). 
Extracted qualitative data therefore met the following criteria: 
i) Data that attests to why or how a person with COPD does not/struggles 
to give up smoking. 
ii) Data is evidenced by quotations that fitted with the interpretation either 
with direct quotations, or clearly based upon quotations, statements or 
numbers of participants stating something. 
iii) Is not simply quotes with absolutely no interpretation or context, nor 
conversely lengthy interpretations without quotes in the discussion 
section of a paper. 
iv) Interpretations must reflect the content of quotes. 
 
To synthesise the extracted data, and to account for different methodologies used, 
thematic analysis (24) was undertaken. It is impossible to bracket all previous 
understanding,  but the lack of validated cognitive models for COPD from which to 
use as a framework permitted a less theory driven approach to deductive coding. 
Additionally, using an existing model would have risked not coding phenomena that 
may not appear as straightforward beliefs, e.g. description of a behaviour. 
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Papers were read and re-read for findings which were extracted into Microsoft 
Excel, codes were created for findings that met the criteria. The codes were then 
analysed and drawn into themes which captured the type of description, process, 
belief or attitude that was being described. Quotes were extracted from the papers 
and checked against these themes to ensure they were captured under these 
themes. 
Quantitative papers measured different variables and therefore meta-analysis was 
not possible. Data extraction from quantitative papers involved interrogating the 
results for findings that may explain why people do not give up smoking with COPD. 
For the fact that data within the papers were, by and large, relative differences 
between smokers with COPD rather than absolute reasons why people do not quit, 
data that stood out as differences or reason (and where applicable, statistically 
significant at <0.05) were extracted for this thematic analysis. 
Themes were created that structured the data to show contrasting positions on 
similar subjects, thus highlighting broad aberrant and contradictory viewpoints, 
rather than on frequency of codes which may have led to theoretical profiles of 
smokers with COPD.  
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Appendix D – Literature Search Results 
Table 1 Literature Search Results Overview 
Number Author Aims and 
Location 
Method and 
Participants (N) 
Summary of Results Key Strengths  Key Weaknesses 
1 Burrows & 
Carlisle (2010) 
Investigate 
how to 
improve 
effectiveness 
of smoking 
cessation 
communication 
 
England 
 
Grounded Theory 
Semi-structured 
Interviews 
N=10 
Smokers deny the contribution of 
their smoking to COPD. A low level 
of acknowledgement of the 
association between smoking and 
COPD was found in long-term 
COPD sufferer. Health and finances 
were biggest motivators for 
cessation of smoking. Over directive 
and ritualistic approaches by health 
professionals was found to be 
counter-productive. Smokers 
avoided health care for reasons of 
embarrassment and fear of 
discrimination. 
 
+ Purposive sampling 
described well and 
balanced  
+ Acknowledgement of 
potential hindsight bias 
of respondents whom 
had quit 
+ Triangulation of 
researchers 
+ Recognised limits of 
results and potential 
non-saturation 
- Little time between consent 
and interview 
- Paucity of reflection on 
authors’ bias in analysis 
beyond the method 
- Lack of discussion of ethics 
beyond approval 
- No verification of findings 
with participants 
2 Eklund, 
Nilsson, 
Hedman, & 
Lindberg 
(2012) 
Find out why 
do smokers 
with COPD not 
quit. 
 
Sweden 
Content Analysis 
Semi-structured 
Interviews 
N=10 
Smokers’ lives were dictated by a 
lifelong habit that was hard to break 
despite knowing the harmful effects 
and consequences of COPD. Life 
events were reasons for not finding 
the right time to quit smoking. 
Demands to quit smoking from 
other people were experienced as 
patronising and would lead to 
continued smoking or relapse. 
Support was desired from relatives 
and health services but participants 
wanted ownership to make the 
decision to quit. 
 
+ Clear methodology for 
collection/analysis of 
data 
+ Selected the first 10 
which reduced 
researcher selection 
bias  
+ Some consideration 
as to the location of 
interviews 
+ Ethical approval 
+ Joint coding 
+ Acknowledgement of 
some limitations 
- Some contradictory 
findings not recognised in 
interpreting data 
- No evidence of reflections 
on own biases when coding 
- Unclear as to why GOLD II 
criteria, not explained. 
- Some quotes are difficult to 
read in English 
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3 Gullick & 
Stainton 
(2006) 
 
Explore the 
embodied 
experience of 
smoking 
addiction in 
COPD 
 
Australia 
Hermeneutic 
Interpretation 
Two semi-
structured 
interviews 
N=15 
COPD sufferers experienced 
smoking as a need of their “taken-
for-granted body”, as an intense 
enjoyment, in response to triggers 
perceived by the automatic body 
long after smoking cessation. 
Sufferers and their families 
described a link between heavy 
smoking and exacerbations of 
breathlessness leading to tension 
between smoking and awareness of 
smoking-related illness. Not getting 
over the body’s addiction could lead 
to denial of the relationship between 
the need to smoke and worsening 
breathlessness. Smoking can lead 
to family anger, mediated by family 
member’s own experience of 
addiction.  
 
+ Rich descriptions of 
embodied experiences 
and automatic impulses 
even in ex-smokers 
+ Includes family 
perspective 
+ Thick descriptions of 
the moments when 
people change their 
minds about smoking 
- No mention of ethics  
- No mention of invitation 
and response rates 
- Few details on inclusion/ 
exclusion criteria 
- Cannot tell the level of 
reflection on influence of 
bias ideas on analysis or 
discussion on analysis 
process as no detail on 
triangulation, reflection, and 
bias 
- No validation from 
participants 
4 Halding, 
Heggdal, & 
Wahl (2011) 
Explore 
experiences of 
self-blame and 
stigmatisation 
for self-
infliction of 
COPD 
 
Norway 
 
Content Analysis 
Two thematic 
interviews 
N=18  
Master theme of “feeling of being 
exiled in the world of the healthy”, 
due to stigmatisation by society of 
COPD as a self-inﬂicted disease, 
and through self-blaming. Feelings 
of disgrace through subtle blaming. 
Lack of support from social 
networks, health professionals and 
society. This led to greater strain 
from COPD and a defensive stance. 
 
+ Longitudinal. Good 
focus and 
acknowledgement of 
power relations in 
interviewing 
+ Detailed description 
of rigorous analysis 
+ Invitation numbers 
given 
+ Large sample size for 
qualitative study 
+ Feedback obtained 
from participants 
+ Acknowledgement of 
limitations 
- Clinicians (instead of 
researchers) recruited and 
obtained consent which may 
be a power relation issue. 
- Convenience sample from 
small group who had 
recently had PR which may 
have skewed viewpoints 
elicited 
- Unclear why took 2 years 
to collect data and further 6 
years to publish 
- Interview schedule not 
listed 
     
  51 
Number Author Aims and 
Location 
Method and 
Participants (N) 
Summary of Results Key Strengths  Key Weaknesses 
5 Hansen, 
Walters, & 
Wood Baker 
(2007) 
Find out how 
COPD 
sufferers 
explain why 
they 
developed the 
disease, and 
the role of 
cigarette 
smoking in 
their 
explanatory 
accounts 
 
Australia 
Custom (based on 
GT and narrative) 
Semi-structured 
Interviews 
N=19 
N=15 expressed scepticism about 
medical links between COPD and 
cigarette smoking, and some 
doubted whether it was COPD at 
all. N=4 described smoking as the 
principal 
reason why they had breathing 
problems. Majority gave 
multiple-causes often with emphasis 
on explanations such as a familial 
tendency to respiratory illness or 
workplace exposure to pollution. 
+ Recruited purposively 
with balancing until 
saturation 
+ Second interview 
allowed participants to 
comment on analysis 
+ Consideration about 
power relations: not 
imposing diagnostic 
label during interviews  
+ Detailed 
demographics 
+ Acceptance and 
refusal numbers 
provided 
+ Large sample size for 
qualitative study 
- Does not state why 46 
declined to take part  
- Homogenous sample in 
some respects (socio-
economic status, all retired) 
- No information on why 8 
did not take part in second 
interview 
- No mention of ethics, 
consent or withdrawal 
6 Jones, Hyland, 
Hanney, & 
Erwin (2004) 
Examining 
perceptions of 
factors that 
influence 
compliance 
with COPD 
treatment 
 
England 
Thematic Analysis 
Focus Groups 
N=29 
N=28 reported good compliance 
with medication but some 
expressed concerns about 
techniques. N=29 reported being 
instructed to stop smoking, but 
varied in beliefs that smoking was 
harmful/not. Some quit, some cut 
down and others continued, but a 
lack of constructive help to quit was 
stated. Participants were told to 
exercise but were unsure why/how 
much/if breathlessness was 
dangerous due to lack of info. 
Reported being given minimal 
advice about diet. 
 
+ Attrition rates stated 
+ Reasons for attrition 
given 
+ Very clear inclusion/ 
exclusion criteria 
- Appears to be a deductive 
thematic analysis, but not 
described as such and lacks 
detail on analysis process 
- No mention of ethics 
anywhere 
- No reflections on effects of 
process on participants or 
validation from them 
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7 Jonsdottir & 
Jonsdottir 
(2007) 
Understand 
the experience 
of women with 
advanced 
chronic 
obstructive 
pulmonary 
disease of 
repeatedly 
relapsing to 
smoking 
 
Iceland 
Interpretative 
Phenomenology 
Semi-structured 
Interviews 
N=7 
Six themes generated: “being 
caught in a spider web”, 
“circumstances of the relapses”, 
“shame”, “the excuse”, 
“ambivalence” and “incomplete 
attempts to quit”. It was found that 
participants had limited ability to 
abstain from smoking and they 
oscillated desiring to quit and not. 
 
+ Rich descriptions 
+ Triangulation by 
second author in 
analysis 
+ Validation by 
presenting first 
interview interpretation 
at second interview 
+ Ethical approval 
obtained  
- Unclear on what counts as 
relapse for inclusion criteria 
- Shortage of quotes at times 
to justify some of the stated 
data 
- Clinicians (instead of 
researchers) recruited and 
obtained consent which may 
be a power relation issue. 
- Discussion is quite 
laboured yet does not many 
implications for practice 
 
8 Lefcoe, 
Pederson, & 
Blennerhassett 
(1988) 
Understand 
attitudes of 
people with 
COPD towards 
smoking 
cessation 
 
Canada 
Categorical/Content 
Analysis 
Interviews 
N=40 
Decisions to attempt quitting related 
to health consequences. Firm 
persistent doctors viewed as the 
most important and credible source 
of advice' around cessation. Firm 
continuing pressure, from doctor 
and then family and friends, was 
found to be strongest stimulus. 
Public media not seen as source of 
information and advice. The 
financial cost of smoker not an 
important consideration. First 
attempt to quit rarely successful, but 
persistence yielded success, but 
reasons why not were not found. 
 
+ Sampling appears to 
be based upon 
physician attendance so 
has opportunity feel to it 
reducing researcher 
selection bias 
+ Large sample size 
+ Considers the non-
generalisability of 
findings 
+ Consideration of 
power-relations and 
settings. 
- No explanation of why 
methodology chosen  
- No explanation of interview 
method or analysis 
- No mention of ethics 
- Non-health attenders not 
sampled 
- Not clear on inclusion 
criteria - other than smoking 
level 
- No validation from 
participants 
 
9 Lindqvist & 
Hallberg 
(2010) 
Examine the 
main concerns 
of people with 
COPD and 
how everyday 
life is handled. 
 
Sweden 
Grounded Theory 
Semi-structured 
Interviews 
N=23 
Theoretical model showed COPD 
sufferers’ primary concerns were 
guilt about self-infliction of the 
disease due to smoking habits. 
There were five strategies identified 
in the model “making sense of 
existence”, “adjusting to bodily 
restrictions”, “surrendering to fate”, 
“making excuses for the smoking-
related cause” and “compliance with 
daily medication”. 
 
+ Large sample size for 
qualitative study 
+ Saturation discussed 
and obtained 
+ Critical reflexivity 
evident within the 
analysis 
+ Good consideration of 
ethical factors 
 
- Sparse description of 
recruitment process.  
- No information on numbers 
who declined 
- Not much in the way of 
critical discussion of their 
findings 
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10 Lundh, 
Hylander, & 
Törnkvist 
(2012) 
Explore why 
some people 
with COPD 
struggle to quit 
smoking and 
develop a 
theoretical 
model that 
describes 
perspectives 
on these 
difﬁculties. 
 
Sweden 
Grounded Theory 
Semi-structured 
Interviews 
N=14 
Theoretical model of ‘Patients with 
COPD trying to quit smoking’. 
Factors related to decisions to try to 
quit smoking, included “pressure-
ﬁlled mental states” and 
“constructive” or “destructive 
pressure relief strategies”. 
“Constructive strategies” led to 
success in quitting or continuing 
attempts to quit. “Destructive 
strategies” led to the loss of hope 
and resignation to continued 
smoking. 
+ Model presented to 
four participants for 
validation 
+ Thorough description 
of analysis including 
theoretical sampling 
+ Clear presentation of 
model 
+ Critically reflexive of 
the model and its 
situatedness 
- No info if any declined to 
be interviewed.  
- No mention of saturation 
 - Lack of quotes on 
understanding of relationship 
of COPD to smoking 
 - ‘Destructive’ is author’s 
term not participant; the 
participant review 
highlighted that people use 
both types of methods 
interchangeably 
 
11 Nykvist, 
Larsson, & 
Dahlborg 
Lyckhage 
(2014) 
To describe 
how a group of 
female 
smokers with 
COPD 
experienced 
everyday life 
and 
relationships to 
smoking. 
 
Sweden 
 
Narrative Approach 
Narrative Interviews 
N=6 
The analysis led to a narrative 
about “a woman with COPD that 
knows what she must do but cannot 
ﬁnd the power within herself to take 
action. She talks about herself like a 
young bird that is going ﬂy for the 
ﬁrst time.” 
+ Detailed ethical 
considerations 
+ Detailed account of 
analysis which appears 
rigorous and credible 
+ Acknowledgement 
potential of biases in 
discussion 
 
- Do not state how many 
were invited/responded 
- No validation from 
participants despite narrative 
approach 
- Lack of demographic 
information 
     
  54 
Number Author Aims and 
Location 
Method and 
Participants (N) 
Summary of Results Key Strengths  Key Weaknesses 
12 Poureslami, 
Shum, & 
FitzGerald 
(2015) 
To compare 
the smoking 
habits and 
beliefs of 
Chinese 
smokers and 
quitters after a 
diagnosis of 
COPD 
 
Canada 
Content Analysis 
Semi-structured 
Interviews 
N=91 
Differences in smoking experience, 
social influences, addiction/habit, 
and advantages and disadvantages 
of smoking were identified. 
Differences were found in terms of 
beliefs that smoking helps 
relaxation, reduces COPD related 
anxiety/stress, and is a 
psychological habit that cannot be 
easily overcome. Barriers to 
successful smoking cessation 
included weight gain, dizziness, 
depression, and mood changes. 
 
+ Very large sample 
size for qualitative study 
+ Broad range of 
practitioners/services 
involved in recruitment 
+ Community based 
participatory research 
meant Service-users 
involved in design 
+ Acknowledge the 
localisation of results 
+ Ethical approval 
 
- Lack of clarity about how 
pilot tool relates to interview 
structure  
- At points, unclear on 
differences between groups 
(smoke/ex) in results  
- Not clear if those involved 
in design were recruited? 
-No clear evidence of 
reflections on bias 
-Not all themes and 
categories displayed in 
results table - poor layout 
- No validation from 
participants 
 
 
13 Robinson 
(2005) 
To describe 
the 
experiences of 
patients living 
with severe 
COPD 
dependent on 
supplementary 
oxygen  
 
England 
Thematic Analysis 
(although not 
stated) 
Unstructured 
Interviews 
N=10 
N=10 reported difficulties with 
physical and psychological 
problems, largely from breathing 
difficulties. N=8 described 
difficulties with family life because of 
their illness, and N=5 reported 
depression. N=10 discussed 
smoking, although not all blamed 
this for their disease and those that 
did recognise its role did not always 
change their behaviour. N= 5 stated 
the need for better communication 
between them and health 
professionals over their disease. 
 
+ Random sampling 
from larger purposive 
sample reduces 
selection bias by 
researcher 
+ Recognition of bias 
risks inherent in medical 
practitioner asking 
questions 
+ Triangulation of 
analysis by random 
selection of two papers 
for third analyst 
+ Validation of data 
from two randomly 
selected participants 
 
- No referencing for analytic 
method/choice of approach 
- No discussion about the 
structure of interviews or 
why this was chosen 
- Little reflection on what the 
interviewer brought to the 
themes 
- Interpretation is difficult 
because discussion section 
is blended with results 
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14 Schofield, Kerr 
& Tolson 
(2007) 
Explore the 
beliefs related 
to smoking in 
older people 
with COPD 
guided by the 
Health Beliefs 
Model 
 
Scotland 
Thematic Analysis 
(secondary analysis 
and partly 
deductive by Health 
Belief Model) 
Semi-structured 
Interviews 
N=22 
More than half of participants 
continued to smoke despite viewing 
smoking as a threat to their health. 
All smokers had attempted smoking 
cessation at some point and 
identified various barriers to quitting. 
More than half were still attempting 
to quit smoking. Externals sources 
provided cues to action rather than 
increasing COPD severity. 
+ Recognises 
saturation from 
purposive sampling 
+ Detailed 
demographics 
+ Acknowledge 
weakness in applying 
model to previously 
collected data 
+ Biases mitigated by 
design as Health Belief 
Model not used for 
original interview 
+ Good consideration of 
ethical issues 
 
- Do not state why only 22 of 
28 interviews were used  
- Appear to have 
misinterpreted data at times.  
- Analytic method not clearly 
described 
- Authors state that it is 
novel for nurses to consider 
own beliefs but do not 
mention their own 
 
15 van Eerd, 
Risør, van 
Rossem, van 
Schayck, & 
Kotz (2015) 
To compare 
justifications 
for smoking, 
i.e. which are 
unique to 
COPD 
sufferers and 
which are 
shared with 
non-COPD 
smokers 
 
Netherlands 
Thematic Analysis 
Semi-structured 
Interviews 
N=20 
Three themes were identified: 
‘balancing the impact on health of 
smoking’, ‘challenging of autonomy 
by social interference’, 
‘prerequisites for quitting’. All 
participants played-down the 
consequences of smoking to their 
health. COPD sufferers appeared 
less knowledgeable about health 
and smoking. Both COPD and non-
COPD smokers described 
autonomy as very important. COPD 
sufferers perceived a lack of 
empathy from doctors and were 
indignant about it. They also had 
little faith in the efficacy of smoking 
cessation products. Motivation to 
quit smoking fluctuated, and for 
those with COPD their vision of life 
was connected to quitting. 
 
+ Contradictory data 
highlighted (playing 
down health link vs 
vision of quitting) 
+ Balanced purposive 
sample in terms of age, 
gender 
+ Detailed description 
of the analytic process 
+ Thoughtful about how 
interviewer was 
perceived 
+ Ethical approval 
+ Recognised own bias 
and stated, and 
acknowledge selection 
bias (those not 
interested may have 
differing views) 
 
- A random sample could 
have been used as many 
people indicated willingness 
to participate 
- No validation from 
participants 
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16 Vuong, 
Hermiz, 
Razee, 
Richmond, & 
Zwar (2016) 
To explore the 
smoking-
cessation 
experiences of 
people with 
COPD in 
primary care 
 
Australia 
Thematic Analysis 
(deductive using 
Behaviour Change 
Wheel framework) 
Semi-structured 
telephone 
interviews 
N=33 
Three inter-related themes were 
identified: ‘the motivation to quit 
smoking’, ‘opportunities to quit 
smoking’ and ‘capabilities to quit 
and maintain cessation’. The 
majority of attempts to quit occurred 
spontaneously and without 
explanation or planning; sometimes 
quitting attempts were motivated by 
family, peers or doctors. Web-based 
cessation programs led by health 
professionals were seen by 
participants as an opportunity to 
attempt to quit. Both ex-smokers 
and smokers attempted to quit 
multiple times. Current smokers 
struggled to maintain cessation 
attempts due to mood changes, 
boredom, irritability, sense of 
identity as a smoker, reinforcement 
by others, cravings for smoking, 
increased hunger and weight gain. 
 
+ Thorough description 
of analytic process  
+ Reflection on own 
knowledge 
+ Data triangulated with 
other researchers 
+ Acknowledge their 
deductive approach and 
left room for inductive 
coding 
+ Ethical approval 
+ Adjusted method for 
those who did not want 
to be recorded 
- No reasons for non-
participations sought 
- No validation from 
participants 
- Difficult in places to discern 
smokers’ and ex-smokers’ 
responses within themes 
17 Wilson, 
Elborn, & 
Fitzsimons 
(2011) 
To explore 
experiences of 
smokers with 
COPD unable 
to stop 
smoking with 
support and 
their decision-
making 
processes 
 
Northern 
Ireland 
Giorgi’s Analysis  
Semi-structured 
interviews 
N=6 
The study highlighted six themes 
that described the participants’ 
decision-making regarding smoking 
with COPD; ”too late to stop now”, 
“ﬁnding motivation”, “guilt about 
continued smoking”, “bargaining 
and contemplation”, “need to stop” 
and “reduced quality of life”. 
 
+ Balanced sample 
+ Evidence of 
consideration of power 
relations to clients 
+ Good balance of data 
and quotes 
+ Clear description of 
interview and guide 
+ Clear descriptions of 
contradictory data 
+ Funding does not 
seem to be related to 
anything in study 
 
- Not discussion around why 
the 6 participants were 
chosen, and why only 6. 
- No mention of saturation 
- No validation from 
participants 
- Analysis is rigorous but 
little reflection on pre-
conceptions as they had 
been researchers in a prior 
RCT which contained 
interventions 
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18 Bjarnason, 
Mikkelsen, & 
Tønnesen 
(2010) 
To understand 
beliefs about 
COPD, 
smoking and 
motivation to 
quit during 
acute 
exacerbation. 
 
Denmark 
Factor Analysis, 
Linear Regression, 
and Kaplan-Meier 
survival analysis 
Cross-sectional 
Questionnaires with 
survival follow-up 
N=100 
Just 16% of COPD sufferers 
thought smoking had caused their 
COPD, and only 24% thought that 
had they not smoked they would not 
suffer from COPD. Factor analysis 
showed three questions could be 
included in a scale to measure 
motivation to quit (alpha = 0.76).  
30% of variance (r = 0.55, p = .005) 
of motivation scale score was 
explained by years smoking 
(negatively associated), daily 
cigarettes consumption (positively 
associated) and BMI (negatively 
associated). Mortality was lower 
than in the reference population 
(RR = 0.63, p = .005), but higher 
than in age-matched general 
population.  
 
+ Included a reference 
group for survival 
analysis 
+ Regression analysis 
of length of time 
smoked, number of 
cigarettes, BMI with 
motivation for quitting 
+ Acknowledge 
selection bias and the 
more severe reference 
group 
+ Controlled for other 
illnesses 
+ Statistically tested 
one of their novel 
questionnaires 
-Included a never-smoked 
group despite being about 
smoking with no rationale 
- Arbitrary and untested tools 
to measure attitudes and 
cessation motivation 
- Survival analysis but no 
checking on smoking status 
which would have added 
extra dimension to 
motivation questionnaire 
- No analysis of attitude data 
to cessation motivation 
 
19 Hilberink, 
Jacobs, 
Schlosser, 
Grol, & Vries 
(2006) 
To understand 
characteristics 
of COPD 
sufferers who 
smoke at 
different levels 
of motivation 
to quit smoking 
 
Netherlands 
ANOVA, Kruskal-
Wallis, Chi-square 
and Factor Analysis 
Cross-sectional 
Questionnaires 
N=633  
 
Smokers categorised as pre-
contemplative of quitting identified 
significantly fewer advantages of 
smoking cessation than those 
contemplating or preparing to quit. 
Those categorised as preparers had 
significantly higher self-efficacy 
expectations about quitting than 
other categories of smokers. Those 
preparing to quit reported suffering 
more COPD complaints than pre-
contemplators. Contemplators and 
preparer categories had more plans 
to turn intentions to quit into action. 
 
+ Large sample size 
+ Broad geographic 
sampling 
+ Some standardised 
scales 
+ All Cronbach's alphas 
>0.7 
+ Sample distribution 
discussed in relation to 
non-responders 
+ Good discussion on 
potential sampling bias 
- Arbitrary and untested tool 
to measure and categorise 
contemplation 
- Missing p value markers in 
table 
- Limited details on statistical 
analyses 
- Funded by pharmaceutical 
company 
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20 Lundh, 
Alinaghizadeh, 
Törnkvist, 
Gilljam, & 
Galanti (2016) 
Test the 
predictive 
validity of Time 
to Quit (TTQ) 
14 item 
questionnaire 
on smoking 
cessation 
outcomes in 
COPD 
sufferers 
 
Sweden 
Logistic Regression 
Cross-sectional 
Questionnaire with 
3 month follow up 
(to ascertain quit 
status) 
N=94 
Higher 19-item TTQ scores (but not 
the 14-item previously standardised 
version) were signiﬁcantly related to 
a lower chance of attempting to quit 
smoking. Sufferers classiﬁed as not 
ready to quit had a lower probability 
of stopping with a high 19-item TTQ 
score (adjusted odds ratio 
(OR)=0.72; 95% conﬁdence interval 
(CI)=0.53–0.99). Those ready to 
quit, had a lower probability of 
attempting to quit when scoring 
highly score on subscale ‘pressure-
ﬁlled mental states’ (OR=0.78; 95% 
CI=0.66–0.94). The same subscale 
was significantly associated with 
higher chance of cutting down 
smoking by 50% in those not ready 
to quit (OR=1.32; 95% CI=1.05–
1.66). 
Trend of greater ambivalence was 
associated with lower chance of 
quitting, 50% reduction or 
attempting to quit, but not 
statistically significant. 
 
+ Broad sampling sites 
+ Tested a novel 
questionnaire 
+ Some support for the 
constructs of previous 
model 
+ States no conflicts of 
interest,  
+ No concerns about 
funding  
- Arbitrary and untested tool 
to measure desire to quit 
- Complete lack of control 
over smoking interventions 
between measurements 
- Unclear a priori 
adjustments 
- Do not seem to 
acknowledge the potential 
for TTQ to be inadequate 
- Self reported cessation on 
follow up, not checked 
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Appendix E – CASP Sub-Questions and Raw Scores 
Table 2 Details of the sub-questions within CASP Qualitative checklist. 
    QUESTION 
MEAN 
SUB 
QUESTION 
RAW 
SCORE 
1       Clear statement of aims?  
2       Qualitative appropriate methodology?  
3       Research design appropriate to aims?  
        > Did Authors justify research design/discussed method used? 2.71 
4       Recruitment strategy appropriate?  
  
   
> Explained how participants were selected? 3.00 
  
   
> How the selected participants were most appropriate? 2.76 
      > Are there discussions around recruitment (e.g. why some did not take part)? 1.40 
5       Data collected in way that addressed issue?  
  
   
> Setting justified? 2.12 
  
   
> Clear how data collected (interviews/groups etc)? 3.00 
  
   
> Have methods chosen been justified 2.53 
  
   
> Methods explicit (e.g. interviews is there a guide or description of how conducted)? 2.47 
  
   
> If methods changed, has this been explained why? 2.50 
  
   
> Form of data is clear (recordings, video, notes etc)? 2.82 
      > Saturation of data discussed? 1.59 
6       Relationship researcher/participant considered?  
  
   
> Critically considered role in bias/influence formulation of research questions? 2.41 
  
   
> Critically considered role in bias/influence in data collection e.g. recruitment and 
location? 
2.12 
      > Response to events during the study and implications of changes to design? 2.50 
7       Ethical issues been considered?  
  
   
> Sufficient details of explanation to participants to assess whether ethical standards 
upheld? 
1.88 
  
   
> Discussion of ethical issues raised (e.g. informed consent, confidentiality, after 
effects of study)? 
2.00 
      > Approval sought from ethics committee 2.47 
8       Data analysis sufficiently rigorous?  
  
   
> In depth discussion of analysis process? 2.65 
  
   
> Is it clear how themes/categories were derived from the data? 2.71 
  
   
> Explains how data presented were selected from sample to demonstrate analysis 
process? 
2.71 
  
   
> Sufficient data presented to justify findings? 2.94 
  
   
> Are contradictory data taken into account? 2.82 
        
> Researcher critically examined own role for bias in selection and analysis of 
presented data? 
1.59 
9       Clear statement of findings?  
  
   
> Are findings explicit? 2.88 
  
   
> Adequate discussion of evidence for/against researcher's argument? 2.71 
  
   
> Credibility (e.g. triangulation, respondent validation, multiple analysts?) 2.47 
      > Findings discussed in relation to original research question? 2.94 
10       Is the research valuable?  
  
   
> Consideration of study as contribution to policy and practice? 2.88 
  
   
> Areas for further research identified? 2.24 
      > Considered the transferability of findings to other populations? 2.06 
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Appendix F – AXIS and CASP Scores  
Table 3 Axis Scores for Quantitative Papers 
Y=Yes, P=Partially, C/T=Cannot tell but implied, N=No, N/A=Not applicable 
AXIS QUESTION 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
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 c
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 Total 
Score 
out of 20 
Total % 
Quality 
18 Bjarnason 
Y y C/T Y P Y C/T C/T P Y Y Y N C/T Y Y Y Y P Y 
16.33 
GOOD 
3 3 1 3 2 3 1 1 2 3 3 3 3 1 3 3 3 3 2 3 81.7% 
1.00 1.00 0.33 1.00 0.67 1.00 0.33 0.33 0.67 1.00 1.00 1.00 1.00 0.33 1.00 1.00 1.00 1.00 0.67 1.00 
19 Hilberink 
Y Y Y Y Y Y N Y P P P Y N Y Y P Y Y P Y 
17.33 
GOOD 
3 3 3 3 3 3 0 3 2 2 2 3 3 3 3 2 3 3 2 3 86.7% 
1.00 1.00 1.00 1.00 1.00 1.00 0.00 1.00 0.67 0.67 0.67 1.00 1.00 1.00 1.00 0.67 1.00 1.00 0.67 1.00 
20 Lundh 
Y Y N Y Y Y Y P P Y N Y N Y P Y P P N Y 
16.33 
GOOD 
3 3 0 3 3 3 3 2 2 3 0 3 3 3 2 3 2 2 3 3 81.7% 
1.00 1.00 0.00 1.00 1.00 1.00 1.00 0.67 0.67 1.00 0.00 1.00 1.00 1.00 0.67 1.00 0.67 0.67 1.00 1.00 
Mean Score 1.00 1.00 0.44 1.00 0.89 1.00 0.44 0.67 0.67 0.89 0.56 1.00 1.00 0.78 0.89 0.89 0.89 0.89 0.78 1.00 Mean 83.3% 
Standard Deviation 0.00 0.00 0.51 0.00 0.19 0.00 0.51 0.33 0.00 0.19 0.51 0.00 0.00 0.38 0.19 0.19 0.19 0.19 0.19 0.00 Std Dev 2.89% 
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Table 4 CASP Scores for Qualitative Papers 
Study 
Number 
First Author 
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n
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n
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th
e
r 
in
te
re
s
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Total 
Score 
(out of 
11) Total % Quality 
1 Burrows 
EXC EXC EXC EXC EXC GOOD GOOD GOOD EXC EXC MOD   EXCELLENT 
3 3 3 9 19 8 7 15 12 9 2 
 
91.6% 
1.00 1.00 1.00 1.00 0.90 0.89 0.78 0.83 1.00 1.00 0.67 10.07 
2 Eklund 
EXC EXC EXC GOOD EXC GOOD EXC EXC EXC EXC EXC   EXCELLENT 
3 3 3 7 18 5 9 17 11 9 3 
 
95.2% 
1.00 1.00 1.00 0.78 1.00 0.83 1.00 0.94 0.92 1.00 1.00 10.47 
3 Gullick 
EXC EXC EXC MOD MOD POOR V POOR GOOD GOOD MOD POOR   MODERATE 
3 3 3 5 12 2 1 16 9 5 1 
 
65.4% 
 
1.00 1.00 1.00 0.56 0.67 0.33 0.11 0.89 0.75 0.56 0.33 7.19 
4 Halding 
EXC EXC EXC EXC EXC GOOD EXC EXC EXC EXC POOR   EXCELLENT 
3 3 3 9 20 7 9 17 12 9 1 
 
91.0% 
1.00 1.00 1.00 1.00 0.95 0.78 1.00 0.94 1.00 1.00 0.33 10.01 
5 Hansen 
EXC EXC EXC GOOD GOOD GOOD V POOR EXC EXC EXC POOR   GOOD 
3 3 3 8 17 7 2 17 12 9 1 
 
81.6% 
1.00 1.00 1.00 0.89 0.81 0.78 0.22 0.94 1.00 1.00 0.33 8.98 
6 Jones 
EXC EXC EXC GOOD GOOD V POOR V POOR MOD GOOD GOOD POOR   MODERATE 
3 3 3 8 16 0 0 12 9 8 1 
 
67.4% 
1.00 1.00 1.00 0.89 0.89 0.00 0.00 0.67 0.75 0.89 0.33 7.42 
7 Jonsdottir 
EXC EXC EXC MOD GOOD MOD GOOD GOOD EXC GOOD POOR   GOOD 
3 3 3 6 15 3 7 15 12 7 1 
 
79.3% 
1.00 1.00 1.00 0.67 0.83 0.50 0.78 0.83 1.00 0.78 0.33 8.72 
8 Lefcoe 
EXC EXC V POOR EXC V POOR EXC V POOR MOD GOOD MOD POOR   MODERATE 
3 3 0 9 4 6 1 10 9 5 1 
 
59.3% 
1.00 1.00 0.00 1.00 0.22 1.00 0.11 0.56 0.75 0.56 0.33 6.53 
9 Lindqvist 
EXC EXC EXC MOD EXC GOOD EXC EXC EXC V 
POOR 
V POOR   GOOD 
3 3 3 6 20 8 9 17 12 2 0 
 
78.9% 
1.00 1.00 1.00 0.67 0.95 0.89 1.00 0.94 1.00 0.22 0.00 8.67 
10 Lundh 
EXC EXC EXC MOD GOOD EXC EXC EXC EXC EXC V POOR   GOOD 
3 3 3 6 17 9 9 18 12 9 0 
 
86.1% 
1.00 1.00 1.00 0.67 0.81 1.00 1.00 1.00 1.00 1.00 0.00 9.48 
11 Nykvist 
EXC EXC EXC EXC GOOD MOD EXC GOOD EXC POOR POOR   GOOD 
3 3 3 6 13 4 9 15 11 4 1 
 
81.1% 
1.00 1.00 1.00 1.00 0.72 0.67 1.00 0.83 0.92 0.44 0.33 8.92 
12 Poureslami 
EXC EXC MOD MOD MOD MOD MOD GOOD GOOD EXC EXC   GOOD 
3 3 2 6 10 4 5 14 9 9 3 
 
78.5% 
1.00 1.00 0.67 0.67 0.56 0.67 0.56 0.78 0.75 1.00 1.00 8.64 
13 Robinson  
EXC EXC MOD MOD MOD EXC EXC GOOD EXC GOOD V POOR   GOOD 
3 3 2 6 12 6 9 16 12 8 0 
 
79.8% 
1.00 1.00 0.67 0.67 0.67 1.00 1.00 0.89 1.00 0.89 0.00 8.78 
14 Schofield 
EXC EXC EXC MOD GOOD MOD EXC MOD GOOD GOOD POOR   GOOD 
3 3 3 6 17 5 9 12 9 7 1 
 
79.0% 
1.00 1.00 1.00 0.67 0.94 0.56 1.00 0.67 0.75 0.78 0.33 8.69 
15 van Eerd 
EXC EXC EXC EXC EXC EXC MOD EXC EXC GOOD POOR   GOOD 
3 3 3 6 18 9 6 18 12 7 1 
 
88.9% 
1.00 1.00 1.00 1.00 1.00 1.00 0.67 1.00 1.00 0.78 0.33 9.78 
16 Vuong 
EXC EXC EXC GOOD EXC EXC GOOD EXC EXC GOOD EXC   EXCELLENT 
3 3 3 7 19 9 7 18 12 7 3 
 
93.1% 
1.00 1.00 1.00 0.78 0.90 1.00 0.78 1.00 1.00 0.78 1.00 10.24 
17 Wilson 
EXC EXC EXC EXC GOOD GOOD EXC GOOD EXC GOOD EXC   EXCELLENT 
3 3 3 9 15 5 9 15 12 8 3 
 
94.4% 
% 
1.00 1.00 1.00 1.00 0.83 0.83 1.00 0.83 1.00 0.89 1.00 10.39 
Mean Score 1.00 1.00 0.90 0.82 0.80 0.75 0.71 0.86 0.92 0.80 0.45 Mean 81.8% 
Standard Deviation 0.00 0.00 0.26 0.16 0.20 0.28 0.37 0.13 0.11 0.23 0.35 Std Dev 10.41% 
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Appendix G – Theme Quality and Coverage by Paper 
Table 5 Quality, Theme and Subtheme Coverage by Paper
 
Paper Number 11 7 17 14 12 15 2 9 3 10 16 1 8 4 5 6 19 20 13 18 
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Themes covered by paper 7 7 7 7 6 6 6 6 5 5 4 5 5 4 4 5 4 4 4 3   
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paper 
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% 
63
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56
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50
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% 
31
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Appendix H – Comparison of Findings to Existing Theories, TTQ and 
TPB 
 
Evidence of mood difficulties, anxiety and self-critical processes within this 
review support the previous findings of increased anxiety and depression in 
smokers with COPD (Armannsdottir & Jonsdottir, 2014 and Gudmundsson et al., 
2006). van Eerd et al. (2015) (a related paper that did not meet the inclusion criteria) 
reported that COPD sufferers were more aware of, and more concerned about, 
health risks of smoking, that they also experienced higher levels of depression than 
non-COPD smokers, and that they received more cues to quit from their GP and 
their social environment. The findings of this review only partially support this; whilst 
papers evidenced acknowledgement of the damage caused by smoking, in many 
cases the damaging role smoking played in COPD was often down-played or 
denied as seem in Theme 2.1 and 2.2. The role of self-criticism and the strong 
negative emotional descriptions that constituted part of Theme 4.1 may be related to 
depression. The increased cues to stop smoking may be related to parts of sub-
theme 1.1 blaming others, however there were also many cues to continue smoking 
in Theme 1. 
Whilst this review has makes no attempt to ascertain factors that predict cessation 
in COPD it is worth comparing findings to the existing models. Despite a factor 
analysis of the 14 item TTQ stating it accounts for 90% of the variance of smoking 
beliefs (48),  comparing overall findings to the TTQ from Lundh et al (2012) and 
(2016) by juxtaposing Table 4 with the weighted percentages in Figure 9, it can be 
seen that their model would only account for 49.15% of the findings of this review. 
A liberal and crude mapping of the themes of this review to the expanded-TPB 
(theme 1 to subjective norms, theme 2 to attitudes, theme 3 to perceived 
behavioural control and theme 6 to self-exempting beliefs) suggests the model 
would capture 63.86% of the of findings from this review, if every data code from 
each theme was encapsulated as a question within the four sub-components. The 
TPB has already been identified as lacking predictive power of cessation intentions 
in non-COPD smokers with studies showing the model to only account for 30% to 
49% of the variance in intention to quit (8,49). TPB subjective norms have also been 
found to be a weak predictor of intentions (50), yet codes for the sub-theme (1.1) 
blaming others were the largest in terms of coded data extracted and would suggest 
otherwise. Additionally, perception of behavioural control, usually the best predictor 
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of behavioural intentions, was evident in Theme 3.1 suggesting that smokers with 
COPD and a sense of control do not necessarily give up. 
The utility of existing models is therefore questionable. The opposing and 
contradictory viewpoints people can hold about smoking with COPD might suggest 
the inherent assumptions of socio-cognitive models, that rational thoughts lead to 
intention/action, may be their greatest weakness when applied to COPD smokers. 
What cannot be elucidated from this review is how much sufferers actually-believe 
the view-points they espouse, it may be that view-points are deployed defensively to 
ward off distress in a way akin to psychodynamic theory, or that they genuinely 
believe the views they express in delusional way, or in the case of hypoxaemia 
possibly in a cognitively deficient way (51). What seems to be clear from this review 
is that there are broad positions, ranging from rational to very irrational, that may be 
adopted by smokers with COPD and that thus far no model has adequately 
captured this. Application of the Beck et al. (1993) model may capture more of this 
broad concourse through the concept of ‘facilitation beliefs’ and ‘automatic thoughts’ 
but these could equally be too vague. Any future attempt to model a process with an 
individual would need to take account of systemic and relational factors which seem 
so key to this review. There may be wider functions of continuing to smoke (or that 
smoking is an expression of other difficulties) than a cognitive health model would 
capture; for example the data found in Theme 3.1 might suggest something about a 
way of perceiving and responding to attempts to be controlled, akin to the Cognitive 
Analytic Therapy concept “If I must then I won’t” (52), which may be a wider way of 
relating to the world, not just about smoking. 
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Appendix I – Contextual Reflections 
 
Some of the data in the review leads to questions about the position of 
smoking in relation to other addictive behaviours; some papers reported participants 
as pointing out the rehabilitation facilities available for drug takers and people who 
misuse alcohol, but a lack of parity for smokers. This subtle difference may reinforce 
the self-blame and critical-self positions as health services and wider-society 
positions smoking as something more of a lifestyle choice, and that should be easier 
to deal with.  The findings of this review maybe particularly useful to clinical teams in 
areas of high incidence and mortality from COPD (often lower socioeconomic areas 
with industrial histories) where ability to help may be more urgently required, e.g. 
Stoke-on-Trent where COPD mortality is 68% higher than UK average (British Lung 
Foundation, 2017).  
Contextualising the results, conflation of maintenance of COPD with its cause 
appears to be utilised by those who wish to continue smoking (Theme 2). However, 
it must be considered from a wider view that targeting smoking in the mainstream 
keeps the focus away from potential blame against industry or authorities which 
COPD sufferers might believe are responsible for their illness. Whilst any links (or 
lack of declarations) between research findings and pharmaceutical or other 
organisations may be entirely spurious, it is implored that the findings from this 
review (particularly Theme 2) are produced in the context of helping people improve 
their current health by trying to improve opportunities for smoking cessation, rather 
than making any inference about the cause of COPD in any given case. Given 
some of the examples within the papers (e.g. Gullick & Stainton, 2006; Hansen et 
al., 2007) clinicians would be wise to focus on the damage being caused currently 
(and the evidence base for this) rather than drawing back to causal inferences 
which may be experienced as dismissive, and may not be entirely true when clients 
have worked in industries linked with respiratory diseases.  
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Appendix J – Journal Submission Guidelines for Authors 
 
Thank you for choosing to submit your paper to us. These instructions will ensure 
we have everything required so your paper can move through peer review, 
production and publication smoothly. Please take the time to read and follow them 
as closely as possible, as doing so will ensure your paper matches the journal's 
requirements. For general guidance on the publication process at Taylor & Francis 
please visit our Author Services website.  
 
 
  
This journal uses ScholarOne Manuscripts (previously Manuscript Central) to peer 
review manuscript submissions. Please read the guide for ScholarOne 
authors before making a submission. Complete guidelines for preparing and 
submitting your manuscript to this journal are provided below.  
 
About the journal 
COPD: Journal of Chronic Obstructive Pulmonary Disease is an 
international, peer-reviewed journal publishing high-quality, original research. 
Please see the journal’s Aims & Scope for information about its focus and 
peer-review policy. 
Peer review 
Taylor & Francis is committed to peer-review integrity and upholding the 
highest standards of review. Once your paper has been assessed for 
suitability by the editor, it will then be single blind peer-reviewed by expert 
referees.  Find out more about what to expect during peer review and read 
our guidance on publishing ethics. 
Preparing your paper 
All authors submitting to medicine, biomedicine, health sciences, allied and 
public health journals should conform to the Uniform Requirements for 
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Abstract 
Objective 
This study used Q-methodology to identify the shared views of people with 
Chronic Obstructive Pulmonary Disease (COPD) about why they continue to 
smoke.  
Design 
Q-sorts were undertaken with 22 participants, who sorted 73 statements by 
their level of agreement. By-person factor analysis was undertaken yielding 
three interpretable factors, each understood to represent a distinct position on 
continuing to smoke with COPD. 
Outcome Measures 
Q-sorts, Hospital Anxiety and Depression Scale (HADS), desire to quit 
Results 
‘Stoic Fatalism’, describes continued enjoyment of cigarettes as a choice, 
justified by it being too late to stop. ‘Optimistic Passivity’, justifies 
continuing by it not being too late to quit, with guilt mitigated by cutting 
down, and planning to quit. Addiction, and regulation of depression and 
anxiety are also strongly implicated in the first two factors. ‘Ambivalent 
Masochism’ describes smoking as enjoyable slavery, uncertainties about the 
relationship between COPD and smoking permit smoking to continue. HADS 
scores were independent of factors, Stoic Fatalism was the only factor to load 
with people with no desire to quit smoking. 
Conclusion 
When working with people with COPD, Clinical Psychologists should 
carefully consider the role of smoking in the formulation of any mental health 
difficulty, adapting interventions to address these in tandem where applicable. 
Further research is needed. 
Keywords: COPD, Smoking, Cessation, Cognitions, Beliefs, Why 
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Introduction 
 
Chronic Obstructive Pulmonary Disease (COPD) is an umbrella term for a 
chronic bronchitis and/or emphysema which are progressive, and ultimately fatal, 
respiratory illnesses; COPD is mainly caused by smoking. A number of approaches 
are recommended for the management of the condition but the most important is 
smoking cessation (National Institute for Health and Care Excellence, 2010). 
Between 30%-43% of people with COPD continue to smoke (Tashkin & Murray, 
2009), and they are at greater risk of mortality than both people who smoke without 
COPD, and people with COPD who do not smoke (Shavelle, Paculdo, Kush, 
Mannino, & Strauss, 2009). People with COPD who smoke experience more 
difficulties with anxiety (Armannsdottir & Jonsdottir, 2014) and low mood 
(Gudmundsson et al., 2006) than people who do not smoke, and strong interactions 
have been found between smoking, anxiety, depression and mortality (Lou et al., 
2014). Adverse childhood experiences have also been shown to be related  to 
continued smoking in sufferers of smoking-related illnesses, and it is suggested that 
the resultant external locus of control, poor self-esteem, and low self-efficacy 
influence both health beliefs and behaviour (Edwards, Anda, Gu, Dube, & Felitti, 
2007). Given the seriousness of continued smoking, understanding the psychological 
health, smoking behaviour, and the interplay between them for people with COPD is 
of paramount concern. 
 
Smoking addiction and behaviour 
Nicotine is a highly addictive stimulant that releases dopamine by acting 
upon nicotinic receptors in the acetylcholine system (Benowitz, 2010). Excitation of 
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dopaminergic neurons is further increased by augmented glutamate and GABA in 
response to nicotine, as desensitisation to nicotine occurs (Benowitz, 2010). Nicotine 
withdrawal is associated with side-effects such as cravings for smoking, sleep 
changes, feeling irritable, and eating more; those who smoke tend to do so repeatedly 
(Morrison & Bennett, 2012). However, biological models do not incorporate beliefs, 
or cognitive processes, which must play a role in deciding to start smoking, and to 
continue, in the face of both hypothetical, and real, health-threat information.  
Festinger hypothesised that receiving information about the health effects of 
smoking, whilst continuing to smoke, leads to cognitive dissonance that is resolved 
by rationalisations or mediating beliefs that render the behaviour acceptable (Cooper, 
2007); an example being ‘I exercise therefore that outweighs the damage from 
smoking’. Two well-researched approaches to understanding the cognitive processes 
involved in decisions about health behaviour are the Theory of Planned Behaviour 
(TPB), and the Health Action Process Approach (HAPA) (Morrison & Bennett, 
2012). The TPB has been applied to smoking attitudes, with findings indicating that 
belief in susceptibility to ill-health and positive behavioural control beliefs are the 
strongest predictors of intention to quit smoking (Norman, Conner, & Bell, 1999). 
An application of an expanded TPB model, including self-exempting beliefs, 
demonstrated that self-exemption was used to deny risk e.g. people believing they 
smoke too few cigarettes to affect their health (Peretti-Watel, Halfen, & Grémy, 
2007). The HAPA model has been applied to smoking and findings have shown 
lower risk perception was related to a lack of intention to quit smoking (Williams, 
Herzog, & Simmons, 2011) and compensatory health beliefs (e.g. I do not need to 
quit smoking because I eat healthily) are strongly negatively correlated with quit 
intentions (Radtke, Scholz, Keller, & Hornung, 2012). The Transtheoretical Model 
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of Change (TTM) is a stage-based model that predicts that people go through five 
stages (six including relapse) in changing addictive behaviours (Prochaska, 
Diclemente, & Norcross, 1992), although the cognitive dimensions of the model are 
less categorically defined than the TPB or HAPA. Collectively, for people without 
COPD, these studies imply beliefs that are compensatory, self-exempting, and 
pertain to low-risk susceptibility, and low behavioural control predict continued 
smoking. Poor knowledge and emotional arousal about tobacco use, and its impact 
on their environment are also implied predictors of continued smoking.  
Beck, Wright, Newman and Liese applied the theories of Cognitive Behavioural 
Therapy (CBT) to difficulties with substance use and alcohol consumption (Beck, 
Wright, Newman, & Liese, 1993); the construct of facilitation beliefs was 
introduced, whereby automatic thoughts, cravings and any prior anticipatory beliefs 
do not lead to the usage of a substance, rather an additional cognitive process occurs, 
where a person must permit themselves to undertake the behaviour (i.e. mediating 
beliefs). The model is distinct in that it describes the maintenance of unhealthy 
behaviour (i.e. models how a behaviour continues) rather than attempting to predict 
health behaviour change (as in socio-cognitive models such as the TPB). The Beck et 
al model has not been applied to tobacco smoking, it is unclear why, but smoking is 
less socially problematic than excessive alcohol use or drugs (Turp, 2002), despite its 
devastating health effects. However, reference has been made to the CBT model in a 
study on self-exempting beliefs in smokers; negative affect aroused from competing 
health messages creates cognitive dissonance, which further reduces the likelihood 
of quitting smoking by healthy smokers who hold strong facilitation beliefs 
(Dijkstra, 2009).  
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A review of several Health Psychology models noted that none are fully inclusive of 
all belief types, there are overlaps between concepts (e.g. self-efficacy and perceived 
behavioural control) and that most models have had limited application beyond 
trying to predict behaviour change (Taylor et al., 2006). These frameworks perhaps 
lack the breadth to model complex addiction behaviours compared to more volitional 
behaviours, and it is notable that beliefs such as reduction of stress and prevention of 
weight gain do not pertain to TPB/HAPA models (Morrison & Bennett, 2012). Yet 
these beliefs have been found in research on people who smoke, and some instances 
continue to persist in in ex-smokers, such as people believe they will gain weight 
from stopping smoking (Chapman, Wai Leng Wong, & Smith, 1993). Facilitation 
beliefs have been shown to inhibit change within the constructs of the TTM 
(Kleinjan, van den Eijnden, Dijkstra, Brug, & Engels, 2006). Given the commentary 
on the complexity of smoking behaviour, categorisation of beliefs (as per most 
behavioural change models), or restriction to a questionnaire, potentially narrows the 
focus of a model and important information may be missed. This, and difficulties 
with replicability of factors identified in previous studies, might suggest that a single 
inclusive category of ‘facilitation beliefs’ is favourable (Dijkstra, 2009). 
Missing variables limit the predictive power of any model; for example a review of 
the TPB from 185 studies found the model accounted for just 27% of the variance of 
behaviour (Armitage & Conner, 2001). Additionally, categorisation of beliefs may 
depend upon the context and the perspective of those applying the category; cutting 
down on cigarettes may be both permissive of continued smoking (in the sense of 
denial), and/or could be considered some acknowledgement of the dangers of 
smoking (Dijkstra, 2018). Categorisation brings into question the rationality of 
facilitation beliefs; risk of weight gain from stopping smoking is a factual belief and 
     
85 
 
is listed as a key risk factor for obesity (Atter et al., 2011), yet other beliefs such as 
‘lung cancer is mostly caused by air pollution’ are patently incorrect (Chapman et 
al., 1993); others involve thinking biases, such as selective abstraction of evidence or 
over-generalization (Beck, 1988), e.g. ‘many people live into very old age despite 
smoking’ (Oakes, Chapman, Borland, Balmford, & Trotter, 2004). Of course, no 
delineation between variables also renders models much more difficult to use 
predictively, but other methods of categorisation exist; notably, none of the studies 
or models discussed explicitly categorised beliefs based upon on their factual 
accuracy or bias-type. 
 
People with COPD who smoke 
People suffering from COPD must differ to healthy smokers in that they now 
have a smoking-related disease, which poses questions about concepts such as 
perception of susceptibility to illness, and self-exemption. Differences in 
characteristics between people who smoke with COPD and those without COPD 
remain somewhat unclear. A large study comparing people who smoke, with and 
without a COPD diagnosis, found no statistically significant differences in ten 
different constructs of attitude towards smoking cessation, but did find levels of 
addiction were significantly higher in those with COPD (Jiménez-Ruiz et al., 2001). 
A survey found that people who smoked with COPD were more likely to be 
depressed, more cigarette dependant, report less self-efficacy and be more aware of 
the health risks of smoking that healthy smokers (van Eerd et al., 2015). Another 
study found that, despite mild COPD being a predictor, neither severe levels of 
COPD nor recent exacerbations of COPD predicted intention to quit smoking, and 
that poorer self-reported health decreases likelihood of intentions to quit smoking 
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(Melzer et al., 2016); this appears at odds to low risk susceptibility discussed 
previously in healthy smokers, and raises questions about if and how compensatory 
and self-exempting beliefs exist in people who smoke with COPD.  
Several qualitative studies would suggest that people with COPD who remain 
smokers do hold these beliefs. Experiences of knowing people with COPD dying 
after stopping smoking, and low enough level of consumption of tobacco products 
being safe have been found as reasons to continue (Poureslami, Shum, & FitzGerald, 
2015). Another study found beliefs that cigarettes improve breathing and clearance 
of phlegm from the chest, or that COPD was down to age, occupation or just luck-
related; this study also noted cues to change smoking behaviour were not related to 
disease progression but external (Schofield, Kerr, & Tolson, 2007). Another found 
that people rated air pollution from cars as far worse than tobacco smoke, and that 
giving up smoking would mean becoming fat (van Eerd et al., 2015). Other beliefs 
include it being too late to stop, and that smoking alleviates anxiety and low mood 
(Vuong, Hermiz, Razee, Richmond, & Zwar, 2016). Accounts of cutting down 
during COPD exacerbations have also been found (Wilson, Elborn, & Fitzsimons, 
2011). Evidence has been found of acceptance of the relationship between smoking 
and COPD, but reasons such as plans not leading to outcomes, and other life-events 
distracting from cessation, were cited as reasons for continued smoking, and 
attempts to influence by others were also seen as demanding and patronising 
(Eklund, Nilsson, Hedman, & Lindberg, 2012). These reasons all have the potential 
to resolve cognitive dissonance when faced with the dilemma of smoking or quitting. 
Hilberink, Jacobs, Schlosser, Grol and Vries, (2006) found those with COPD who 
are unmotivated require support with finding advantages to quit, whereas people 
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motivated to quit require support with self-efficacy and planning. However, the 
benefits of motivation-stage-based interventions for smoking cessation in the general 
population remains unclear (Cahill, Lancaster, & Green, 2010). Motivational 
Interviewing (MI) for smoking cessation has been subjected to a Cochrane 
systematic review with findings suggesting a limited success rate in healthy smokers, 
but more effective than advice or no treatment (Lindson-Hawley, Thompson, & 
Begh, 2015). There is little evidence for the effectiveness of MI specifically with 
people with COPD who smoke, but one study suggests it has very limited efficacy 
for evoking reasons to change behaviour, but that is complicated by deviations of 
practitioners from MI methods in the study (Efraimsson et al., 2015). 
The Trying to Quit (TTQ) questionnaire was created to test whether scales, 
developed from a prior qualitative study on the process of trying to quit smoking 
with COPD,  predicted smoking cessation, (Lundh, Hylander, & Törnkvist, 2012). 
The results of the 19-item TTQ were largely insignificant, but demonstrated a higher 
score predicted less chance of a quit attempt, and that ‘pressure filled mental states’ 
(pertaining to largely self-critical thoughts) predicted lower chance of quitting in 
those ready to quit, and higher chance of reduced smoking in those not ready to quit 
(Lundh, Alinaghizadeh, Törnkvist, Gilljam, & Galanti, 2016). Whether this ‘cutting 
down’ is a compensatory belief, or a move to prepare to quit, is unclear. This again 
highlights the problems with categorisation of beliefs / constructs within 
questionnaires. Confrontational counselling was developed for people with early-
stage COPD to encourage people to think and discuss their smoking related beliefs 
and behaviours (Kotz, Huibers, Vos, van Schayck, & Wesseling, 2008). A 
randomised controlled trial concluded that the content of the therapy (rather than 
intensity) may alter smoking related cognitions and lead to successful smoking 
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cessation (Kotz, Huibers, West, Wesseling, & van Schayck, 2009).  
However, a recent Cochrane review of smoking cessation interventions for people 
with COPD found that high intensity behavioural interventions combined with 
pharmacotherapy resulted in people being twice as likely to quit than with 
behavioural interventions alone; some evidence suggested higher intensity 
behavioural interventions are more effective, but there was no evidence of difference 
in effectiveness of behavioural method. The review also concluded there is still a 
lack of evidence as to whether smoking cessation needs are different for people with 
COPD to those without (van Eerd, van Der Meer, van Schayck, & Kotz, 2016). 
The lack of evidence for motivational interviewing, relative homogeneity of 
effectiveness of behavioural smoking interventions, the heterogeneity of the beliefs 
that people who smoke with COPD hold, as well as the relationship with anxiety and 
depression behoves further understanding of the psychological mechanisms that 
maintain smoking. Viewpoints of healthy smokers have been explored using Q-
methodology (Collins, Maguire, & O’Dell, 2002; Farrimond, Joffe, & Stenner, 
2010), but no study has applied this to explore viewpoints amongst people with 
COPD to identify the viewpoints that permit continued smoking.  
 
Aims 
The aim of this study is to understand the diversity of, and relationships 
between, the shared explanations of people with COPD in making the decision to 
continue smoking. The research question being ‘what are the shared explanations 
people with COPD give when deciding to continue smoking?’ 
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Method 
 
Design 
This cross-sectional study utilised Q-methodology to examine inter-
subjectivity of beliefs used by people with COPD to justify smoking. Q-
methodology utilises the placement of statements (referred to as the Q-set) onto a 
grid for identifying how groups of people makes sense of a subject in similar or 
differing ways (Watts & Stenner, 2005). Q-methodology differs from R-
methodology (regular factor analysis) in that the participants (referred to as the P-
Set) are considered the variables, rather than statements/questions (which would be 
the case in a questionnaire). Factor analysis in Q-methodology compares the sorts 
(i.e. each person) with one another to identify factors, rather than comparing 
statements with one another. The outcome of this by-person factor analysis are 
groups who share similar viewpoints based on the set of statements (Watts & 
Stenner, 2012). Q-sorts which load on to a factor are merged to give an ideal factor 
array from which these shared viewpoints can be interpreted. Although not used to 
generate predictions, Q-methodology is an abductive approach, and can be used to 
create hypothetical explanations generated from individual unique experiences 
(Shank, 1998).  
 
Ethical Approval 
The study protocol was peer-reviewed and approved by the sponsor 
(Staffordshire University). Health Research Authority, NHS Research Ethics 
Committee and local NHS body approvals were obtained (see Appendixes A-F). 
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People invited to the study were asked to express interest in participation directly to 
the researcher to minimise effects of power relations (i.e. avoid a sense of obligation 
to the inviting clinician who is also providing their clinical care); the information 
packs given were designed to be accessible in terms of reading age ability, these 
factors ensured that consent to be contacted was both informed and voluntary. After 
taking part, participants were given time to withdraw their data; none withdrew 
consent after completing their participation. Data was anonymised.  
 
Materials and Measures 
Derivation of the concourse (the Q-set) involved using information from a 
systematic search and review of the research literature in July 2017 (see Chapter 1) 
to create 52 statements. Consultations with other psychologists, NHS COPD staff, a 
peer-led charity support group for COPD sufferers, as well as reflections on clinical 
experiences, edited and refined this to 73 (see Appendix I). These were printed onto 
laminated cards with a unique number on the reverse. Velcro was added to enable 
ease of placement. An A0-size foam board was utilised to create the Q-grid. 
The Q-grid was designed for the process of ipsative (forced choice) sorting of these 
statement cards based on a quasi-normal distribution curve, with 13 columns ranked 
from -6 (least like my thoughts) to +6 (most like my thoughts) – see Figure 1. The 
ipsative approach was deemed acceptable due to the enormous number of 
permutations available in a 73 statement 13 column grid. An electronic duplicate of 
the study was created using the software QSortWare (Pruneddu, 2018) and Qualtrics 
(Qualtrics, 2018) and made available online with a dedicated website. 
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 Rank -6 -5 -4 -3 -2 -1 0 +1 +2 +3 +4 +5 +6 
Statements (n) 2 4 5 6 7 8 9 8 7 6 5 4 2 
Figure 1 Q-grid Layout 
The Hospital Anxiety and Depression Scale (HADS) was utilised to measure 
depression and generalised anxiety (Mykletun, Stordal, & Dahl, 2001). Age, gender, 
ethnicity, desire to quit smoking, and the number of previous quit attempts were also 
recorded about the participants (P-Set); this information was used to help understand 
the factors derived from the Q-sort process, and how they may differ from one 
another (e.g. is one viewpoint predominantly expressed by men?) (see Appendix M). 
Key points and remarks were written down to aid understanding of the ideal factor 
arrays during the analysis process. 
 
Participants 
The P-Set comprised of a purposive sample of 18 participants with a 
diagnosis of COPD, under the care of three Secondary Care NHS Respiratory 
Teams, with another 4 participants recruited online using social-media platforms. 
Table 1 illustrates participant characteristics. 
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Table 1 Participant Characteristics 
Variable Name Category No. (%) 
Age 50-59 3 (13.6%) 
 60-69 7 (31.8%) 
 70-79 12 (54.5%) 
Gender Male 10 (45.5%) 
 Female 12 (54.5%) 
Ethnicity White 21 (95.5%) 
 Not Stated 1 (4.5%) 
Previous Quit Attempts 1-5 14 (63.6%) 
 6-10 6 (27.3%) 
 11+ 2 (9.1%) 
Desire to Quit Smoking No Desire 6 (27.3%) 
 Somewhat 6 (27.3%) 
 Very Much 9 (40.9%) 
 Quitting Now 1 (4.5%) 
 
Participants seen face-to-face were invited to the study by specialist nurses and 
physiotherapists. Online participants were recruited via promoted posts and tweets 
and relied on interested parties sharing the links directing them to the dedicated 
website. Informed consent was obtained.  
Inclusion criteria were being a smoker (i.e. smoked in last 3 months) with COPD, to 
have capacity to consent to the study, and over 18 years old. People on Advanced 
Respiratory Disease Pathways and thought to be within 6 months of death, and those 
whose consent could not be reliably ascertained, were excluded from recruitment for 
ethical reasons. 
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Procedure  
Participants completed the questionnaires and were then asked to think about 
why they continue smoking and to sort the 73 cards into piles of agree, disagree and 
neutral/unsure. They were then asked to place these on the grid in order that fitted 
their view, and when complete, asked to check the placements. They were invited to 
freely comment on the process and their beliefs throughout the process 
Data Analysis 
Q-sorts were analysed using the web-based program Ken-Q (Banasick, 2018) 
following guidelines from Watts & Stenner (2012). Factor interpretation considered 
both ideal factor arrays and participants’ comments. A senior Clinical Psychologist 
also independently interpreted the ideal factor arrays, which yielded a consensus on 
the factors.  
Results 
 
Correlations 
Significant correlation (p<0.05) was calculated to be (1.96 x (1/√n 
statements)) = 0.23 using the formula from Brown, (1980). Participants inter-
correlated strongly indicating similarities in their viewpoints, with each sort 
correlating with between 2 and 17 other sorts (median 10.5) (Correlation Matrix is 
provided in Appendix G). 
Data Analysis 
Q-sorts were subjected to Factor Analysis (Table 2) to explore latent 
variables present in the data-set (Clark-Carter, 2010); the Centroid method has a long 
standing use in Q-methodology and is known for producing indeterminate numbers 
of solutions whilst not violating statistical assumptions (Ramlo, 2011). This 
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indeterminacy is compatible with the abductive approach of Q-methodology (Brown, 
1980). Whilst the Kaiser-Guttman criteria (Watts & Stenner, 2012) indicates a 2-
factor solution (Eigenvalues >1), the third factor’s eigenvalue was close to one; 
minority views risk being overlooked by blanket application of arbitrary cut-off 
criteria (e.g. is a factor with an eigenvalue of 1.01 more important that one with 
0.99) (Ledesma & Valero-mora, 2007), that is the number of sorters does not 
determine if a viewpoint is relevant (Ramlo, 2011). Humphrey’s Rule, where a factor 
can be considered significant if the cross-product of the two highest loadings 
(independent of sign) of the factor exceed the standard error (Brown, 1980), was 
applied and indicated that a three-factor [1,2,3] solution was acceptable (see 
Appendix H). This solution explained 35% of the variance in the data and is 
considered a successful model (Watts & Stenner, 2012). Varimax orthogonal rotation 
was applied to maximise the differences between the three factors (Field, 2016) (see 
Appendix H for details).  
 
Table 2 Unrotated Factor Loadings 
Factor 
Eigenvalues % Explained Variance 
1 5.2834 24 
2 1.4933 7 
3 0.9418 4 
4 0.8021 4 
5 0.7534 3 
6 0.1866 1 
7 0.1847 1 
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Reliability 
Reliability was checked by repeating the Q-sort process four weeks later, 
with two people, early in the data collection process. Both repeat sorts correlated 
strongly with their original sorts at 0.72 and 0.66, with strong 
agreement/disagreement statements noted to be in similar positions suggesting 
viewpoints were stable. 
 
Consensus Statements 
Multiple statements were broadly consensual (no statistically-significant 
difference, p>0.05) across the people loading onto the three factors. Smoking helps 
them to relax and not feel stressed (49, F1+5, F2+5, F3+4), and stops them becoming 
too irritable (52, F1+5, F2+3, F3+2). They accept that smoking worsens their COPD 
and it is their responsibility and the price they pay (5, F1+4, F2+3, F3+4), and 
disagree that smoking is just irritating their chests (4, F1-2, F2-4, F3-1), or there are 
no benefits to smoking cessation (39, F1-4, F2-5, F3-4). They also view alternatives 
to smoking as having too many side-effects (56, F1+2, F2+1, F3+1), do not 
experience embarrassment as a barrier to seeking help (24, F1-4, F2-3, F3-5), and do 
not see their engagement in Pulmonary Rehabilitation as mitigating their continued 
smoking (65, F1-3, F2-3, F3-4), nor do they vary the amount of smoke they inhale 
when unwell (32, F1-3, F2-4, F3-2). Smoking is not seen as particularly sociable or 
part of their social lives (58, F1-1, F2-1, F3-2). Despite being significantly different 
at p<0.01, they shared the belief that the decision to stop smoking has to be their 
own (15, F1+5, F2+6, F3+4).  
Beyond this consensus, three distinct positions justifying continued smoking with 
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COPD were identified. The ideal factor arrays are shown in Appendix J, and tables 
of distinguishing and consensus statements in Appendix K. Distinguishing 
statements within this text are referred to with an asterisk* next to the rank number 
for those significant at p<0.05, those at p<0.01 are shown with double asterisk**. 
 
Factor 1: 
This factor explained 15% of the variance, and 8 participants loaded on to 
this factor. Two participants were aged 50-59, six were aged 70-79. Five had no 
desire to quit, two some desire, one very much wanted to quit smoking. The number 
of previous attempts to quit ranged from 3 to 6. Mean HADS anxiety and depression 
scores were 6.6(±4.8) (none) and 7.4(±5.9) (none). 
In addition to the consensus statements, this viewpoint represents people who justify 
continuing to smoke because they strongly enjoy it (18 +6), and they see being a 
smoker as somewhat part of their identity (59 +2*). Participant 2 particularly 
explained the various types of cigarettes they enjoyed in their lifetime. It is their 
choice and their business to continue smoking (10 +5**), and somewhat believe they 
could stop if they really wanted to (29 +2), yet, they are almost unsure as to whether 
they have the willpower and self-discipline to quit (28 +1), and experience addiction 
withdrawal symptoms as too unpleasant to stop smoking (14 +4), as having tried 
quitting before, it was awful (70 +3). However, in justifying continuing they are also 
very resigned to the idea that it is too late to stop as the damage is done (40 +6**), 
despite knowing that smoking causes and worsens COPD, they do not feel 
threatened by it (2 +2), and that you have to die from something (64 +4), most did 
not comment on these, excepting Participant 17 who said ‘maybe it’s not that bad-a-
way to go’. Future-plans to stop smoking do not feature as part of their view (30 -
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3**). They do not want to see doctors (27 +3**), are unsure whether cutting down 
smoking means there is no need to stop (71 0) and are unique in being ambivalent 
about whether they would accept someone flipping a switch to make them stop (33 
0**). 
As well as helping them to stay calm and less irritable, people represented in this 
factor also describe a number of additional benefits from smoking in that it 
stimulates them (50 +3**) and helps them to concentrate (48 +4*). They also see 
smoking as preventing them from becoming too anxious (51 +4), as well as stopping 
them from becoming depressed (53 +3). Participant 3 explained that ‘If I quit I 
would go back because of my mood, it’s a balancing act between smoking and 
depression’. They believe to some degree that smoking helps them clear their chest 
(45 +2) and think they would be bored if they stopped smoking (57 +2**).  
They are realistic about the relationship between COPD and their smoking, strongly 
refuting the belief that smoking does not cause or worsen COPD (3 -6*), or that it is 
simply bad luck (6 -5), or just down to being old (7 -5). Unlike others they do not 
want to be shocked by what will happen if they do not stop (-16 6**), suggesting 
they might be aware of the consequences and do not want hear the details, but it is 
not their fault as the dangers of COPD were not known when they started smoking 
(11 +3). They hold some mitigating views by thinking of relatives who have lived to 
an old age despite a lifetime of smoking (69 +3*), or a possibility that quitting 
smoking may be dangerous to their health (41 +1); Participant 7 explained ‘my mum 
died of cancer and never smoked, yet my dad quit smoking and then died from an 
arterial blockage, question is, did quitting smoking cause plaques to break off’. 
They do not find it easier to deny and hide the fact they smoke (22 -5), and do not 
     
98 
 
blame feelings of guilt and shame for making them smoke (25 -2). Despite being 
resigned to the damage, they do not hold the view that smoking lighter cigarettes (72 
-3**) or cutting down smoking when unwell (31 -2**), are justifications for 
continuing to smoke. 
 
Factor 2:  
This factor explained 12% of the variance, and 6 participants loaded on to 
this factor. One participant was aged 50-59, five were aged 60-69. One had some 
desire to quit, with five very much wanting to quit smoking. The number of previous 
attempts to quit ranged from 1 to 10. Mean HADS anxiety and depression scores 
were 8.5(±4.2) (mild) and 5.2(±3.7) (none). 
People represented in this factor most strongly wish someone could simply flip a 
switch to get them to stop smoking (33 +6), and simultaneously believe it has to be 
their own decision to stop (15 +6). They strongly deny it is their fault as the dangers 
of COPD were not known when they started smoking (11 +5**). Being a smoker 
forms no part of their identity (59 -6**) and they strongly refute that they would 
mourn their cigarettes if they gave up (63 -6**); cigarettes are not their friends (61 -
3**), and as such they are unsure if they like smoking (18 0**). Participant 10 
illustrated this ambivalence in saying ‘I like smoking, but I don’t like it’.  
They somewhat believe that other air pollutants are more damaging that smoking (73 
+2), and strongly believe that it is helpful to cut down their cigarettes when feeling 
unwell (31 +5**). Participant 12 explained ‘I’ve moved the cigarettes away from the 
sofa, so I have to get up and walk to get one, that has forced me to cut down; I also 
test my cough each day and if it’s ok then I see it is ok to smoke’.  
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They also quite strongly believe they lack the willpower to quit (28 +4) yet purchase 
smoking aides and alternatives in case they wish to stop (35 +3**). They wish to be 
told to stop, and shocked about the consequences of not doing so (16 +2*), but 
conversely, strongly believe the more they are told not to smoke the more they do 
smoke (67 +4**). It is never the right time to quit as other things get in the way (23 
+3); however, they plan on stopping in future which helps them feel okay (30 +4). 
Participant 15 went as far as saying ‘I plan to stop when I go in for my operation’. 
To some extent they believe they are not offered enough support to quit smoking (21 
+2**). They feel inferior for still smoking (26 +3), and guilty or ashamed of making 
themselves ill which leads them to smoke more (25 +2**). Participant 5 explained 
‘there is very little [cessation] help available from the NHS nowadays… I feel guilty 
for still smoking though’. They feel a sense of hopelessness about their smoking and 
their illness (42 +4), but do not tend to adapt to their symptoms (36 -4**), and are 
able to retain some optimism in not believing that it is too late to quit (40 -5**), nor 
that you have to die of something so why not carry on (64 -2**).  
Beyond these, in addition to consensus statements, exemplars of factor two agree 
with factor one about preventing them from becoming depressed (53 +4), and to a 
lesser extent assisting with anxiety (51 +2), and concentration (48 +2). They 
somewhat believe that they can stop smoking if they really want to (29 +2), and do 
not deny and hide the fact that they smoke (22, -3), nor do they see COPD as just 
down to bad luck (6 -5). Withdrawal symptoms are described as unpleasant (14 +3), 
and quitting being awful is strongly cited (70 +5).  
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Factor 3:  
This factor explained 8% of the variance, with a loading of 3 participants. 
Ages were in the 70-79 range, and quit attempts ranged from 1-17. Two participants 
very much wanted to quit smoking, whilst the other somewhat wanted to quit. Mean 
HADS anxiety and depression scores were 8.0(±3.6) (mild) and 6.7(±4.0) (none). 
People represented in this factor very strongly see themselves as slaves to smoking 
(20 +5**) who adapt their lives to their COPD symptoms, so they do not notice their 
health worsening (36 +5**). They view cigarettes as friends (61 +5**) that would be 
mourned if given up (63 +2), and uniquely are very against the idea of banning 
smoking (17 -5**). They justify continuing to smoke by cutting their consumption 
right down (71 +2), participant 13 explained ‘I wish I’d stopped when I had to go 
into hospital, but I’ve cut down from 30/40 to 10/15 per day’. Hiding or denying 
they smoke is seen as easier (22 +3**).  Unlike the other two factors, withdrawal 
symptoms from smoking are not cited as problematic (14 -1**), and their smoking is 
not related to managing anxiety (51 -3**) or depression (53 -5**). The environment 
is seen as influential, as coming home to a familiar place after stopping starts them 
smoking again (19 +2*). Participant 18 explained ‘I don’t smoke at my daughter’s, 
but I don’t know why’.   
There is understandable uncertainty as to whether they could quit if they wanted to 
(29 0*). They emphasise that they did not know smoking caused COPD (1 +3) and 
there is some agreement that their COPD is just down to bad luck (6 +1**). Despite 
accepting responsibility, an overall position of uncertainty is taken on whether 
smoking causes or worsens COPD within this factor (3 0**), and there is uncertainty 
as to whether there is a genetic reason for their condition (8 0**), as well as whether 
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smoking is part of their identity (59 0*). Participant 18 explained ‘I believe that 
smoking is related to heart disease but not COPD’. Similarly, participant 13 stated ‘I 
accept people say it’s caused by smoking, I’m not sure if it is or it isn’t’.  
Participants in this factor share some characteristics of factors one and two. They 
have a similar strong enjoyment of smoking to factor one (18 +6), and to a lesser 
degree believe that it is too late to quit smoking as the damage is done (40 +3**) and 
that you have got to die of something (64 +3). They too believe that smoking helps 
them clear their chest of phlegm (45 +3). Like those in factor two, they wish that 
someone could flip a switch to make them stop (33 +6), and more strongly wish 
someone would shock them into stopping (16 +4*). They share a degree of 
hopelessness about their smoking (42 +3), a lack of willpower (28 +2), yet they 
strongly identify with planning to stop smoking in future (30 +5), but it is never the 
right time to stop (23 +2), and air pollution is considered more damaging for their 
health (73 +4). Participant 18 explained that ‘the diesel fumes by the roads are 
terrible’. 
 
Non-exemplar Q-sorts 
Five sorts did not load onto a single factor. Participants 1 and 6 both loaded 
onto all three factors, and both discussed smoking when alone. Participant 1 
described ‘since I lost my partner I’ve noticed loneliness is a trigger, I get anxious 
which sets me off smoking, but I don’t smoke when I’m with my friends’. 
Participant 6 also lived alone and explained that they had survived cancer, and 
noticed they smoked a lot more when alone ‘those are the enjoyable cigarettes, when 
I’m on my own I’m not hurting anybody else, those are the ones I enjoy’. Both 
agreed smoking alleviates loneliness in their sorts (60 +6 and +4 respectively). 
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Participant 4 loaded onto factors two and three and stated that it was difficult living 
close to a shop, and that the more they try and stop thinking about smoking the more 
it happens. Participant 11 was actively preparing to quit on holiday and strongly 
loaded onto factors two and three but interestingly found several of the statements 
did not quite fit because she had decided to stop smoking. Participant 21 had just 
started a quit attempt and loaded onto factors two and three. 
 
Post-Hoc Analysis 
Inspection of supplementary data (HADS, the desire to quit, gender etc) 
noted differences in age and desire to quit between factors. Fisher’s Exact Tests 
showed that there was a statistically significant difference in the distribution of age 
bands; factor two loaded with younger participants than factor one (p=0.001) and 
factor three (p= 0.012). Desire to quit was significantly greater in factor two than 
factor one (p=0.018), but differences in desire to quit between factors one and three 
did not reach statistical significance (p=0.121). See Appendix L for details.  
 
Discussion  
Twenty-Two Q-sorts were undertaken, with factor analysis identifying three 
shared viewpoints across seventeen participants, each giving differing reasons and 
justifications for continuing to smoke with COPD, there were no observed 
differences in HADS scores between factors, but those who had no desire to quit 
smoking only loaded onto factor one. A summary of the factors and their meaning is 
given in table 3. 
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Table 3 Factor Interpretations 
 
  
Factor Name Explanation of Factor 
1 Stoic Fatalism People with this viewpoint accept that COPD is related to smoking and say that 
smoking prevents anxiety and low mood. Difficulties with addiction are also 
stated and smoking is a part of person’s identity. The view is that continuing to 
smoke is the business and choice of the person with COPD, and they do not want 
to be shocked about what will happen, suggesting they do not wanting to stir up 
feelings (Stoicism).  
 
People with this view also say that the damage from smoking is already done, 
and that you have to die of something, meaning they think nothing can really be 
done (Fatalism) which justifies choosing to continue enjoying smoking. 
 
2 Optimistic 
Passivity 
People with this viewpoint accepts that COPD is related to smoking and, like 
factor 1, think that smoking prevents anxiety and low mood. However, people 
with this view do not particularly like smoking, and smoking is not a part of their 
identity. There is a desire to quit, and they are positive that it is not too late as 
there will be benefits to quitting (Optimism).  
 
There is a feeling of guilt. By cutting down smoking when unwell, smoking 
lighter cigarettes, buying nicotine replacement therapy, planning on quitting in 
future, and thinking that it is never being the right time, they put off quitting. The 
wish that someone could flip a switch, or shock them into stopping is there, but 
when they are told to stop they just smoke more. This takes a step back from an 
active and determined position to quit (Passivity). 
3 Ambivalent 
Masochism 
People with this viewpoint have some positive thoughts about it not being too 
late to stop and about plans to quit, but also that it also might be too late – the 
mind cannot be made up. They seem to accept that smoking is probably making it 
worse, but also have some doubts about smoking causing their COPD 
(Ambivalent). 
 
People with this view are not worried about withdrawal symptoms from smoking 
but describe themselves as slaves to cigarettes. They would desperately like 
someone to be able to stop this magically, but just as strongly really enjoy 
smoking; control remains with the cigarettes and the harm is adapted to 
(Masochism). 
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Factor 1 – Stoic Fatalism 
This factor appears to be a paradoxical juxtaposition of resignation and 
choice. Emphasis is on enjoyment and choosing to smoke which on face value may 
suggest choosing pleasure over health; however, the viewpoint also contains 
contradictory positions such as the damage is now done, and that you must die of 
something, but agreeing there are benefits to stopping. Furthermore, there are 
difficulties with addiction withdrawal symptoms, emotions and will-power. Choice 
is almost antonymous to addiction, yet paradoxically smoking is described as both. 
This contradictory positioning suggests a dilemma, perhaps that the perceived costs 
of quitting outweigh the benefits (e.g. worsening COPD and not depressed vs 
depression and still having COPD), or that quitting is futile i.e. my COPD will not 
get better either way. Essentially, people with this viewpoint express that because the 
damage is already done (fatalistic resignation), there is no point in stopping, 
therefore one chooses to continue smoking because one enjoys it (stoicism in the 
face of very few options). Further contradictory positions are noted, such as knowing 
the dangers of continuing, but suspicion that quitting might be harmful, and the 
denial of feeling hopeless about smoking and COPD, yet strong disagreement with 
the idea of being shocked about what will happen by continuing to smoke; this 
suggests despite intellectual understanding, that it might be emotionally 
uncomfortable to really consider the outcome of continuing to smoke. It would 
appear cognitive dissonance around quitting is resolved by framing smoking as a 
reasoned active choice, which gives a sense of control against the idea of being 
addicted; conversely, the fated outcome means it is unrelated to their choice (yet 
oddly most attend pulmonary rehabilitation classes) which serves to avoid feelings 
associated with smoking and the outcome.  
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Factor 2 – Optimistic Passivity 
Whilst sharing similar perspectives on addiction, low mood and anxiety, 
what appears to distinguish this factor is a sense of desperation, guilt and wanting 
support against an addiction; the wish for an external magic solution is as strong as 
the almost opposing belief that they must make the decision in their own mind to 
quit, but yet they continue smoking cigarettes, despite not particularly liking 
smoking. Mitigating and exempting beliefs, and their related behaviours, appear to 
be deployed to deal with the guilt of continuing to smoke; these include cutting 
down smoking when unwell, rating air pollution as being worse than smoking, 
stocking-up on smoking cessation aides, smoking lighter cigarettes, and planning to 
quit one day, held around the idea that the damage is not done, and they do not have 
to die from their smoking (retaining a sense of optimism). The sense of this is ‘yes I 
want to stop, but…’, essentially quitting smoking is deferred but not dismissed and 
procrastination occurs. Uniquely, smoking is related to a feeling of inferiority, but a 
strong emphasis on not knowing the dangers previously, it not being the right time to 
stop, and that prior attempts to quit were terrible; these might further mitigate guilt 
and permit smoking to continue (passivity and procrastination). They state they 
require more support to quit, and want to be shocked in to it, but to tell them they 
need to stop leads to more smoking (in either defiance or helplessness); either-way 
the other becomes responsible, and they are further ensconced into a passive 
position. The passivity appears to link back to desperation in wishing smoking was 
banned. These findings are similar to those described by Eklund et al., (2012). Like 
factor one, there are also reasons around mood and anxiety for continuing, which 
might exacerbate the sense of desperation, and possibly exacerbate the guilt and 
     
106 
 
shame they experience, but in contrast they are not fatalistic and retain hope of 
change. The cognitive dissonance (and possibly the guilt) for this viewpoint seems to 
be resolved by a sense of deferral; planning to stop one day when they get enough 
support, that they have made changes, and it is not too late yet.  
 
Factor 3 – Ambivalent Masochism 
Factor three has a conflicted and undecided feel and is like being in two-
minds; smoking is positioned as out of personal control, as they are slaves to their 
cigarettes, which they desperately want to stop, wishing something could do it for 
them at the flick of a switch. Paradoxically, they really enjoy smoking, all the while 
sacrificing their health for it by adapting and not noticing it getting worse 
(masochistic sacrificing relationship). Uniquely, whilst there is some 
acknowledgement of the reality of the link, smoking and COPD have a less clearly 
defined relationship in this viewpoint, particularly around whether it is the cause of 
COPD (ambivalence). Cigarettes are companions who would be missed. There is an 
indecisive relationship with smoking, one part really wants to leave, but the other 
wants to stay an enslaved smoker. There are some justifications made about damage 
already being done and feeling somewhat hopeless; although the worsening of 
COPD by smoking was not denied, it was not highly believed either, yet there are 
still plans to quit and smoking cessation medications are ready on standby; it is as if 
one moment there is hope and they will leave, the next minute there is no point and 
they must stay. The mind is never made up. The cognitive dissonance seems 
prevalent in this factor and instead of resolving, seems to move from one view to the 
other. A reluctance to fully believe the relationship to smoking (particularly to the 
genesis of their COPD), finding it easier to hide their smoking, and adapt to their 
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COPD symptoms might function to loosen the association of illness and smoking, 
which makes it easier to continue in an enslaved relationship, from which one 
derives pleasure, than to leave. 
 
Non-Loading Sorts and Loneliness  
Two people indicated loneliness was a large part of their smoking and did not 
load onto one factor. Two others, one of whom was just about to attempt to quit 
smoking, and the other had just started a quit attempt, did not load either. This 
suggests that people taking some form of action may have another viewpoint to their 
smoking; however, one participant loading onto factor two had verbalised their plans 
to quit when they go into hospital for an elective operation. 
 
Relationships to Existing Research 
Many of the statements rated positively in this study are supported by 
existing research from which many of them were derived. For example, people 
believing it is too late to stop (factors one and three) is well documented by Wilson 
et al., (2011), Jones, Hyland, Hanney, and Erwin, (2004), Nykvist, Larsson, and 
Dahlborg Lyckhage, (2014), and Vuong et al., (2016). However, in contrast to the 
literature, this study did not find evidence of viewpoints that smoking was 
considered sociable (e.g. Hilberink et al., 2006, Wilson et al., 2011) or the levels of 
outright denial of links between COPD and smoking seen in some studies (e.g. 
Bjarnason, Mikkelsen, and Tønnesen, 2010). No evidence was found in the factors 
that health professionals lack sympathy (van Eerd et al., 2015). Anxiety about 
smoking leading to further smoking, and concerns about weight-gain (Nykvist et al., 
2014) were not demonstrated either, nor were beliefs about smoking preventing 
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infections (Poureslami et al., 2015). There was no evidence that COPD is perceived 
as an age-related illness idea or the idea that smoking just irritates the lungs, or that it 
helps breathing (Schofield et al., 2007)  
The viewpoints in this study appear more complex than being reduced into a handful 
of thought categories; mediators of confrontational counselling (Kotz et al., 2009) 
were partially supported, as were some of the constructs of the expanded-TPB 
(Peretti-Watel et al., 2007) and HAPA (Radtke et al., 2012), but beliefs about control 
and attitudes were often contradictory. All viewpoints had an awareness of the risks 
of continuing to smoke; however, factors two and three utilise some ‘self-exempting’ 
or ‘compensatory’ beliefs (e.g. cutting down cigarettes, air pollution being worse), 
but others were absent, such as not needing to quit because of attending Pulmonary 
Rehabilitation etc. The factors also do not fit neatly onto the TTM model (Prochaska 
et al., 1992); for example, factor one crudely appears pre-contemplative, but those 
that loaded had attempted quitting at least three times, and some had a desire to quit. 
Based on the supplementary desire-to-quit data, it is more accurate to say factor one 
encompassed people who are pre-contemplative, and all factors encompassed people 
with some level of contemplation.  
 
Contextual Relevance of Findings 
Improvements are underway for people with COPD who have difficulties 
with anxiety and depression under the Improving Access to Psychological Therapies 
(IAPT) programme for long-term conditions (Roth & Pilling, 2015); however, there 
are no competencies listed for psychological practitioners to be able to undertake 
interventions to help people consider/stop smoking. This study suggests, broadly in 
line with Tselebis et al., (2016), that psychological formulation with people with 
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COPD should be idiosyncratic, and inclusive of smoking, rather than treating low 
mood and anxiety difficulties as separate entities. It may be helpful to work jointly 
with a smoking cessation specialist; however, this may be challenging as smoking 
cessation services in the UK have experienced drastic cuts (Cancer Research UK and 
Action on Smoking Health, 2018). Furthermore, COPD services in the UK also have 
very varied levels of access to Clinical Psychology input outside of IAPT. 
 
Utility of the findings 
This study offers a novel understanding of smoking with COPD by 
interrogating the maintenance of the behaviour rather than the desire to change it. 
Contrary to existing socio-cognitive models, it accounts for both contradictions in 
thoughts, and similarity of views with differing levels of desire to quit. Equally, it 
recognises idiosyncratic perspectives, whilst illuminating shared latent variables, and 
accounts for relationships between smoking, anxiety and low mood 
The current evidence base for psychological approaches to depression and anxiety in 
COPD is sparse (Pollok et al., 2016; Usmani et al., 2013), as such joined-up 
psychological interventions will require careful thought. The utility of an 
intervention will be guided by the formulation and feedback from the client; to assist 
with smoking and mental health difficulties, Clinical Psychologists will likely need 
to draw upon and synthesise multiple methods e.g. CBT, Psychodynamic, Systemic, 
Attachment Theory etc, as well as models from Health Psychology domains. 
Processes that could be important for addressing smoking and mental health 
difficulties might include carefully moving from a stoic position to experiencing 
emotional arousal, as highlighted in the TTM (Prochaska et al., 1992), but also 
prevalent in psychodynamic theories  (Leiper, 2014). The negative future component 
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of the cognitive triad (Beck, Rush, Shaw, & Emery, 1979) may link low mood and 
fatalistic outlooks on smoking; as such, the use of motivational interviewing, 
CBT/evidence-based reasoning, and careful Socratic questioning (Padesky, 1994) of 
possible cognitive biases (e.g. still attending pulmonary rehabilitation versus ‘it is 
too late’) may be helpful in trying to shift from fatalism to determinism, improve 
mood, and identify advantages to stopping. Value-based interventions from 
Acceptance and Commitment Therapy (ACT) have been shown to improve health-
related behaviours in chronic pain (Vowles & McCracken, 2008), and might also be 
useful for people with COPD (Duckworth & Dionne, 2011). Improving self-efficacy 
via implementation intentions (Armitage, 2016), undertaking behavioural 
experiments (Bennett–Levy et al., 2004) and challenging procrastination (without 
which optimism becomes increasingly unrealistic, see Jefferson, Bortolotti, & 
Kuzmanovic, 2017), might each help reduce passivity. Examining relationship 
processes, promotion of self-confidence and assertiveness may reduce submission 
and build a more internal locus of control. Consideration of attachment-style, and 
parallels in accounts of smoking, may also be important (e.g. factor one appears 
avoidant of feelings, whereas factor three describes being overly-attached to 
cigarettes). Evidence-based reasoning, and direct challenge of unrealistic beliefs to 
reduce ambivalence may also be indicated individually (Kotz et al., 2008), or in 
group programmes such as pulmonary rehabilitation.  
The utility of these techniques will of course depend upon the contract between the 
Psychologist and the person wanting help, and the broader formulation; a decision 
balance sheet is likely to be far easier to undertake informally than exploring hidden 
feelings psychodynamically. Consideration as to the wider relational patterns 
(including loneliness and grief), and the family and cultural scripts (Dallos & Draper, 
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2010) is of course warranted and part of psychological formulation; intervention 
might need to be at a social and community level, or may involve working with 
respiratory teams to adapt their approaches.  
Lastly, it must be respected that people ultimately have the right to smoke and view 
it as separate to any mental health difficulty they wish to seek help for; psychological 
practice must remain ethical and respect this choice. Being overt about including 
smoking in a formulation from the outset would be wise. 
 
Limitations 
The sample size was adequate for Q-methodology (Watts & Stenner, 2012); 
however, the method is abductive, not predictive, and therefore caution should be 
applied when considering the generalisability of the findings. The sample in this 
study is homogenous in terms of ethnicity. Two non-exemplar sorts referred to 
loneliness, a suspected fourth factor may have been identified within a larger sample. 
Whilst viewpoints regarding depression, anxiety and smoking were independent of 
HADS scores, this study was cross-sectional, as such it cannot be concluded that 
viewpoints are fully independent of symptom experience. It may also be that the 
effectiveness of smoking at reducing depression/anxiety is idiosyncratic to the 
person. Whilst three distinctive viewpoints have been revealed it is not possible to 
say whether these are static or change over time, or if indeed they represent stages to 
do with disease progression and aging. Further analysis of factors may also have 
been aided by an additional question on intention to quit, and other measures such as 
time to first cigarette. 
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Future research 
Testing the replicability of these novel findings is important; questionnaires 
may also be of benefit in reaching a larger group of COPD sufferers (e.g. fatalism, 
depression and optimism have been measured in Stroke survivors (Morgenstern et 
al., 2012)). A longitudinal version of this study could also test the stability of 
viewpoints. Whilst HADS scores were independent of viewpoints, underlying 
schema (Schmidt, Joiner, Young, & Telch, 1995) and attachment styles (McChargue, 
Cohen, & Cook, 2004) were not explored; these may warrant investigation. The Q-
board was well received by participants as a method of investigation and explaining 
their smoking; a smaller tool based on this method of sorting cards warrants 
evaluation as a method of assessment. 
 
Conclusion 
Three different viewpoints appear to maintain smoking, with two 
emphasising the role of smoking in the management of anxiety and depression. More 
research is needed, and studies in COPD should fundamentally consider mental 
health when researching smoking, and vice versa. 
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From: "AMENDMENTASSESSMENT, Hra (HEALTH RESEARCH AUTHORITY)" 
<hra.amendmentassessment@nhs.net> 
Date: 25 May 2018 at 13:36:17 BST 
To: "c001201d@student.staffs.ac.uk" <c001201d@student.staffs.ac.uk>, 
"n.chockalingam@staffs.ac.uk" <n.chockalingam@staffs.ac.uk> 
Cc: "Researchconsortium (WORCESTERSHIRE ACUTE HOSPITALS NHS TRUST)" <wah-
tr.researchconsortium@nhs.net>, "AMENDMENTASSESSMENT, Hra (HEALTH 
RESEARCH AUTHORITY)" <hra.amendmentassessment@nhs.net> 
Subject: IRAS 236588. HRA Approval for the Amendment  
Dear Mr Chimonides, 
  
Further to the below, I am pleased to confirm HRA Approval for the referenced amendment.  
You should implement this amendment at NHS organisations in England, in line with the 
conditions outlined in your categorisation email.   
User Feedback 
The Health Research Authority is continually striving to provide a high quality service to all 
applicants and sponsors. You are invited to give your view of the service you have received 
and the application procedure. If you wish to make your views known please use the 
feedback form available on the HRA website: http://www.hra.nhs.uk/about-the-
hra/governance/quality-assurance/. 
Please contact hra.amendments@nhs.net for any queries relating to the assessment of this 
amendment. 
Kind regards 
Chris Kitchen 
Assessor 
 
Dr Chris Kitchen 
Assessor 
Health Research Authority 
3
rd
 Floor, Barlow House, 4 Minshull Street, Manchester, M1 3DZ  
T. 0207 104 8193 
E. hra.approval@nhs.net 
W. www.hra.nhs.uk  
  
Our latest guidance on how the upcoming GDPR affects health research is now live. 
  
Sign up to receive our newsletter HRA Latest. 
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Appendix D - Local NHS R&D Approval Confirmations 
 
 
From: WALKER, Anna (WORCESTERSHIRE ACUTE HOSPITALS NHS TRUST) 
<anna.walker7@nhs.net> 
Sent: Tuesday, March 13, 2018 1:30:59 PM 
To: CHIMONIDES Clive 
Cc: ROWAN, Emma (WORCESTERSHIRE ACUTE HOSPITALS NHS TRUST); NOLAN, Jane 
(WORCESTERSHIRE ACUTE HOSPITALS NHS TRUST); COMBES Helen 
Subject: IRAS 236588 Confirmation of Capacity and Capability at Worcestershire Acute 
Hospitals NHS Trust  
  
Dear Mr Chimonides, 
Re: IRAS 236588 Confirmation of Capacity and Capability at Worcestershire Acute 
Hospitals NHS Trust (WAHT) 
[Psychological exploration of the cognitions preventing smoking cessation or maintaining 
smoking in Chronic Obstructive Pulmonary Disease (COPD) suffers; A Q-Methodological 
Study] 
This email confirms that Worcestershire Acute Hospitals NHS Trust has the capacity and 
capability to host the above referenced study. Please find attached our agreed Statement 
of Activities as confirmation. 
We agree that research activities in relation to this study may commence on 13th March 
2018, as previously discussed. Please refer to the HRA Letter of Approval dated 19th 
February 2018 for the latest versions of approved documentation. 
I have attached an electronic copy of the Letter of Access that will allow you to undertake 
your research activities at WAHT. 
Please do not hesitate to contact me if you have any queries regarding this study. 
 
Kind regards 
Anna 
Anna Walker 
Research Support Facilitator 
R&D Management Office, Worcestershire Clinical Research Unit, Newtown Road, 
Worcester, WR5 1HN 
Tel: 01905 760256 
Ext: 34789 
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From: "Grocott Chantel-Lea (RRE) MPFT" <Chantel-Lea.Grocott@mpft.nhs.uk> 
Date: 19 June 2018 at 15:56:59 BST 
To: "c001201d@student.staffs.ac.uk" <c001201d@student.staffs.ac.uk>, "Chimonides Clive 
(RRE) MPFT" <Clive.Chimonides@mpft.nhs.uk> 
Cc: "Oakley Lisa (RRE) MPFT" <Lisa.Oakley@mpft.nhs.uk>, "Lambley-Burke Ruth J. (RRE) 
MPFT" <Ruth.Lambley-Burke@mpft.nhs.uk> 
Subject: Confirmation of Capacity and Capability at MPFT 
Dear Clive  
RE: IRAS 216931. Confirmation of Capacity and Capability at MPFT 
Full Study Title: ‘Psychological exploration of the cognitions preventing 
smoking cessation or maintaining smoking in Chronic Obstructive Pulmonary 
Disease (COPD) sufferers: A Q-Methodological Study. (What thoughts permit 
people with COPD to continue smoking?)’ 
On behalf of Ruth Lambley-Burke, Head of Research and Innovation, this email 
confirms that Midlands Partnership NHS Foundation Trust has the capacity and 
capability to deliver the above referenced study.  
I have attached the schedule of events for your information. Can you also complete 
the delegation log towards the end and return a signed copy to me before you start 
your recruitment. 
If you wish to discuss further, please do not hesitate to contact me; good luck with 
your study. 
  
Kind Regards 
  
Tilly 
   
Chantel-lea Grocott  
Senior Research Administrator   
   Midlands Partnership NHS Foundation Trust 
Research and Innovation Department   
Barker Unit,Haywood Hospital 
High Lane, Burslem 
ST6 7AG 
T: 01782 673608  
E: chantel-lea.grocott@mpft.nhs.uk or chantellea.grocott@nhs.net 
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Appendix E – Information Pack for Participants 
 
[INSERT TRUST LOGO] 
 
 
 
 
Participant Information Sheet – Q-Sort  
Study Title: What thoughts permit people with COPD to continue smoking? 
 
What is this? 
You are being asked to think about taking part in a research study. It aims to find 
out what thoughts people have that allow them to continue to smoke with COPD. 
This study is being run by Clive Chimonides, an NHS student at Staffordshire 
University. Clive also works for South Staffordshire and Shropshire NHS Foundation 
Trust, as part of the training course. 
 
Before deciding whether to take part you should know what the research will 
involve, and why it is being done. Please read these sheets and make contact if you 
have any questions, or if you wish to take part. 
 
Aims of the Research 
We want to know how smokers with Chronic Obstructive Pulmonary Disease 
(COPD) decide not to stop smoking, despite being advised to stop. The aim of the 
research is to find out more about these thought patterns. 
Stopping smoking is one of the best things a person can do to slow down their 
COPD. Research has not yet found out if beliefs about smoking are the same for 
people with COPD who smoke, as those who do not have the disease.  This study 
will help to find out how people with COPD decide to continue smoking, and help 
NHS staff to know more about why some people with COPD still smoke. The results 
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may also help with future research to improve the health, and quality of life, of 
people with COPD.  
 
How will the study work? 
A list of beliefs found to be held by people who smoke with COPD have been put 
onto cards. People who still smoke with COPD will be asked to put these cards onto 
a grid. Each person who smokes with COPD can put the cards in an order that best 
matches their own thoughts.  
 
Why have I been invited? 
As a person with COPD who smokes your help would be really useful in finding out 
more about how people with COPD decide to continue smoking. 
 
Do I need to take part? 
No. You do not have to take part. You are free to choose. If you decide not to take 
part in this study or withdraw at any time, your current standard of medical care will 
not be affected in any way. 
 
What will happen if I do take part? 
If you choose to take part in this study, the researcher will contact you to arrange to 
meet with you at a local place that best suits you. This will either be the place you 
go for your COPD exercises, your local hospital, or at your home. You will be asked 
to read and sign a consent form. You will be given a copy of this to keep. 
You will be asked to read through some cards with statements on them and place 
them into piles of “agree” “neutral” and “disagree”. You will then be asked to place 
the statements on a grid to show how much you agree or disagree with them. The 
position of the cards will be written down by the researcher using a coded grid 
sheet. A photo of the layout of your cards (not of you) will also be taken. You will 
then be asked a little about your thoughts on the task. A few notes may be made on 
these. Some basic information about you will be collected including your age, 
gender, ethnic group. You will also be asked about whether you want to quit 
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smoking and the number of times you have tried to stop. Your mood levels, and 
anxiety levels will also be collected using a similar type of sheet that the COPD 
team uses. If you become distressed or want help after taking part, the researcher 
will talk to you about options to help you. 
 
What are the risks and benefits of taking part? 
There are no direct benefits to you in taking part. By taking part, you are helping to 
find out how people with COPD continue to smoke. This may help future studies on 
how to help people who wish to stop smoking.  
You might become more aware of your own views on smoking if you were not 
before. There is a slight risk that thinking about reasons you still smoke might upset 
you, and cause you emotional stress or anxiety. In the event of this the researcher 
would be happy to discuss support options. This might include psychological 
support from your local primary care service or advice on smoking from your COPD 
team (Your COPD Team phone number is INSERT PHONE NUMBER). 
 
Who will have access to information about me? 
The information held on you will be accessed by the research team. All data 
collected will be made anonymous. Your name will not be used, your data will be 
given a number instead. Data, from which no one can identify you, will be held by 
the researchers for up to 10 years for use in future studies. Sheets and forms will be 
put into the University’s secure archive. 
You can withdraw your data from the study at any time prior to the end of March 
2018. After this the study will be written-up and published. You can ask for your 
archived data to be removed after this and not used in any future study. Please 
keep the reference number on your consent form in case you wish to do this. 
 
Who is funding the research? 
The research is not funded by any grant, instead it is part of a 3-year Clinical 
Psychology Doctorate. It has been checked and approved by a University Ethics 
Panel and an NHS Research Ethics Committee. 
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Can I see the results of the research? 
The results of the study will be available online once finished. Type the following 
into your browser: 
https://www.researchregistry.com/browse-the-registry.html#home/  
You will then need to type what thoughts permit people with COPD to continue 
smoking into the search box and press enter. This box is found under ‘Registrations’ 
title. You should then see the research listed, click on the ‘view’ text under the 
column ‘Details’. 
 
What should I do if there is a problem? 
If you have concerns about any aspect of this research project please contact the 
principal researcher Clive Chimonides by email at c001201d@student.staffs.ac.uk. 
Alternatively you may contact the research supervisor Dr Helen Combes at 
Staffordshire University on h.a.combes@staffs.ac.uk If you do not wish to speak to 
the researchers you may contact Patient Advice and Liaison Service (PALS) by 
telephoning 01785 783026, writing to Patient Advice and Liaison Service (PALS), 
Freepost WV2103, South Staffordshire and Shropshire NHS Foundation Trust, St 
George’s Hospital, Corporation Street, Stafford, ST16 3AG, or by email 
sssft.customerservice@nhs.net.   
 
Further questions or wish to take part? 
If you want to know more, or would like to take part in this study please contact 
Clive Chimonides stating your interest to take part with your name and contact 
details either by: 
 
 
 Email c001201d@student.staffs.ac.uk OR  
 Calling 07379 871 953 and leaving a voice message OR 
 Completing and Sending the Slip Below in a Sealed Envelope 
 
 
     
132 
 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -  
IRAS 236588 
 
I am interested in taking part in your research and would like further 
information please. 
 
Name:          
 
Contact Number:    Email Address:   
  
 
Signature        Date  
  
Please send this slip to Clive Chimonides, c/o INSERT TEAM ADDRESS 
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Appendix F – Consent Form 
 
 
 
[INSERT TRUST LOGO] 
 
 
 
Consent Form: Q-Sort 
Study: What thoughts permit people with COPD to continue smoking? 
Research Team: Clive Chimonides, Helen Combes, Anna Bogucki 
 
Please initial the “yes” box for each statement to indicate your consent. 
 
1. I confirm that I am a current smoker/quit less than 3 months ago with COPD
          
YES  
 
2. I confirm that I have read and that I understand the participant information 
sheet (version 2.4). I have had the opportunity to consider the information 
given, and have asked any questions I had before agreeing to participate 
and confirm I have had these answered satisfactorily.   
          
         YES 
          
3. I understand that I am participating voluntarily and that I am free to withdraw 
at any time prior to presentation of the results/publication in July 2018 
without giving any reason and without my rights being affected.   
  
YES 
  
  
  
4. I understand that anonymised direct quotations may be used in the reporting 
and/or presentation of the findings, including publication in scientific journals.
                                
          
         YES 
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5. I understand that any identifiable information I provide during the Q-sort 
process will be removed from any presentations to preserve anonymity.  
YES 
6. I agree that should I become distressed by participating in the Q-method 
card placing task the researcher will discuss appropriate support available. I 
understand that in exceptional circumstances (e.g. if I disclose a risk of 
significant harm to myself or others) the researcher may speak to my 
GP/care team about appropriate support.     
          
          
         YES 
 
7. I agree to take part in the above study.  
         YES 
 
8. I agree to the anonymised raw-data collected in this study to be used in 
subsequent research projects for up to 10 years.    
          
         YES 
 
 
 
Participant 
Name     Signed:        Date:    
 
Researcher  
Name     Signed:        Date:    
 
Participant Copy/File Copy (delete as appropriate) 
Reference Number: 
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Appendix G – Correlation Matrix  
QSort  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 
1 1 0.27 0.35 0.3 0.15 0.42 0.2 0.31 0.32 0.13 0.26 0.15 0.13 0.39 0.08 0.32 0.29 0.24 0.14 0.16 0.25 0.41 
2 
 
1 0.26 0.21 0 0.21 0.42 -0.1 0.32 -0.1 0.02 0.01 0.13 0.22 0.14 -0 0.39 0.08 0.12 0.01 0.13 0.34 
3 
  
1 0.19 0.25 0.36 0.27 0.23 0.5 0.14 0.36 0.32 0.05 0.5 0.25 0.21 0.5 0.3 0.35 0.35 0.32 0.44 
4 
   
1 0.26 0.24 0.16 0.2 0.27 0.26 0.39 0.09 -0.1 0.3 0.07 0.35 0.14 0.3 0.24 0.1 0.11 0.04 
5 
    
1 0.17 0.05 0.25 0.22 0.24 0.3 0.29 -0.1 0.19 0.2 0.41 0.19 0.08 0.15 0.26 0.34 0.1 
6 
     
1 0.31 0.32 0.43 0.24 0.33 0.17 0.19 0.5 0.07 0.34 0.4 0.38 0.29 0.32 0.38 0.2 
7 
      
1 0.23 0.26 0.02 0.11 0.19 0.35 0.35 0.19 0.11 0.46 0.24 0.26 0.13 0.22 0.32 
8 
       
1 0.21 0.35 0.35 0.46 0.26 0.26 0.12 0.09 0.3 0.16 0.11 0.23 0.27 0.16 
9 
        
1 0.15 0.1 0.35 -0.1 0.42 0.2 0.24 0.44 0.15 0.36 0.33 0.31 0.34 
10 
         
1 0.38 0.28 0.05 0.32 0.14 0.24 0.14 0.22 0.26 0.1 0.42 0.08 
11 
          
1 0.36 0.19 0.23 0.19 0.28 0.15 0.24 -0 0.27 0.26 -0 
12 
           
1 0.21 0.29 0.21 0.09 0.23 0.24 0.03 0.15 0.21 0.1 
13 
            
1 0.15 0.14 -0.1 0.23 0.2 -0.1 -0.1 0.18 0.01 
14 
             
1 0.1 0.26 0.55 0.24 0.4 0.22 0.51 0.42 
15 
              
1 0.16 0.12 0.11 0.21 0.27 0.21 0.09 
16 
               
1 0.1 0.14 0.23 0.18 0.34 0.08 
17 
                
1 0.24 0.41 0.24 0.51 0.54 
18 
                 
1 0.24 0.06 0.12 0 
19 
                  
1 0.11 0.41 0.26 
20 
                   
1 0.19 0.01 
21 
                    
1 0.25 
22 
                     
1 
(Significant Correlation (Brown, 1980) at p<0.05 r≥0.23 (grey) and p<0.01 r≥0.3 (grey bold underline))
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Appendix H – Humphrey’s Rule and Rotated Factor Loading  
 
Humphrey’s Rule  
Inclusion Criteria is Cross Products of Factors Highest Loads > Standard Error 
Standard Error = 1 / √No Statements = 1/√73 = 0.117 
Factor 1 (√0.7057)2 X (√0.6772)2 = 0.4779 
Factor 2 (√0.4796)2 X (√-0.4627)2 = 0.221911 
Factor 3 (√0.4773)2 X (√0.3339)2 = 0.15937 
 
Factor Matrix with Defining Sorts Flagged 
    
       Participant No. Factor 1 
 
Factor 2 
 
Factor 3 
 1 0.3765 
 
0.2275 
 
0.3139 
 2 0.5575 flagged -0.1347 
 
0.1228 
 3 0.56 flagged 0.3745 
 
0.128 
 4 0.163 
 
0.2694 
 
0.312 
 5 0.0449 
 
0.6878 flagged -0.0387 
 6 0.4432 
 
0.2869 
 
0.368 
 7 0.5133 flagged 0.0287 
 
0.3188 
 8 0.0932 
 
0.3689 
 
0.4342 flagged 
9 0.4978 flagged 0.351 
 
0.0995 
 10 0.0137 
 
0.5282 flagged 0.2115 
 11 -0.0709 
 
0.5259 
 
0.5226 
 12 0.129 
 
0.3678 flagged 0.3042 
 13 0.0459 
 
-0.1063 
 
0.5066 flagged 
14 0.5779 flagged 0.3183 
 
0.2708 
 15 0.1431 
 
0.3031 flagged 0.0921 
 16 0.123 
 
0.4647 flagged 0.0928 
 17 0.7488 flagged 0.1958 
 
0.1667 
 18 0.1796 
 
0.1173 
 
0.4558 flagged 
19 0.451 flagged 0.2936 
 
-0.0735 
 20 0.1764 
 
0.3837 flagged -0.0089 
 21 0.4179 
 
0.4486 
 
0.1032 
 22 0.6559 flagged 0.0274 
 
-0.0113 
 %Explained Variance 15 
 
12 
 
8 
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Appendix I – Concourse Statements (Q-Set) 
 
No. Statements 
1 I didn’t know that smoking caused COPD 
2 I know smoking causes and worsens COPD but I do not feel threatened by it 
3 Smoking does not cause or worsen COPD 
4 Smoking just irritates my chest, it doesn't actually damage anything 
5 I accept that smoking is worsening my COPD but it's my responsibility and it's the price I pay 
6 COPD is just down to bad-luck 
7 COPD is just a part of old-age 
8 I got COPD by genetically inheriting it, not from smoking 
9 My COPD was caused by the industry I worked in, not from smoking 
10 It's my business and my choice to smoke 
11 It is not my fault; the dangers of COPD were not known when I started smoking 
12 Health Professionals have no sympathy and I feel blamed by them 
13 I wouldn't know what to do, the regular habit makes it too difficult to stop smoking 
14 Withdrawal symptoms from the addiction make it too unpleasant to stop smoking 
15 It has to be my decision in my own mind to stop 
16 I wish someone would tell me directly to stop and give me shock about what will happen if I don’t 
17 I wish smoking was just banned 
18 I really enjoy smoking 
19 I stop smoking, but coming back home (or another familiar place) just starts me smoking again 
20 I am a slave to smoking 
21 I am not offered enough support to stop smoking 
22 It’s easier to deny that I smoke, and just hide it from others 
23 Other difficult life-events mean it's never the right time to stop 
24 I am too embarrassed to seek help to stop 
25 I feel too guilty or ashamed for making myself ill and that makes me want to smoke more 
26 I feel inferior for still smoking 
27 I don’t want to see the doctor 
28 I don’t have the will-power or self-discipline to stop 
29 If I really wanted to stop smoking I could do 
30 I plan on stopping in the future some time so it’s ok 
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31 I cut down when I'm not feeling well so that improves things 
32 I inhale less smoke when I'm not feeling well so that reduces the damage 
33 I wish someone could just flip a switch and make me stop 
34 The Doctors have got me better before they can do it again 
35 I tend to buy nicotine patches/gum/vaping products in case I want to stop 
36 I tend to adapt to my symptoms so I don’t notice if my health is getting worse 
37 The thought of COPD and quitting smoking makes me so anxious I smoke more 
38 I get angry at myself for smoking which just makes me smoke more 
39 There are no benefits to stopping smoking 
40 It's too late, I am too old and the damage is already done 
41 Quitting smoking is dangerous, people get other illnesses or just die if they quit 
42 I feel a sense of hopelessness about smoking and my COPD 
43 Smoking helps me to digest my food and settle my stomach 
44 Smoking helps me go to the toilet 
45 Smoking helps me cough up phlegm 
46 Smoking keeps infections away 
47 Smoking helps me breathe 
48 Smoking helps me concentrate 
49 Smoking helps me relax and not feel stressed 
50 Smoking stimulates me 
51 Smoking stops me becoming too anxious 
52 Smoking stops me becoming too irritable 
53 Smoking stops me becoming depressed 
54 If I stop smoking I'll put on too much weight 
55 Vaping, nicotine products or smoking medications are ineffective 
56 Vaping, nicotine products or smoking medications have too many side-effects 
57 If I stop smoking I'll get bored 
58 Smoking is sociable and I continue because it's part of my social life 
59 Being a smoker is a part of my identity 
60 Smoking alleviates loneliness 
61 Cigarettes are like friends to me 
62 Other people close to me won't give up, so why should I? 
63 If I give up smoking I'll mourn my cigarettes 
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64 You've got to die of something 
65 I exercise or attend Pulmonary Rehabilitation so I don't need to stop smoking 
66 I've made other changes like eating healthily and cutting alcohol so I don’t need to stop smoking 
67 The more I am told not to smoke, the more I do smoke 
68 Everyone around me smokes so there's no point in stopping as I still inhale their smoke 
69 My relative lived to very old age and they smoked all their life 
70 I have tried quitting before and it was awful 
71 I have cut my smoking right down so there's no need to quit 
72 I smoke light cigarettes now they do less damage 
73 Air pollution and fumes are far more damaging than smoking 
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Appendix J – Ideal Factor Arrays 
 
     
Z-Score 
variance No Statement factor 1 factor 2 factor 3 
1 I didn’t know that smoking caused COPD 1 1 3 0.101 
2 I know smoking causes and worsens COPD but I do not feel threatened by it 2 0 1 0.073 
3 Smoking does not cause or worsen COPD -6 -4 0 0.676 
4 Smoking just irritates my chest, it doesn't actually damage anything -2 -4 -1 0.076 
5 I accept that smoking is worsening my COPD but it's my responsibility and it's the price I pay 4 3 4 0.002 
6 COPD is just down to bad-luck -5 -5 1 0.575 
7 COPD is just a part of old-age -5 -5 -3 0.082 
8 I got COPD by genetically inheriting it, not from smoking -4 -4 0 0.262 
9 My COPD was caused by the industry I worked in, not from smoking -1 0 -1 0.018 
10 It's my business and my choice to smoke 5 1 1 0.439 
11 It is not my fault; the dangers of COPD were not known when I started smoking 3 5 2 0.282 
12 Health Professionals have no sympathy and I feel blamed by them -2 -1 0 0.088 
13 I wouldn't know what to do, the regular habit makes it too difficult to stop smoking 0 1 1 0.02 
14 Withdrawal symptoms from the addiction make it too unpleasant to stop smoking 4 3 -1 0.424 
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15 It has to be my decision in my own mind to stop 5 6 4 0.123 
16 I wish someone would tell me directly to stop and give me shock about what will happen if I don’t -6 2 4 1.536 
17 I wish smoking was just banned -1 1 -5 0.851 
18 I really enjoy smoking 6 0 6 1.38 
19 I stop smoking, but coming back home (or another familiar place) just starts me smoking again -4 0 2 0.566 
20 I am a slave to smoking 0 1 5 0.368 
21 I am not offered enough support to stop smoking -1 2 -3 0.586 
22 It’s easier to deny that I smoke, and just hide it from others -5 -3 3 0.999 
23 Other difficult life-events mean it's never the right time to stop 1 3 2 0.1 
24 I am too embarrassed to seek help to stop -4 -3 -5 0.032 
25 I feel too guilty or ashamed for making myself ill and that makes me want to smoke more -2 2 -2 0.331 
26 I feel inferior for still smoking 1 3 -4 1.004 
27 I don’t want to see the doctor 3 -2 -3 0.685 
28 I don’t have the will-power or self-discipline to stop 1 4 2 0.1 
29 If I really wanted to stop smoking I could do 2 2 0 0.118 
30 I plan on stopping in the future some time so it’s ok -3 4 5 1.178 
31 I cut down when I'm not feeling well so that improves things -2 5 1 0.892 
32 I inhale less smoke when I'm not feeling well so that reduces the damage -3 -4 -2 0.053 
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33 I wish someone could just flip a switch and make me stop 0 6 6 0.955 
34 The Doctors have got me better before they can do it again -1 0 0 0.083 
35 I tend to buy nicotine patches/gum/vaping products in case I want to stop -4 3 -3 1.036 
36 I tend to adapt to my symptoms so I don’t notice if my health is getting worse 1 -4 5 1.113 
37 The thought of COPD and quitting smoking makes me so anxious I smoke more -2 -1 0 0.088 
38 I get angry at myself for smoking which just makes me smoke more 0 0 -1 0.011 
39 There are no benefits to stopping smoking -4 -5 -4 0.003 
40 It's too late, I am too old and the damage is already done 6 -5 3 1.966 
41 Quitting smoking is dangerous, people get other illnesses or just die if they quit 1 0 -1 0.062 
42 I feel a sense of hopelessness about smoking and my COPD -1 4 3 0.39 
43 Smoking helps me to digest my food and settle my stomach -1 -3 -3 0.027 
44 Smoking helps me go to the toilet 0 -2 -6 0.84 
45 Smoking helps me cough up phlegm 2 -1 3 0.423 
46 Smoking keeps infections away -5 -2 -5 0.118 
47 Smoking helps me breathe -3 -3 -6 0.309 
48 Smoking helps me concentrate 4 2 1 0.139 
49 Smoking helps me relax and not feel stressed 5 5 4 0.057 
50 Smoking stimulates me 3 -2 -1 0.549 
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51 Smoking stops me becoming too anxious 4 2 -3 0.84 
52 Smoking stops me becoming too irritable 5 3 2 0.032 
53 Smoking stops me becoming depressed 3 4 -5 1.519 
54 If I stop smoking I'll put on too much weight 0 -1 -2 0.081 
55 Vaping, nicotine products or smoking medications are ineffective 0 0 -2 0.171 
56 Vaping, nicotine products or smoking medications have too many side-effects 2 1 1 0.041 
57 If I stop smoking I'll get bored 2 -1 -2 0.288 
58 Smoking is sociable and I continue because it's part of my social life -1 -2 -2 0.011 
59 Being a smoker is a part of my identity 2 -6 0 1.121 
60 Smoking alleviates loneliness 0 -1 0 0.038 
61 Cigarettes are like friends to me 2 -3 5 1.363 
62 Other people close to me won't give up, so why should I? -2 -1 -4 0.137 
63 If I give up smoking I'll mourn my cigarettes 1 -6 2 1.545 
64 You've got to die of something 4 -2 3 0.612 
65 I exercise or attend Pulmonary Rehabilitation so I don't need to stop smoking -3 -3 -4 0.032 
66 I've made other changes like eating healthily and cutting alcohol so I don’t need to stop smoking -1 -2 -1 0.034 
67 The more I am told not to smoke, the more I do smoke 1 4 -4 1.12 
68 Everyone around me smokes so there's no point in stopping as I still inhale their smoke -2 -1 -1 0.101 
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69 My relative lived to very old age and they smoked all their life 3 1 1 0.156 
70 I have tried quitting before and it was awful 3 5 -2 0.701 
71 I have cut my smoking right down so there's no need to quit 0 0 2 0.045 
72 I smoke light cigarettes now they do less damage -3 1 0 0.264 
73 Air pollution and fumes are far more damaging than smoking -3 2 4 0.749 
         
  
     
145 
 
Appendix K - Distinguishing and Consensus Statements 
Distinguishing Statements for Factor 1 
          (P < .05 : Asterisk (*) Indicates Significance at P < .01) 
          Both the Factor Q-Sort Value and the Z-Score (Z-SCR) are Shown 
Statem
e
n
t 
facto
r1
 Q
-SV
 
facto
r1
 Z-sco
re 
  
facto
r2
 Q
-SV
 
facto
r2
 Z-sco
re 
  
Facto
r3
 Q
-SV
 
Facto
r3
 Z-sco
re   Statement 
40 It's too late, I am too old and the damage is already done 40 6 1.89 * -5 -1.439   3 0.955   
10 It's my business and my choice to smoke 10 5 1.73 * 1 0.365   1 0.277   
48 Smoking helps me concentrate 48 4 1.2   2 0.68   1 0.291   
50 Smoking stimulates me 50 3 1.06 * -2 -0.681   -1 -0.25   
69 My relative lived to very old age and they smoked all their life 69 3 0.99   1 0.112   1 0.2   
27 I don’t want to see the doctor 27 3 0.86 * -2 -0.578   -3 -1.093   
61 Cigarettes are like friends to me 61 2 0.69 * -3 -0.989   5 1.855   
59 Being a smoker is a part of my identity 59 2 0.68   -6 -1.821   0 0.014   
57 If I stop smoking I'll get bored 57 2 0.64 * -1 -0.274   -2 -0.639   
67 The more I am told not to smoke, the more I do smoke 67 1 0.36 * 4 1.292   -4 -1.268   
36 I tend to adapt to my symptoms so I don’t notice if my health is getting worse 36 1 0.35 * -4 -1.183   5 1.385   
44 Smoking helps me go to the toilet 44 0 0.11 * -2 -0.802   -6 -2.122   
33 I wish someone could just flip a switch and make me stop 33 0 0 * 6 2.193   6 1.922   
42 I feel a sense of hopelessness about smoking and my COPD 42 -1 -0.14 * 4 1.298   3 1.035   
17 I wish smoking was just banned 17 -1 -0.49   1 0.166   -5 -2.035   
34 The Doctors have got me better before they can do it again 34 -1 -0.68   0 -0.128   0 -0.029   
31 I cut down when I'm not feeling well so that improves things 31 -2 -0.78 * 5 1.524   1 0.526   
12 Health Professionals have no sympathy and I feel blamed by them 12 -2 -0.86   -1 -0.338   0 -0.162   
68 Everyone around me smokes so there's no point in stopping as I still inhale their smoke 68 -2 -0.96   -1 -0.309   -1 -0.253   
30 I plan on stopping in the future some time so it’s ok 30 -3 -0.97 * 4 1.304   5 1.356   
73 Air pollution and fumes are far more damaging than smoking 73 -3 -0.99 * 2 0.437   4 1.082   
72 I smoke light cigarettes now they do less damage 72 -3 -1.03 * 1 0.098   0 0.007   
19 I stop smoking, but coming back home (or another familiar place) just starts me smoking again 19 -4 -1.08 * 0 -0.066   2 0.762   
16 I wish someone would tell me directly to stop and give me shock about what will happen if I don’t 16 -6 -1.6 * 2 0.566   4 1.321   
3 Smoking does not cause or worsen COPD 3 -6 -1.82   -4 -1.219   0 0.147   
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            Distinguishing Statements for Factor 2 
          (P < .05 : Asterisk (*) Indicates Significance at P < .01) 
          Both the Factor Q-Sort Value and the Z-Score (Z-SCR) are Shown 
Statem
e
n
t  
facto
r1
 Q
-SV
 
facto
r1
 Z-sco
re 
  facto
r2
 Q
-SV
 
facto
r2
 Z-sco
re 
  Facto
r3
 Q
-SV
 
Facto
r3
 Z-sco
re 
  
Statement 
    
  
11 It is not my fault; the dangers of COPD were not known when I started smoking 11 3 1.04   5 2.01 * 2 0.78   
31 I cut down when I'm not feeling well so that improves things 31 -2 -0.78   5 1.52 * 1 0.526   
67 The more I am told not to smoke, the more I do smoke 67 1 0.36   4 1.29 * -4 -1.268   
35 I tend to buy nicotine patches/gum/vaping products in case I want to stop 35 -4 -1.29   3 1.1 * -3 -0.733   
21 I am not offered enough support to stop smoking 21 -1 -0.73   2 0.82 * -3 -0.871   
16 I wish someone would tell me directly to stop and give me shock about what will happen if I don’t 16 -6 -1.6   2 0.57   4 1.321   
25 I feel too guilty or ashamed for making myself ill and that makes me want to smoke more 25 -2 -0.79   2 0.5 * -2 -0.632   
17 I wish smoking was just banned 17 -1 -0.49   1 0.17   -5 -2.035   
19 I stop smoking, but coming back home (or another familiar place) just starts me smoking again 19 -4 -1.08   0 -0.07   2 0.762   
18 I really enjoy smoking 18 6 2.34   0 -0.22 * 6 2.192   
45 Smoking helps me cough up phlegm 45 2 0.84   -1 -0.51 * 3 0.895   
64 You've got to die of something 64 4 1.15   -2 -0.63 * 3 0.874   
44 Smoking helps me go to the toilet 44 0 0.11   -2 -0.8 * -6 -2.122   
46 Smoking keeps infections away 46 -5 -1.37   -2 -0.82   -5 -1.64   
61 Cigarettes are like friends to me 61 2 0.69   -3 -0.99 * 5 1.855   
36 I tend to adapt to my symptoms so I don’t notice if my health is getting worse 36 1 0.35   -4 -1.18 * 5 1.385   
3 Smoking does not cause or worsen COPD 3 -6 -1.82   -4 -1.22   0 0.147   
40 It's too late, I am too old and the damage is already done 40 6 1.89   -5 -1.44 * 3 0.955   
59 Being a smoker is a part of my identity 59 2 0.68   -6 -1.82 * 0 0.014   
63 If I give up smoking I'll mourn my cigarettes 63 1 0.55   -6 -2.01 * 2 0.695   
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Distinguishing Statements for Factor 3 
          (P < .05 : Asterisk (*) Indicates Significance at P < .01) 
          Both the Factor Q-Sort Value and the Z-Score (Z-SCR) are Shown 
Statem
e
n
t 
facto
r1
 Q
-SV
 
facto
r1
 Z-sco
re 
  facto
r2
 Q
-SV
 
facto
r2
 Z-sco
re 
  Facto
r3
 Q
-SV
 
Facto
r3
 Z-sco
re 
  
Statement 
 
   
61 Cigarettes are like friends to me 61 2 0.69   -3 -0.99   5 1.86 * 
20 I am a slave to smoking 20 0 0.08   1 0.22   5 1.43 * 
36 I tend to adapt to my symptoms so I don’t notice if my health is getting worse 36 1 0.35   -4 -1.18   5 1.39 * 
16 I wish someone would tell me directly to stop and give me shock about what will happen if I don’t 16 -6 -1.6   2 0.57   4 1.32   
40 It's too late, I am too old and the damage is already done 40 6 1.89   -5 -1.44   3 0.96 * 
22 It’s easier to deny that I smoke, and just hide it from others 22 -5 -1.38   -3 -0.92   3 0.93 * 
19 I stop smoking, but coming back home (or another familiar place) just starts me smoking again 19 -4 -1.08   0 -0.07   2 0.76   
31 I cut down when I'm not feeling well so that improves things 31 -2 -0.78   5 1.52   1 0.53 * 
6 COPD is just down to bad-luck 6 -5 -1.41   -5 -1.48   1 0.16 * 
3 Smoking does not cause or worsen COPD 3 -6 -1.82   -4 -1.22   0 0.15 * 
29 If I really wanted to stop smoking I could do 29 2 0.86   2 0.85   0 0.13   
59 Being a smoker is a part of my identity 59 2 0.68   -6 -1.82   0 0.01   
8 I got COPD by genetically inheriting it, not from smoking 8 -4 -1.29   -4 -1.13   0 -0.13 * 
14 Withdrawal symptoms from the addiction make it too unpleasant to stop smoking 14 4 1.06   3 1.04   -1 -0.33 * 
70 I have tried quitting before and it was awful 70 3 0.94   5 1.44   -2 -0.53 * 
55 Vaping, nicotine products or smoking medications are ineffective 55 0 0.25   0 0.07   -2 -0.7   
51 Smoking stops me becoming too anxious 51 4 1.13   2 0.67   -3 -1 * 
67 The more I am told not to smoke, the more I do smoke 67 1 0.36   4 1.29   -4 -1.27 * 
26 I feel inferior for still smoking 26 1 0.46   3 0.95   -4 -1.38 * 
53 Smoking stops me becoming depressed 53 3 1.06   4 1.27   -5 -1.44 * 
17 I wish smoking was just banned 17 -1 -0.49   1 0.17   -5 -2.04 * 
44 Smoking helps me go to the toilet 44 0 0.11   -2 -0.8   -6 -2.12 * 
47 Smoking helps me breathe 47 -3 -0.96   -3 -1.1   -6 -2.2 * 
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Consensus Statements -- Those That Do Not Distinguish Between ANY Pair of Factors 
          All Listed Statements are Non-Significant at P > 0.01, and with * are also Non-Significant at P > 0.05) Statem
e
n
t  
facto
r1
 Q
-SV
 
facto
r1
 Z-sco
re 
  facto
r2
 Q
-SV
 
facto
r2
 Z-sco
re 
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-SV
 
Facto
r3
 Z-sco
re 
  
Statement 
 
 
  
1 I didn’t know that smoking caused COPD 1 1 0.367   1 0.27   3 0.99   
2 I know smoking causes and worsens COPD but I do not feel threatened by it 2 2 0.66   0 -0.01   1 0.348   
4 Smoking just irritates my chest, it doesn't actually damage anything 4 -2 -0.867 * -4 -1.097 * -1 -0.432 * 
5 I accept that smoking is worsening my COPD but it's my responsibility and it's the price I pay 5 4 1.111 * 3 1.18 * 4 1.061 * 
7 COPD is just a part of old-age 7 -5 -1.416   -5 -1.58   -3 -0.9   
9 My COPD was caused by the industry I worked in, not from smoking 9 -1 -0.289 * 0 -0.116 * -1 -0.449 * 
12 Health Professionals have no sympathy and I feel blamed by them 12 -2 -0.86   -1 -0.34   0 -0.16   
13 I wouldn't know what to do, the regular habit makes it too difficult to stop smoking 13 0 -0.01 * 1 0.294 * 1 0.281 * 
15 It has to be my decision in my own mind to stop 15 5 1.888   6 2.18   4 1.34   
24 I am too embarrassed to seek help to stop 24 -4 -1.177 * -3 -0.944 * -5 -1.385 * 
29 If I really wanted to stop smoking I could do 29 2 0.86   2 0.85   0 0.13   
32 I inhale less smoke when I'm not feeling well so that reduces the damage 32 -3 -0.963 * -4 -1.253 * -2 -0.688 * 
34 The Doctors have got me better before they can do it again 34 -1 -0.68   0 -0.13   0 -0.03   
37 The thought of COPD and quitting smoking makes me so anxious I smoke more 37 -2 -0.77   -1 -0.47   0 -0.05   
38 I get angry at myself for smoking which just makes me smoke more 38 0 -0.053 * 0 -0.004 * -1 -0.246 * 
39 There are no benefits to stopping smoking 39 -4 -1.341 * -5 -1.377 * -4 -1.254 * 
41 Quitting smoking is dangerous, people get other illnesses or just die if they quit 41 1 0.363 * 0 0.021 * -1 -0.246 * 
43 Smoking helps me to digest my food and settle my stomach 43 -1 -0.554 * -3 -0.959 * -3 -0.76 * 
46 Smoking keeps infections away 46 -5 -1.37   -2 -0.82   -5 -1.64   
49 Smoking helps me relax and not feel stressed 49 5 1.661 * 5 1.524 * 4 1.101 * 
52 Smoking stops me becoming too irritable 52 5 1.236 * 3 0.992 * 2 0.797 * 
54 If I stop smoking I'll put on too much weight 54 0 0.14   -1 -0.36   -2 -0.53   
56 Vaping, nicotine products or smoking medications have too many side-effects 56 2 0.601 * 1 0.106 * 1 0.384 * 
58 Smoking is sociable and I continue because it's part of my social life 58 -1 -0.762 * -2 -0.721 * -2 -0.517 * 
60 Smoking alleviates loneliness 60 0 -0.073 * -1 -0.443 * 0 0 * 
65 I exercise or attend Pulmonary Rehabilitation so I don't need to stop smoking 65 -3 -1.014 * -3 -0.816 * -4 -1.251 * 
66 I've made other changes like eating healthily and cutting alcohol so I don’t need to stop smoking 66 -1 -0.474 * -2 -0.707 * -1 -0.253 * 
68 Everyone around me smokes so there's no point in stopping as I still inhale their smoke 68 -2 -0.96   -1 -0.31   -1 -0.25   
71 I have cut my smoking right down so there's no need to quit 71 0 0.194 * 0 0.048 * 2 0.554 * 
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Appendix L – Post Hoc Tests 
 
SPSS Outputs Shown Below for comparisons of Age Band and Quit Desire by 
Factor: 
 
Crosstabs 
 
 
Notes 
Output Created 02-AUG-2018 19:58:14 
Comments  
Input   
Active Dataset DataSet1 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in Working Data 
File 
17 
Missing Value Handling Definition of Missing User-defined missing values 
are treated as missing. 
Cases Used Statistics for each table are 
based on all the cases with 
valid data in the specified 
range(s) for all variables in 
each table. 
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Syntax CROSSTABS 
  /TABLES=FACTOR BY 
AGEBAND2 
  /FORMAT=AVALUE 
TABLES 
  /STATISTICS=CHISQ 
  /CELLS=COUNT 
  /COUNT ROUND CELL 
  /METHOD=EXACT 
TIMER(5). 
Resources Processor Time 00:00:00.06 
Elapsed Time 00:00:00.21 
Dimensions Requested 2 
Cells Available 524245 
Time for Exact Statistics 0:00:00.07 
 
 
 
 
 
Case Processing Summary 
 
Cases 
Valid Missing Total 
N Percent N Percent N Percent 
Which Factor * AGEBAND2 17 100.0% 0 0.0% 17 100.0% 
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Which Factor * AGEBAND2 Crosstabulation 
Count   
 
AGEBAND2 
Total 50-59 60-69 70-79 
Which Factor Factor 1 2 0 6 8 
Factor 2 1 5 0 6 
Factor 3 0 0 3 3 
Total 3 5 9 17 
 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 15.111
a
 4 .004 .003  
Likelihood Ratio 19.689 4 .001 .001  
Fisher's Exact Test 13.564   .001  
Linear-by-Linear Association .099
b
 1 .753 .844 .465 
N of Valid Cases 17     
 
Chi-Square Tests 
 Point Probability 
Pearson Chi-Square  
Likelihood Ratio  
Fisher's Exact Test  
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Linear-by-Linear Association .153 
N of Valid Cases  
 
a. 9 cells (100.0%) have expected count less than 5. The minimum expected count is .53. 
b. The standardized statistic is .315. 
 
 
 
Crosstabs 
 
 
 
Notes 
Output Created 02-AUG-2018 19:59:00 
Comments  
Input Data  
Active Dataset DataSet1 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in Working Data 
File 
17 
Missing Value Handling Definition of Missing User-defined missing values 
are treated as missing. 
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Cases Used Statistics for each table are 
based on all the cases with 
valid data in the specified 
range(s) for all variables in 
each table. 
Syntax CROSSTABS 
  /TABLES=FACTOR BY 
QUIT 
  /FORMAT=AVALUE 
TABLES 
  /STATISTICS=CHISQ 
  /CELLS=COUNT 
  /COUNT ROUND CELL 
  /METHOD=EXACT 
TIMER(5). 
Resources Processor Time 00:00:00.13 
Elapsed Time 00:00:00.16 
Dimensions Requested 2 
Cells Available 524245 
Time for Exact Statistics 0:00:00.08 
 
 
Case Processing Summary 
 
Cases 
Valid Missing Total 
N Percent N Percent N Percent 
Which Factor * Desire to quit 17 100.0% 0 0.0% 17 100.0% 
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Which Factor * Desire to quit Crosstabulation 
Count   
 
Desire to quit 
Total None Some Very 
Which Factor Factor 1 5 2 1 8 
Factor 2 0 1 5 6 
Factor 3 0 1 2 3 
Total 5 4 8 17 
 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 9.828
a
 4 .043 .036  
Likelihood Ratio 12.244 4 .016 .040  
Fisher's Exact Test 9.065   .020  
Linear-by-Linear Association 6.377
b
 1 .012 .012 .006 
N of Valid Cases 17     
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Chi-Square Tests 
 Point Probability 
Pearson Chi-Square  
Likelihood Ratio  
Fisher's Exact Test  
Linear-by-Linear Association .005 
N of Valid Cases  
 
a. 9 cells (100.0%) have expected count less than 5. The minimum expected count is .71. 
b. The standardized statistic is 2.525. 
 
 
 
Crosstabs 
 
 
 
Notes 
Output Created 02-AUG-2018 19:59:55 
Comments  
Input Data  
Active Dataset DataSet2 
Filter <none> 
Weight <none> 
Split File <none> 
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N of Rows in Working Data 
File 
14 
Missing Value Handling Definition of Missing User-defined missing values 
are treated as missing. 
Cases Used Statistics for each table are 
based on all the cases with 
valid data in the specified 
range(s) for all variables in 
each table. 
Syntax CROSSTABS 
  /TABLES=FACTOR BY 
AGEBAND2 
  /FORMAT=AVALUE 
TABLES 
  /STATISTICS=CHISQ 
  /CELLS=COUNT 
  /COUNT ROUND CELL 
  /METHOD=EXACT 
TIMER(5). 
Resources Processor Time 00:00:00.08 
Elapsed Time 00:00:00.13 
Dimensions Requested 2 
Cells Available 524245 
Time for Exact Statistics 0:00:00.05 
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Case Processing Summary 
 
Cases 
Valid Missing Total 
N Percent N Percent N Percent 
Which Factor * AGEBAND2 14 100.0% 0 0.0% 14 100.0% 
 
 
Which Factor * AGEBAND2 Crosstabulation 
Count   
 
AGEBAND2 
Total 50-59 60-69 70-79 
Which Factor Factor 1 2 0 6 8 
Factor 2 1 5 0 6 
Total 3 5 6 14 
 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 11.278
a
 2 .004 .001  
Likelihood Ratio 15.302 2 .000 .001  
Fisher's Exact Test 11.095   .001  
Linear-by-Linear Association 2.370
b
 1 .124 .180 .114 
N of Valid Cases 14     
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Chi-Square Tests 
 Point Probability 
Pearson Chi-Square  
Likelihood Ratio  
Fisher's Exact Test  
Linear-by-Linear Association .086 
N of Valid Cases  
 
a. 6 cells (100.0%) have expected count less than 5. The minimum expected count is 1.29. 
b. The standardized statistic is -1.540. 
 
 
 
Crosstabs 
 
 
 
Notes 
Output Created 02-AUG-2018 20:00:28 
Comments  
Input Data  
Active Dataset DataSet2 
Filter <none> 
Weight <none> 
Split File <none> 
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N of Rows in Working Data 
File 
14 
Missing Value Handling Definition of Missing User-defined missing values 
are treated as missing. 
Cases Used Statistics for each table are 
based on all the cases with 
valid data in the specified 
range(s) for all variables in 
each table. 
Syntax CROSSTABS 
  /TABLES=FACTOR BY 
QUIT 
  /FORMAT=AVALUE 
TABLES 
  /STATISTICS=CHISQ 
  /CELLS=COUNT 
  /COUNT ROUND CELL 
  /METHOD=EXACT 
TIMER(5). 
Resources Processor Time 00:00:00.09 
Elapsed Time 00:00:00.13 
Dimensions Requested 2 
Cells Available 524245 
Time for Exact Statistics 0:00:00.07 
 
 
Case Processing Summary 
 Cases 
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Valid Missing Total 
N Percent N Percent N Percent 
Which Factor * Desire to quit 14 100.0% 0 0.0% 14 100.0% 
 
 
 
 
 
 
Which Factor * Desire to quit Crosstabulation 
Count   
 
Desire to quit 
Total None Some Very 
Which Factor Factor 1 5 2 1 8 
Factor 2 0 1 5 6 
Total 5 3 6 14 
 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 7.875
a
 2 .019 .024  
Likelihood Ratio 9.896 2 .007 .024  
Fisher's Exact Test 7.511   .018  
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Linear-by-Linear Association 7.251
b
 1 .007 .007 .006 
N of Valid Cases 14     
 
Chi-Square Tests 
 Point Probability 
Pearson Chi-Square  
Likelihood Ratio  
Fisher's Exact Test  
Linear-by-Linear Association .006 
N of Valid Cases  
 
a. 6 cells (100.0%) have expected count less than 5. The minimum expected count is 1.29. 
b. The standardized statistic is 2.693. 
 
 
Warning # 67.  Command name: GET FILE 
The document is already in use by another user or process.  If you make 
changes to the document they may overwrite changes made by others or your 
changes may be overwritten by others. 
 
 
 
 
Crosstabs 
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Notes 
Output Created 02-AUG-2018 20:01:27 
Comments  
Input Data  
Active Dataset DataSet3 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in Working Data 
File 
11 
Missing Value Handling Definition of Missing User-defined missing values 
are treated as missing. 
Cases Used Statistics for each table are 
based on all the cases with 
valid data in the specified 
range(s) for all variables in 
each table. 
Syntax CROSSTABS 
  /TABLES=FACTOR BY 
AGEBAND2 
  /FORMAT=AVALUE 
TABLES 
  /STATISTICS=CHISQ 
  /CELLS=COUNT 
  /COUNT ROUND CELL 
  /METHOD=EXACT 
TIMER(5). 
Resources Processor Time 00:00:00.05 
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Elapsed Time 00:00:00.08 
Dimensions Requested 2 
Cells Available 524245 
Time for Exact Statistics 0:00:00.02 
 
 
 
 
Case Processing Summary 
 
Cases 
Valid Missing Total 
N Percent N Percent N Percent 
Which Factor * AGEBAND2 11 100.0% 0 0.0% 11 100.0% 
 
 
Which Factor * AGEBAND2 Crosstabulation 
Count   
 
AGEBAND2 
Total 50-59 70-79 
Which Factor Factor 1 2 6 8 
Factor 3 0 3 3 
Total 2 9 11 
 
 
Chi-Square Tests 
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 Value df 
Asymptotic 
Significance (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .917
a
 1 .338 .564 .509 
Continuity Correction
b
 .006 1 .936   
Likelihood Ratio 1.434 1 .231 .564 .509 
Fisher's Exact Test    1.000 .509 
Linear-by-Linear Association .833
c
 1 .361 .564 .509 
N of Valid Cases 11     
 
Chi-Square Tests 
 Point Probability 
Pearson Chi-Square  
Continuity Correction
b
  
Likelihood Ratio  
Fisher's Exact Test  
Linear-by-Linear Association .509 
N of Valid Cases  
 
a. 3 cells (75.0%) have expected count less than 5. The minimum expected count is .55. 
b. Computed only for a 2x2 table 
c. The standardized statistic is .913. 
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Notes 
Output Created 02-AUG-2018 20:01:58 
Comments  
Input Data  
Active Dataset DataSet3 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in Working Data 
File 
11 
Missing Value Handling Definition of Missing User-defined missing values 
are treated as missing. 
Cases Used Statistics for each table are 
based on all the cases with 
valid data in the specified 
range(s) for all variables in 
each table. 
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Syntax CROSSTABS 
  /TABLES=FACTOR BY 
QUIT 
  /FORMAT=AVALUE 
TABLES 
  /STATISTICS=CHISQ 
  /CELLS=COUNT 
  /COUNT ROUND CELL 
  /METHOD=EXACT 
TIMER(5). 
Resources Processor Time 00:00:00.11 
Elapsed Time 00:00:00.11 
Dimensions Requested 2 
Cells Available 524245 
Time for Exact Statistics 0:00:00.08 
 
 
Case Processing Summary 
 
Cases 
Valid Missing Total 
N Percent N Percent N Percent 
Which Factor * Desire to quit 11 100.0% 0 0.0% 11 100.0% 
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Which Factor * Desire to quit Crosstabulation 
Count   
 
Desire to quit 
Total None Some Very 
Which Factor Factor 1 5 2 1 8 
Factor 3 0 1 2 3 
Total 5 3 3 11 
 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 4.278
a
 2 .118 .182  
Likelihood Ratio 5.253 2 .072 .182  
Fisher's Exact Test 3.968   .121  
Linear-by-Linear Association 3.889
b
 1 .049 .061 .061 
N of Valid Cases 11     
 
Chi-Square Tests 
 Point Probability 
Pearson Chi-Square  
Likelihood Ratio  
Fisher's Exact Test  
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Linear-by-Linear Association .055 
N of Valid Cases  
 
a. 6 cells (100.0%) have expected count less than 5. The minimum expected count is .82. 
b. The standardized statistic is 1.972. 
 
 
 
Crosstabs 
 
 
 
Notes 
Output Created 02-AUG-2018 20:02:45 
Comments  
Input Data  
Active Dataset DataSet4 
Filter <none> 
Weight <none> 
Split File <none> 
N of Rows in Working Data 
File 
9 
Missing Value Handling Definition of Missing User-defined missing values 
are treated as missing. 
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Cases Used Statistics for each table are 
based on all the cases with 
valid data in the specified 
range(s) for all variables in 
each table. 
Syntax CROSSTABS 
  /TABLES=FACTOR BY 
AGEBAND2 
  /FORMAT=AVALUE 
TABLES 
  /STATISTICS=CHISQ 
  /CELLS=COUNT 
  /COUNT ROUND CELL 
  /METHOD=EXACT 
TIMER(5). 
Resources Processor Time 00:00:00.09 
Elapsed Time 00:00:00.11 
Dimensions Requested 2 
Cells Available 524245 
Time for Exact Statistics 0:00:00.06 
 
 
 
 
 
 
Case Processing Summary 
 Cases 
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Valid Missing Total 
N Percent N Percent N Percent 
Which Factor * AGEBAND2 9 100.0% 0 0.0% 9 100.0% 
 
 
Which Factor * AGEBAND2 Crosstabulation 
Count   
 
AGEBAND2 
Total 50-59 60-69 70-79 
Which Factor Factor 2 1 5 0 6 
Factor 3 0 0 3 3 
Total 1 5 3 9 
 
 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 9.000
a
 2 .011 .012  
Likelihood Ratio 11.457 2 .003 .012  
Fisher's Exact Test 7.683   .012  
Linear-by-Linear Association 6.125
b
 1 .013 .012 .012 
N of Valid Cases 9     
 
Chi-Square Tests 
 Point Probability 
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Pearson Chi-Square  
Likelihood Ratio  
Fisher's Exact Test  
Linear-by-Linear Association .012 
N of Valid Cases  
 
a. 6 cells (100.0%) have expected count less than 5. The minimum expected count is .33. 
b. The standardized statistic is 2.475. 
 
 
 
Crosstabs 
 
 
 
Notes 
Output Created 02-AUG-2018 20:03:10 
Comments  
Input Data C:\Users\Clive\Dropbox\DCli
nPsy\Thesis\Data\Write Up 
SPSS Outputs\Compare 2 
and 3.sav 
Active Dataset DataSet4 
Filter <none> 
Weight <none> 
Split File <none> 
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N of Rows in Working Data 
File 
9 
Missing Value Handling Definition of Missing User-defined missing values 
are treated as missing. 
Cases Used Statistics for each table are 
based on all the cases with 
valid data in the specified 
range(s) for all variables in 
each table. 
Syntax CROSSTABS 
  /TABLES=FACTOR BY 
QUIT 
  /FORMAT=AVALUE 
TABLES 
  /STATISTICS=CHISQ 
  /CELLS=COUNT 
  /COUNT ROUND CELL 
  /METHOD=EXACT 
TIMER(5). 
Resources Processor Time 00:00:00.05 
Elapsed Time 00:00:00.05 
Dimensions Requested 2 
Cells Available 524245 
Time for Exact Statistics 0:00:00.02 
 
 
Case Processing Summary 
 Cases 
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Valid Missing Total 
N Percent N Percent N Percent 
Which Factor * Desire to quit 9 100.0% 0 0.0% 9 100.0% 
 
 
 
 
Which Factor * Desire to quit Crosstabulation 
Count   
 
Desire to quit 
Total Some Very 
Which Factor Factor 2 1 5 6 
Factor 3 1 2 3 
Total 2 7 9 
Chi-Square Tests 
 Value df 
Asymptotic 
Significance (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square .321
a
 1 .571 1.000 .583 
Continuity Correction
b
 .000 1 1.000   
Likelihood Ratio .309 1 .578 1.000 .583 
Fisher's Exact Test    1.000 .583 
Linear-by-Linear Association .286
c
 1 .593 1.000 .583 
N of Valid Cases 9     
 
Chi-Square Tests 
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 Point Probability 
Pearson Chi-Square  
Continuity Correction
b
  
Likelihood Ratio  
Fisher's Exact Test  
Linear-by-Linear Association .500 
N of Valid Cases  
 
a. 4 cells (100.0%) have expected count less than 5. The minimum expected count is .67. 
b. Computed only for a 2x2 table 
c. The standardized statistic is -.535. 
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Appendix M – Questionnaires  
[INSERT TRUST LOGO] 
 
 
 
 
 
AGE?        Declined to say  
 
HOW DO YOU DESCRIBE YOUR GENDER?  Declined to say  
 
WHAT WOULD DESCRIBE AS YOUR ETHNICITY? Declined to say  
 
HOW MUCH DO YOU WISH TO QUIT SMOKING CURRENTLY? 
 NOT AT ALL / SOMEWHAT / VERY MUCH 
 
HOW MANY TIMES HAVE YOU ATTEMPTED TO QUIT PREVIOUSLY? 
 
REFERENCE NUMBER: 
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INSERT TRUST LOGO 
 
 
 
 
Hospital Anxiety and Depression Scale (HADS) 
Instructions: Read each item and circle the reply which comes closest 
to how you have been feeling in the past week. Don’t take too long 
over your replies: your immediate reaction to each item will probably 
be more accurate than a long thought out response.  
 
I feel tense or ‘wound up’:  A   I feel as if I am slowed down:  D  
Most of the time  3   Nearly all of the time  3  
A lot of the time  2   Very often  2  
Time to time, occasionally  1   Sometimes  1  
Not at all  0   Not at all  0  
     
I still enjoy the things I used to enjoy:  D    I get a sort of frightened feeling like 
‘butterflies in the stomach’:  
A  
Definitely as much  0    Not at all  0  
Not quite so much  1    Occasionally  1  
Only a little  2    Quite often  2  
Not at all  3    Very often  3  
     
I get a sort of frightened feeling like 
something awful is about to happen:  
A   I have lost interest in my appearance:  D  
Very definitely and quite badly  3   Definitely  3  
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Yes, but not too badly  2   I don’t take as much care as I should  2  
A little, but it doesn’t worry me  1   I may not take quite as much care  1  
Not at all  0   I take just as much care as ever  0  
 
 
    
I can laugh and see the funny side of things:  D    I feel restless as if I have to be on the 
move:  
A  
As much as I always could  0    Very much indeed  3  
Not quite so much now  1    Quite a lot  2  
Definitely not so much now  2    Not very much  1  
Not at all  3    Not at all  0  
     
Worrying thoughts go through my mind:  A   I look forward with enjoyment to 
things:  
D  
A great deal of the time  3   A much as I ever did  0  
A lot of the time  2   Rather less than I used to  1  
From time to time but not too often  1   Definitely less than I used to  3  
Only occasionally  0   Hardly at all  2  
     
I feel cheerful:  D    I get sudden feelings of panic:  A  
Not at all  3    Very often indeed  3  
Not often  2    Quite often  2  
Sometimes  1    Not very often  1  
Most of the time  0    Not at all  0  
     
I can sit at ease and feel relaxed:  A   I can enjoy a good book or radio or 
TV programme:  
D  
Definitely  0   Often  0  
Usually  1   Sometimes  1  
Not often  2   Not often  2  
Not at all  3   Very seldom  3  
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REFERENCE NUMBER 
 
 
 
 
 
Appendix N - Journal Submission Guidelines 
 
 
Instructions for authors 
Thank you for choosing to submit your paper to us. These instructions will ensure 
we have everything required so your paper can move through peer review, 
production and publication smoothly. Please take the time to read and follow them 
as closely as possible, as doing so will ensure your paper matches the journal's 
requirements. For general guidance on the publication process at Taylor & Francis 
please visit our Author Services website.  
 
 
  
This journal uses ScholarOne Manuscripts (previously Manuscript Central) to peer 
review manuscript submissions. Please read the guide for ScholarOne 
authors before making a submission. Complete guidelines for preparing and 
submitting your manuscript to this journal are provided below.  
 
Contents 
 About the Journal 
 Peer Review 
 Preparing Your Paper 
  
o Structure 
o Word Limits 
o Style Guidelines 
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o Formatting and Templates 
o References 
o Checklist 
 Using Third-Party Material 
 Submitting Your Paper 
 Data Sharing Policy 
 Publication Charges 
 Copyright Options 
 Complying with Funding Agencies 
 Open Access 
 My Authored Works 
 Reprints 
About the Journal 
Psychology & Health is an international, peer-reviewed journal publishing 
high-quality, original research. Please see the journal's Aims & Scope for 
information about its focus and peer-review policy. 
Please note that this journal only publishes manuscripts in English. 
Psychology & Health accepts the following types of article: Article, Editorial, 
Commentary. 
Peer Review 
Taylor & Francis is committed to peer-review integrity and upholding the 
highest standards of review. Once your paper has been assessed for 
suitability by the editor, it will then be single blind peer reviewed by 
independent, anonymous expert referees. Find out more about what to 
expect during peer review and read our guidance on publishing ethics. 
Preparing Your Paper 
Structure 
Your paper should be compiled in the following order: title page; abstract; 
keywords; main text introduction, materials and methods, results, discussion; 
acknowledgments; declaration of interest statement; references; appendices 
(as appropriate); table(s) with caption(s) (on individual pages); figures; figure 
captions (as a list). 
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Word Limits 
Article and Editorial: 30 Pages  
Commentary: 1000 words. 
Style Guidelines 
Please refer to these quick style guidelines when preparing your paper, 
rather than any published articles or a sample copy. 
Please use British (-ise) spelling style consistently throughout your 
manuscript. 
Please use single quotation marks, except where ‘a quotation is “within” a 
quotation’. Please note that long quotations should be indented without 
quotation marks. 
Formatting and Templates 
Papers may be submitted in Word format. Figures should be saved 
separately from the text. To assist you in preparing your paper, we provide 
formatting template(s). 
Word templates are available for this journal. Please save the template to 
your hard drive, ready for use. 
If you are not able to use the template via the links (or if you have any other 
template queries) please contact us here. 
References 
Please use this reference guide when preparing your paper. 
An EndNote output style is also available to assist you. 
  
Checklist: What to Include 
1. Author details. All authors of a manuscript should include their full name and 
affiliation on the cover page of the manuscript. Where available, please also include 
ORCiDs and social media handles (Facebook, Twitter or LinkedIn). One author will 
need to be identified as the corresponding author, with their email address normally 
displayed in the article PDF (depending on the journal) and the online article. 
Authors’ affiliations are the affiliations where the research was conducted. If any of 
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the named co-authors moves affiliation during the peer-review process, the new 
affiliation can be given as a footnote. Please note that no changes to affiliation can 
be made after your paper is accepted. Read more on authorship. 
2. Should contain a structured abstract of 200 words. Objective, Design, Main 
Outcome Measures, Results, Conclusion. 
3. You can opt to include a video abstract with your article. Find out how these can 
help your work reach a wider audience, and what to think about when filming. 
4. Read making your article more discoverable, including information on choosing a 
title and search engine optimization. 
5. Funding details. Please supply all details required by your funding and grant-
awarding bodies as follows:  
For single agency grants  
This work was supported by the [Funding Agency] under Grant [number xxxx].  
For multiple agency grants  
This work was supported by the [Funding Agency #1] under Grant [number xxxx]; 
[Funding Agency #2] under Grant [number xxxx]; and [Funding Agency #3] under 
Grant [number xxxx]. 
6. Disclosure statement. This is to acknowledge any financial interest or benefit that 
has arisen from the direct applications of your research. Further guidance on what is 
a conflict of interest and how to disclose it. 
7. Data availability statement. If there is a data set associated with the paper, please 
provide information about where the data supporting the results or analyses 
presented in the paper can be found. Where applicable, this should include the 
hyperlink, DOI or other persistent identifier associated with the data 
set(s). Templates are also available to support authors. 
8. Data deposition. If you choose to share or make the data underlying the study 
open, please deposit your data in a recognized data repository prior to or at the time 
of submission. You will be asked to provide the DOI, pre-reserved DOI, or other 
persistent identifier for the data set. 
9. Supplemental online material. Supplemental material can be a video, dataset, 
fileset, sound file or anything which supports (and is pertinent to) your paper. We 
publish supplemental material online via Figshare. Find out more 
about supplemental material and how to submit it with your article. 
10. Figures. Figures should be high quality (1200 dpi for line art, 600 dpi for grayscale 
and 300 dpi for colour, at the correct size). Figures should be supplied in one of our 
preferred file formats: EPS, PS, JPEG, GIF, or Microsoft Word (DOC or DOCX). For 
information relating to other file types, please consult our Submission of electronic 
artworkdocument. 
11. Tables. Tables should present new information rather than duplicating what is in the 
text. Readers should be able to interpret the table without reference to the text. 
Please supply editable files. 
12. Equations. If you are submitting your manuscript as a Word document, please 
ensure that equations are editable. More information about mathematical symbols 
and equations. 
13. Units. Please use SI units (non-italicized). 
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Using Third-Party Material in your Paper 
You must obtain the necessary permission to reuse third-party material in 
your article. The use of short extracts of text and some other types of 
material is usually permitted, on a limited basis, for the purposes of criticism 
and review without securing formal permission. If you wish to include any 
material in your paper for which you do not hold copyright, and which is not 
covered by this informal agreement, you will need to obtain written 
permission from the copyright owner prior to submission. More information 
on requesting permission to reproduce work(s) under copyright. 
Submitting Your Paper 
Please note that Psychology & Health uses Crossref™ to screen papers for 
unoriginal material. By submitting your paper to Psychology & Health you are 
agreeing to originality checks during the peer-review and production 
processes. 
On acceptance, we recommend that you keep a copy of your Accepted 
Manuscript. Find out more about sharing your work. 
Data Sharing Policy 
This journal applies the Taylor & Francis Basic Data Sharing Policy. Authors 
are encouraged to share or make open the data supporting the results or 
analyses presented in their paper where this does not violate the protection 
of human subjects or other valid privacy or security concerns. 
Authors are encouraged to deposit the dataset(s) in a recognized data 
repository that can mint a persistent digital identifier, preferably a digital 
object identifier (DOI) and recognizes a long-term preservation plan. If you 
are uncertain about where to deposit your data, please see this 
information regarding repositories. 
Authors are further encouraged to cite any data sets referenced in the article 
and provide a Data Availability Statement. 
At the point of submission, you will be asked if there is a data set associated 
with the paper. If you reply yes, you will be asked to provide the DOI, pre-
registered DOI, hyperlink, or other persistent identifier associated with the 
data set(s). If you have selected to provide a pre-registered DOI, please be 
prepared to share the reviewer URL associated with your data deposit, upon 
request by reviewers. 
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Where one or multiple data sets are associated with a manuscript, these are 
not formally peer reviewed as a part of the journal submission process. It is 
the author’s responsibility to ensure the soundness of data. Any errors in the 
data rest solely with the producers of the data set(s). 
Publication Charges 
There are no submission fees, publication fees or page charges for this 
journal. 
Colour figures will be reproduced in colour in your online article free of 
charge. If it is necessary for the figures to be reproduced in colour in the print 
version, a charge will apply. 
Charges for colour figures in print are £300 per figure ($400 US Dollars; 
$500 Australian Dollars; €350). For more than 4 colour figures, figures 5 and 
above will be charged at £50 per figure ($75 US Dollars; $100 Australian 
Dollars; €65). Depending on your location, these charges may be subject to 
local taxes. 
Copyright Options 
Copyright allows you to protect your original material, and stop others from 
using your work without your permission. Taylor & Francis offers a number of 
different license and reuse options, including Creative Commons licenses 
when publishing open access. Read more on publishing agreements. 
Complying with Funding Agencies 
We will deposit all National Institutes of Health or Wellcome Trust-funded 
papers into PubMedCentral on behalf of authors, meeting the requirements 
of their respective open access policies. If this applies to you, please tell our 
production team when you receive your article proofs, so we can do this for 
you. Check funders’ open access policy mandates here. Find out more 
about sharing your work. 
Open Access 
This journal gives authors the option to publish open access via our Open 
Select publishing program, making it free to access online immediately on 
publication. Many funders mandate publishing your research open access; 
you can check open access funder policies and mandates here. 
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Taylor & Francis Open Select gives you, your institution or funder the option 
of paying an article publishing charge (APC) to make an article open access. 
Please contact openaccess@tandf.co.uk if you would like to find out more, or 
go to our Author Services website. 
For more information on license options, embargo periods and APCs for this 
journal please go here. 
My Authored Works 
On publication, you will be able to view, download and check your article’s 
metrics (downloads, citations and Altmetric data) via My Authored Works on 
Taylor & Francis Online. This is where you can access every article you have 
published with us, as well as your free eprints link, so you can quickly and 
easily share your work with friends and colleagues. 
We are committed to promoting and increasing the visibility of your article. 
Here are some tips and ideas on how you can work with us to promote your 
research. 
Article Reprints 
You will be sent a link to order article reprints via your account in our 
production system. For enquiries about reprints, please contact the Taylor & 
Francis Author Services team at reprints@tandf.co.uk. You can also order 
print copies of the journal issue in which your article appears. 
Queries 
Should you have any queries, please visit our Author Services website or 
contact us here. 
Updated 23-05-2018 
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WHY WAS THIS PROJECT UNDERTAKEN? 
 
 Smoking is the leading cause of COPD (1)  
 The only proven way to slow the progress of COPD 
is to stop smoking (1) 
 Around 3 out of 10 people with COPD still smoke (2) 
 Smoking is linked to higher rates of depression, 
anxiety and death for people with COPD (3) 
 
 Current methods for helping people with COPD to 
stop smoking work as well as each-other (4) 
 It is not known whether people who smoke with 
COPD have different needs to those without COPD 
(4) 
 People can struggle with competing thoughts about 
stopping smoking, but somehow decide to continue 
(5) 
 Research has found some of the thoughts people 
with COPD have about smoking, but it is not known 
how people decide to continue smoking with COPD 
(6) 
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WHAT WAS DONE? 
 
 The scientific evidence was searched to find out what was 
already known about reasons people give for not quitting 
smoking with COPD, 52 reasons were identified 
 We wanted to know which reasons are held together as 
viewpoints  
 
 
 
 
 
 
 Approval from Staffordshire University and NHS Ethics 
panels was granted to use Q-Methodology to find out 
 The 52 reasons found were checked with other 
Psychologists, people with COPD, and NHS staff working 
with COPD 
 Another 21 reasons were found from talking to these 
people 
 The total of 73 reasons were printed onto plastic cards 
It’s too late to stop 
smoking the 
damage is done 
I plan on stopping 
in future one day  
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 People with COPD who smoke were asked by NHS staff, if 
they wanted to take part in this study. An online version of 
the study was advertised on Facebook™ and Twitter™ 
 People who were very ill or with dementia were not 
asked to take part to protect them, as we could not be 
certain that they would be able to understand what they 
were agreeing to 
 Q-Methodology involves placing cards on a grid by level 
of agreement 
 22 people took part, 18 of them face-to-face 
 The 18 people completed some questionnaires and sorted 
the plastic cards into agree/not sure and disagree piles 
 The cards were put onto a pyramid-shaped grid to show 
what they believed (see picture below) 
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 The other 4 people did the same thing using a special 
website on their computer 
 People were also asked to comment about how they 
sorted the cards 
 Each pyramid of cards showed a person’s view about why 
they still smoke with COPD 
 Each view was compared to the other 21 views using a 
computer program 
 The program produced ideal viewpoints that represented 
the shared view of some of the people who took part (see 
next diagram for an example computerised diagram)  
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An example of a Q-sort as recorded by the computer program 
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WHAT WAS FOUND? 
 
 17 out of 21 people held 1 of 3 distinct viewpoints – the 
table below shows the statements people most strongly 
agreed with and disagreed with by the 3 groups 
 
 
Factor 
(Viewpoint) 
No. of 
People 
Statements Most Strongly 
Agreed With 
Statements Most Strongly 
Disagreed With 
1 8  It’s too late I am too old, 
and the damage is done 
(+6) 
 I really enjoy smoking 
(+6) 
 
 Smoking does not cause 
or worsen COPD (-6) 
 I wish someone would tell 
me directly to stop and 
give me a shock about 
what will happen if I don’t 
(-6) 
2 6  It has to be my decision in 
my own mind to stop (+6) 
 I wish someone could flip 
a switch and make me 
stop (+6) 
 Being a smoker is part of 
my identity (-6) 
 If I give up smoking I'll 
mourn my cigarettes (-6) 
3 3  I really enjoy smoking 
(+6) 
 I wish someone could just 
flip a switch and make me 
stop (+6) 
 Smoking helps me to 
breathe (-6) 
 Smoking helps me go to 
the toilet (-6) 
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 The remaining 5 people shared more than 1 viewpoint 
 The people represented in each of the 3 viewpoints did 
not differ in terms of average anxiety or depression 
levels, nor in terms of gender 
 People with the 1st viewpoint were generally older than 
people with the 2nd and 3rd viewpoints  
 The people who had no interest in stopping smoking only 
held the 1st viewpoint  
 2 of the remaining 5 people (who did not load onto 1 
factor) gave loneliness as one of the reasons for still 
smoking 
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The diagram below shows how statements were unique to, or 
shared by, each factor. Where the circles overlap this 
represents a shared view, where they do not this indicates what 
makes the viewpoint unique 
 
 
 
Factor 3:
I am a slave to smoking, cigarettes 
are like friends to me, and I adapt 
to my symptoms so I do not notice 
my health getting worse. It is 
easier to deny I smoke and just 
hide it. I'm not sure what caused 
my COPD
Factor 1:
It's too late to stop smoking 
the damage is done. It is my 
choice and my business to 
smoke. It is part of my 
identity. It stimulates me. 
I do not plan on stopping, 
I do not want to see
 the doctor, and I don't
want to be shocked
         about what will happen
Factor 2:
Smoking is not a part
 of my identity, I'm not sure 
if I even enjoy it. I cut down 
when I feel unwell and buy 
alternatives, but I feel guilty, 
and lack the support to stop 
smoking. Telling 
me to stop just
 makes me
 smoke
 more
Consensus  2 & 3: 
I wish someone would 
give me a shock, or 
just flip a switch. I feel 
hopeless about 
smoking.
 I don't have
the will-power,
 but I plan on 
stopping
 in future
 so it is
 ok.
Consensus 1 & 2:
Smoking stops me becoming 
depressed and anxious, and 
helps me to concentrate. 
Withdrawal symptoms are 
too unpleasant, but I could 
stop if I really wanted
 to
Consensus 1 & 3 
I really enjoy 
smoking, and it 
helps me to cough 
up phlegm. You 
have got to die of 
something.
Consensus All 
Factors:
Smoking helps me to relax 
not feel stressed and 
irritable. I accept that 
smoking is worsening my 
COPD. Quitting has to be 
my own decision. I am not 
embarrassed to seek help.
Smoking Alleviates 
Loneliness?
Disagreed with by all Factors:
COPD is just a part of old-age. There are no benefits to stopping smoking.
 I am too embarrassed to seek help to stop. I inhale less smoke when I'm not feeling well so that reduces the damage. Smoking helps me to 
breathe. I exercise or attend Pulmonary Rehabilitation so I don't need to stop smoking. Smoking is sociable and I continue because it's part of 
my social life
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WHAT DOES THIS MEAN? 
Factor Name Cambridge 
Dictionary 
Definition of Name 
Explanation of Factor 
1 Stoic 
Fatalism 
Stoicism:  
the quality of 
experiencing pain 
or trouble without 
complaining or 
showing your 
emotions: 
 
Fatalism: 
the belief that 
people cannot 
change the way 
events will happen 
and that events, 
especially bad ones, 
cannot be avoided 
People with this viewpoint accept that COPD is 
related to smoking and say that smoking prevents 
anxiety and low mood. Difficulties with addiction are 
also stated and smoking is a part of person’s identity. 
The view is that continuing to smoke is the business 
and choice of the person with COPD, and they do not 
want to be shocked about what will happen, 
suggesting they do not wanting to stir up feelings 
(Stoicism).  
 
People with this view also say that the damage from 
smoking is already done, and that you have to die of 
something, meaning they think nothing can really be 
done (Fatalism) which justifies choosing to continue 
enjoying smoking. 
 
2 Optimistic 
Passivity 
Optimism: 
the quality of being 
full of hope and 
emphasizing the 
good parts of a 
situation, or a belief 
that something good 
will happen 
 
Passive: 
not acting to 
influence or change 
a situation; allowing 
other people to be 
in control 
People with this viewpoint accept that COPD is 
related to smoking and, like factor 1, think that 
smoking prevents anxiety and low mood. However, 
people with this view do not particularly like 
smoking, and smoking is not a part of their identity. 
There is a desire to quit, and they are positive that it 
is not too late as there will be benefits to quitting 
(Optimism).  
 
There is a feeling of guilt. By cutting down smoking 
when unwell, smoking lighter cigarettes, buying 
nicotine replacement therapy, planning on quitting 
in future, and thinking that it is never being the right 
time, they put off quitting. The wish that someone 
could flip a switch, or shock them into stopping is 
there, but when they are told to stop they just smoke 
more. This takes a step back from an active and 
determined position to quit (Passivity). 
3 Ambivalent 
Masochism 
Ambivalent: 
having two opposing 
feelings at the same 
time, or being 
People with this viewpoint have some positive 
thoughts about it not being too late to stop and plan 
to quit, but also that it also might be too late – the 
mind cannot be made up. They seem to accept that 
smoking is probably making it worse, but also have 
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 The 3 viewpoints are more complex than (and differ from) 
the traditional categories of smoker: pre-contemplative, 
contemplative and preparing to quit (7)  
 Some people who had some interest in stopping still held 
Stoic Fatalistic views – just because they saw it as their 
fate did not mean they were not thinking about quitting 
smoking 
 2 of the 3 viewpoints expressed showed people believed 
that smoking prevents them from becoming anxious or 
depressed despite no differences in anxiety and 
depression levels between people with different views 
 No evidence found that people who held the 3 viewpoints 
believed that Pulmonary Rehabilitation made up for the 
damage from smoking 
 No evidence was found that smoking was seen as part of 
people’s social life 
 
 
uncertain about how 
you feel 
 
Masochism: 
(informal)  
the enjoyment of an 
activity or situation 
that most people 
would find very 
unpleasant 
some doubts about smoking causing their COPD 
(Ambivalent). 
 
People with this view are not worried about 
withdrawal symptoms from smoking but describe 
themselves as slaves to cigarettes. They would 
desperately like someone to be able to stop this 
magically, but just as strongly really enjoy smoking; 
control remains with the cigarettes and the harm is 
adapted to (Masochism). 
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HOW DO WE USE THESE RESULTS? 
 
 People with a Stoic Fatalistic viewpoint may need help to 
find reasons to stop smoking and perhaps face difficult 
feelings 
 People with a Passive Optimistic viewpoint may need 
help to put their plans into action and to check whether 
their current ideas and strategies are helpful or not 
 People with an Ambivalent Masochistic viewpoint may 
need help with making an informed decision and building 
self-control 
 
 Many people with COPD may need help with anxiety and 
depression at the same time as trying to stop smoking 
 Psychologists and other professionals working with 
people with COPD need to consider mental health and 
smoking as often being related 
 However, there are still many unanswered questions and 
further research is needed… 
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? This was a small study; we do not know how widespread 
these viewpoints are, this would require further research 
? Although ages differed by viewpoint, we do not know if a 
person’s view of their reasons for smoking changes as 
they get older or their COPD gets worse, this needs more 
research 
? We do not know if people with COPD who believe 
smoking prevents depression and anxiety actually 
experience increased distress when changing their habit 
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If you would like further information on the study please email Dr Helen Combes 
h.a.combes@staffs.ac.uk  
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